TRANSGENIC SOYBEAN EVENT GM_CSM63714 AND METHODS FOR DETECTION AND USES THEREOF

Information

  • Patent Application
  • 20230348927
  • Publication Number
    20230348927
  • Date Filed
    April 25, 2023
    a year ago
  • Date Published
    November 02, 2023
    7 months ago
Abstract
A transgenic soybean event, Gm_CSM63714, is provided. Transgenic plant cells, plant parts, plants, seeds, progeny plants, and agricultural and commodity products containing event Gm_CSM63714 are also provided. Recombinant DNA molecules unique to the event Gm_CSM63714, and methods of using and detecting Gm_CSM63714 are also provided. Soybean plants containing the event Gm_CSM63714 exhibit tolerance to benzoic acid auxins such as dicamba; phenoxy auxins such as 2,4-D; inhibitors of glutamine synthetase such as glufosinate; and β-triketone inhibitors of 4-hydroxyphenylpyruvate dioxygenase (HPPD) such as mesotrione.
Description
INCORPORATION OF SEQUENCE LISTING

The sequence listing contained in the file named “MONS532US_ST26.xml”, which is 222 kilobytes (measured in MS-Windows), was created on Feb. 13, 2023, is filed herewith by electronic submission, and is incorporated herein by reference in its entirety.


FIELD OF THE INVENTION

The present disclosure relates generally to the fields of agriculture, plant biotechnology and molecular biology. More specifically, the disclosure relates to compositions and methods for providing herbicide tolerance in transgenic soybean plants. More specifically, recombinant DNA molecules of soybean event Gm_CSM63714 are provided. Also provided are transgenic soybean plants, plant parts, seeds, cells, and agricultural products comprising the soybean event Gm_CSM63714, as well as methods of producing and using transgenic soybean plants, plant parts, seeds, cells, and agricultural products comprising soybean event Gm_CSM63714, methods of detecting soybean event Gm_CSM63714, and methods of controlling weeds. Transgenic soybean plants, plant parts, seeds and cells comprising soybean event Gm_CSM63714 exhibit tolerance to benzoic acid auxins such as dicamba; inhibitors of glutamine synthetase such as glufosinate; phenoxy auxins such as 2,4-D; and β-triketone herbicides (inhibitors of 4-hydroxyphenylpyruvate dioxygenase, or HPPD) such as mesotrione.


BACKGROUND OF THE INVENTION

Increasing sustainable crop production is crucial to meet the need for food for the growing global population, feed for increased demand on animal-based diets in developing nations, and expanded use of crop products to produce biofuel, fiber, and other agricultural product-based commodities, while using limited natural resources. In agricultural systems, the effective management of weedy species in agricultural fields is essential for maintaining favorable crop growing conditions and yield. Weeds compete with crops for space, nutrients, water, and light and can contaminate harvests, and present one of the major challenges to sustainable crop production. In soybean alone, poor weed control can cause up to nearly 50% of yield reduction and up to $16 billion of annual loss in the United States (Weed Science Society of America). Selective herbicides had significantly contributed to weed management before the deployment of herbicide tolerant crops. Application of herbicides provides an important tool to reduce weed pressure, improve productivity and increase security for global crop production.


Soybean (Glycine max) is an important crop in many areas of the world. The introduction of genetically modified crops containing herbicide tolerance traits has successfully provided additional tools available to farmers to better control weeds. Transgenic herbicide tolerance enables the use of an herbicide in a crop growing environment without crop injury or with minimal crop injury (e.g., less than about 10% injury). Transgenic soybean traits have been used to impart tolerance to glyphosate and/or dicamba and are used broadly in commercial soybean production for weed management. However, weeds have evolved resistance to herbicides and weed resistance continues to present a challenge in soybean production today. Therefore, there is a need for additional herbicide tolerance trait options to manage weeds effectively and to sustain crop productivity. One of the solutions is to employ multiple herbicide modes of action.


Combinations of herbicide tolerance traits are desirable to provide weed control options that increase grower flexibility and enable the use of multiple herbicide modes of action for controlling challenging weeds. Combining multiple desired traits in the genome can be achieved by making crosses between two parents each having a desired trait, and identifying progeny plants that have combination of the desired traits, or by retransforming a transgenic plant comprising one or more desired trait(s) with one or more genes for additional desired traits, either through random integration or through targeted integration of the one or more genes for additional desired traits. Alternatively, combining multiple desired traits can be achieved by inserting multiple genes as a single DNA molecule into one location, or locus, in the genome. The combination of multiple herbicide tolerance traits at a single locus in soybean would provide a useful tool in weed control that is much simpler and less expensive to maintain during subsequent breeding into a diverse pool of elite germplasms.


The expression of transgenes in a transgenic plant, plant part, seed, cell or progeny, and thus their effectiveness, may be influenced by many factors, such as the regulatory elements used in the transgenes' expression cassettes, the combination and/or interaction of these regulatory elements, the chromosomal location of the transgene insertion site, the chromatin structure of the genome at or near the transgene insertion site, and the presence or proximity of any endogenous cis and/or trans regulatory elements or genes close to the transgene insertion site. In addition, the performance of the traits in the transgenic plant is further complicated when the transgenic insert comprises multiple expression cassettes, each having a different transgene conferring a distinct trait. These differences or factors may result in variation in the level of transgene expression or in the spatial or temporal pattern of transgene expression among different transgenic insertion events of the same expression cassettes. Furthermore, different transgenic events can also vary in terms of the molecular quality of the events. For example, a transgenic event may contain two or more copies of the transgene insertion at one or more chromosomal locations, or a transgenic insertion may be truncated relative to the intended insertion or contain vector backbone sequences, or a transgene may be inserted into an endogenous gene or in a repeated region. Such characteristics may result in undesirable outcomes, such as gene silencing, altered pattern and/or expression of the transgene, altered pattern and/or expression of the endogenous genes. There may also be undesirable phenotypic or agronomic differences among different events.


Even in the case of targeted sequence insertion, variability in the level of transgene expression between independent but genetically identical targeted sequence insertion (TSI) events was observed in a subset of transgenic events (Verkest et al., 2019). This expression variability and silencing occurred independently of the transgene sequence and could be attributed to DNA methylation that was further linked to different DNA methylation mechanisms. The fact that a considerable variation in transgene expression was observed in a subset of clean TSI events shows that even when integration events are targeted, selection remains necessary similarly to the practice for random integration events in order to identify TSI events with stable gene of interest expression over generations.


A commercially useful multi-gene transgenic event requires that each of the transgenes in the transgenic insert express in the manner necessary for that trait to be successful, and involves rigorous testing, evaluation and selection. Once one or more tolerance traits have been chosen, individual expression cassettes are designed and tested in vitro and/or in planta to select for the best expression cassettes for each trait. Such tests include testing different regulatory elements (e.g., promoters, introns, leaders, and 3′ UTRs) and combinations of different regulatory elements for desirable spatial and temporal expression of the transgenes, as well as examining whether to target the product of the transgenes (proteins) to subcellular compartments such as chloroplasts. Then the selected expression cassettes for each trait are then combined into one construct, and the construct is tested to ensure that all the expression cassettes function well together and each transgene is properly expressed. The selected combinations of expression cassettes are then used for transformation to produce transgenic plants. Since Agrobacterium-mediated transformation with a T-DNA construct comprising one or more transgene cassettes is largely variable and random in terms of where the transgene(s) can be inserted into the plant genome, each transgenic event is unique with random and unique insertion of the transgenic DNA in a different plant genomic location. Thus, the selected combinations of expression cassettes are used to produce hundreds of unique multi-gene transgenic events, each the result of a random insertion of the foreign DNA in a different plant genomic location.


For these reasons, the performance of different transformation events from the same transformation construct can vary, and the identification of transformation events conferring the most beneficial traits or characteristics without other potential off-types or concerns is needed to select a superior event for commercial use. Therefore, a large number of individual transgenic events must be produced and analyzed to select an event having superior commercial properties, which can be a significant undertaking that involves analysis and selection among many different transformation events.


To establish a multi-gene event for commercial use requires rigorous molecular characterization, greenhouse testing, and field trials over multiple years, in multiple locations and under a variety of conditions, allowing extensive agronomic, phenotypic, and molecular data to be obtained. The resulting data are then analyzed to select an event that is suitable for commercial purposes. The commercial multi-gene event, once identified as having the desired transgene expression, molecular characteristics, efficacy and field performance, can then be introgressed as a single locus having multiple herbicide tolerance traits into other soybean genetic backgrounds using plant breeding methods. The resulting soybean varieties contain the new traits combined with other desirable qualities such as native traits, disease tolerance traits, insect control traits, high-yielding germplasm or traits, and/or one or more other transgenic herbicide tolerance traits.


SUMMARY OF THE INVENTION

Recombinant DNA molecules are provided herein. Examples of such recombinant DNA molecules include a sequence selected from the group consisting of SEQ ID NO:10, SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9, and a complete complement of any of the foregoing. In some embodiments, the recombinant DNA molecule is derived from a soybean plant, seed, plant part, plant cell, progeny plant, or commodity product comprising soybean event Gm_CSM63714 a representative sample of seed comprising the event having been deposited as ATCC Accession No. PTA-127099. In some embodiments, the recombinant DNA is comprised in a soybean plant, seed, plant part, plant cell, or progeny plant comprising soybean event Gm_CSM63714, or a commodity product produced therefrom, a representative sample of seed comprising the event having been deposited as ATCC Accession No. PTA-127099. The recombinant DNA molecule can be formed by the insertion of a heterologous nucleic acid molecule into the genomic DNA of a soybean plant or soybean cell. The recombinant DNA molecule can comprise an amplicon diagnostic for the presence of soybean event Gm_CSM63714.


DNA molecules that function as DNA probes are provided. An example of such a DNA molecule is a DNA molecule comprising a polynucleotide segment of sufficient length to function as a DNA probe that hybridizes specifically under stringent hybridization conditions with soybean event Gm_CSM63714 DNA in a sample. Detecting hybridization of the DNA molecule under the stringent hybridization conditions is diagnostic for the presence of soybean event Gm_CSM63714 in the sample.


Also provided is a DNA molecule comprising a polynucleotide segment of sufficient length to function as a DNA probe specific for detecting in a sample at least one of: a 5′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714; a 3′ junction sequence between the transgenic insert of soybean event Gm_CSM63714 and flanking soybean genomic DNA; SEQ ID NO:9; and a fragment of SEQ ID NO:9 comprising a sufficient length of contiguous nucleotides of SEQ ID NO:9 to identify the sequence as a fragment of the transgenic insert of Gm_CSM63714.


The DNA probe can comprises SEQ ID NO:16. Alternatively, the DNA molecule that functions as a DNA probe can comprise a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and a complement of any of the foregoing. the sample can be derived from a soybean plant, seed, plant part, plant cell, progeny plant, or commodity product.


A pair of DNA molecules is provided. The pair of DNA molecules comprises a first DNA molecule and a second DNA molecule. The first and the second DNA molecules comprise a fragment of SEQ ID NO:10 or a complement thereof and function as DNA primers when used together in an amplification reaction with DNA comprising soybean event Gm_CSM63714 to produce an amplicon diagnostic for soybean event Gm_CSM63714 in a sample. For example, the first and the second DNA molecules can comprise SEQ ID NO:14 and SEQ ID NO:15. The amplicon can comprise a nucleotide sequence selected from the group consisting of: SEQ ID NO:1; SEQ ID NO:2; SEQ ID NO:3; SEQ ID NO:4; SEQ ID NO:5; SEQ ID NO:6; SEQ ID NO:7; SEQ ID NO:8; SEQ ID NO:9; SEQ ID NO:10; and a fragment of any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, wherein the fragment is at least 10 nucleotides in length and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10.


Methods for detecting the presence of soybean event Gm_CSM63714 in a sample derived from a soybean seed, plant, plant part, plant cell, progeny plant, or commodity product are provided. In a first example of such a method, the method comprises: a) contacting the sample with any of the DNA molecules that function as probes described herein; b) subjecting the sample and the DNA molecule that functions as a probe to stringent hybridization conditions; and c) detecting the hybridization of the DNA molecule that functions as a probe to a DNA molecule in the sample. The hybridization of the DNA molecule that functions as a probe to the DNA molecule in the sample is diagnostic for the presence of soybean event Gm_CSM63714 in the sample.


Another method of detecting the presence of soybean event Gm_CSM63714 in a sample derived from a soybean seed, plant, plant part or plant cell, progeny plant and commodity product is provided. The method comprises: a) contacting the sample any of the pairs of DNA molecules described herein; b) performing an amplification reaction sufficient to produce a DNA amplicon; and c) detecting the presence of the DNA amplicon; wherein the DNA amplicon comprises at least one of: a 5′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714; a 3′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714; SEQ ID NO: 9; and a fragment of SEQ ID NO: 9 comprising a sufficient length of contiguous nucleotides of SEQ ID NO: 9 to identify the sequence as a fragment of the transgenic insert of Gm_CSM63714. The presence of the DNA amplicon indicates the presence of soybean event Gm_CSM63714 in the sample. The DNA amplicon can be at least 10 nucleotides in length, at least 11 nucleotides in length, at least 12 nucleotides in length, at least 13 nucleotides in length, at least 14 nucleotides in length, at least 15 nucleotides in length, at least 16 nucleotides in length, at least 17 nucleotides in length, at least 18 nucleotides in length, at least 19 nucleotides in length, at least 20 nucleotides in length, at least 25 nucleotides in length, at least 30 nucleotides in length, at least 35 nucleotides in length, at least 40 nucleotides in length, at least 45 nucleotides in length, at least 50 nucleotides in length, at least 60 nucleotides in length, at least 70 nucleotides in length, at least 80 nucleotides in length, at least 90 nucleotides in length, or at least 100 nucleotides in length. The DNA amplicon can comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:10; SEQ ID NO:9; SEQ ID NO:8; SEQ ID NO:7; SEQ ID NO:6; SEQ ID NO:5; SEQ ID NO:4; SEQ ID NO:3; SEQ ID NO:2; SEQ ID NO:1; and a fragment of any of SEQ ID NO:10, SEQ ID NO:8, SEQ ID NO:7, SEQ ID NO:6, SEQ ID NO:5, SEQ ID NO:4, SEQ ID NO:3, SEQ ID NO:2, and SEQ ID NO:1 that is at least 10 nucleotides in length and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10.


A further method of detecting the presence of soybean event Gm_CSM63714 in a sample of DNA derived from a soybean seed, plant, plant part, plant cell, progeny plant or commodity product is provided. The method comprises: a) contacting the sample with any of the DNA molecules that function as probes described herein; and b) performing a sequencing reaction to produce a target sequence. The target sequence comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a complete complement of any thereof, and a fragment of any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:10 that is at least 10 nucleotides long and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10.


Another method of detecting the presence of soybean event Gm_CSM63714 in a sample derived from a soybean seed, plant, plant part, cell, progeny plant or commodity product is provided. The method comprises: a) contacting the sample with at least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714; and b) detecting binding of the antibody to the protein in the sample. The binding of the antibody indicates the presence of soybean event Gm_CSM63714 in the sample.


DNA detection kit for detecting the presence of soybean event Gm_CSM63714 in a sample are provided. One example of such a DNA detection kit is a kit comprising any of the pairs of DNA primers described herein. Another example of a DNA detection kit is a kit comprising any of the DNA molecules that functions as a probe described herein.


Also provided are protein detection kits for detecting the presence of soybean event Gm_CSM63714 in a sample. One example of such a kit is a kit comprising at least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714. Detecting binding of the at least one antibody to the at least one protein encoded by soybean event Gm_CSM63714 in a sample is diagnostic for the presence of soybean event Gm_CSM63714 in the sample.


Also provided are a soybean plants, plant seeds, plant parts, and plant cells that comprise a recombinant DNA molecule comprising a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9, and a complete complement of any of the foregoing. The soybean plant, plant seed, plant part, or plant cell can express at least one herbicide tolerance gene selected from the group consisting of dicamba monooxygenase (DMO), phosphinothricin N-acetyltransferase (PAT), alpha-ketoglutarate-dependent non-heme iron dioxygenase variant FT_Tv7, triketone dioxygenase (TDO), and any combination thereof. The soybean plant, plant seed, plant part, or plant cell can be tolerant to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and combinations of any thereof. The benzoic acid auxin can comprise dicamba; the phenoxy auxin can comprise 2,4-D; the glutamine synthetase inhibitor can comprise glufosinate; and the β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. For example, the β-triketone HPPD inhibitor can comprise mesotrione. The soybean plant, plant seed, plant part, or plant cell can further comprise an additional transgene for tolerance to at least one additional herbicide. For example, the at least one additional herbicide is glyphosate. Where the at least one additional herbicide is glyphosate, the additional transgene can comprise a polynucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO:57. The soybean plant, plant seed, plant part, or plant cell can comprise soybean event Gm_CSM63714, a representative sample of seed comprising the event having been deposited under ATCC Accession No. PTA-127099. The soybean plant, plant seed, plant part, or plant cell can be further defined as a progeny plant of any generation of a soybean plant comprising soybean event Gm_CSM63714, or a soybean plant part, plant seed, or plant cell derived therefrom.


Further soybean plants, plant parts, plant seeds, and plant cells are provided. The soybean plants, plant parts, plant seeds, and plant cells comprise soybean event Gm_CSM63714, a representative sample of seed comprising soybean event Gm_CSM63714 having been deposited under ATCC Accession No. PTA-127099.


Any of the soybean plant parts described herein can comprises a microspore, pollen, an anther, an ovule, an ovary, a flower, a pod, an embryo, a stem, a leaf, a root, or a callus.


Methods for controlling or preventing weed growth in an area are provided. One example of such a method comprises planting soybean comprising event Gm_CSM63714 in the area, and applying an effective amount of at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof, to control weeds in the area without injury to the soybean or with less than about 10% injury to the soybean. Applying the effective amount of at least one herbicide can comprise applying at least two or more herbicides selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof over a growing season. The β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and any combination thereof. The effective amount of dicamba can be about 0.5 lb/acre to about 2 lb/acre over a growing season. The effective amount of glufosinate can be about 0.4 lb/acre to about 1.6 lb/acre over a growing season. The effective amount of 2,4-D can be about 0.5 lb/acre to about 4 lb/acre over a growing season. When the β-triketone HPPD inhibitor comprises mesotrione, the effective amount of mesotrione can be about 0.09 lb/acre to about 0.36 lb/acre over a growing season.


Methods for controlling volunteer soybean comprising soybean event Gm_CSM63714 in an area are provided. One example of such a method comprises applying an herbicidally effective amount of at least one herbicide other than dicamba, glufosinate, 2,4-D, or a β-triketone HPPD inhibitor, wherein the herbicide application prevents growth of soybean comprising soybean event Gm_CSM63714. The herbicide other than dicamba, glufosinate, 2,4-D, or a β-triketone HPPD inhibitor can be selected from the group consisting of atrazine, bronioxynil (3,5-di-bromo-4-hydroxybenzonitrile), clopyralid, pyrithiobac, isoxaflutole, topramezone, fluometuron, trifloxysulfuron, monosodium methyl arsenate (MSMA), an inhibitor of protoporphyrinogen oxidase (PPO), and combinations of any thereof. Examples of inhibitors of protoporphyrinogen oxidase (PPO) include saflufenacil, flumioxazin, sulfentrazone, and combinations of any thereof.


Methods of obtaining a seed of a soybean plant or a soybean plant that is tolerant to benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, or any combination thereof are provided. In one example of such a method, the method comprises: a) obtaining a population of progeny seed or plants grown therefrom, at least one of which comprises soybean event Gm_CSM63714; and b) identifying at least a first progeny seed or plant grown therefrom that comprises soybean event Gm_CSM63714. Identifying the progeny seed or plant grown therefrom that comprises soybean event Gm_CSM63714 can comprise: a) growing the progeny seed or plant to produce progeny plants; b) treating the progeny plants with an effective amount of at least one herbicide selected from the group consisting of a benzoic acid auxin, a phenoxy auxin, an inhibitor of glutamine synthetase, a β-triketone HPPD inhibitor, and any combination thereof; and c) selecting a progeny plant that is tolerant to the at least one herbicide selected from the group consisting of a benzoic acid auxin, a phenoxy auxin, an inhibitor of glutamine synthetase, a β-triketone HPPD inhibitor, and any combination thereof. The benzoic acid auxin can comprise dicamba. The phenoxy auxin can comprise 2,4-D. The glutamine synthetase inhibitor can comprise glufosinate. The β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. For example, the β-triketone HPPD inhibitor can comprise mesotrione. I Alternatively or in addition, identifying the progeny seed or plant grown therefrom that comprises soybean event Gm_CSM63714 comprises detecting the presence of soybean event Gm_CSM63714 in a sample derived from the progeny seed or plant grown therefrom. Alternatively or in addition, identifying the progeny seed or plant grown therefrom that comprises soybean event Gm_CSM63714 can comprise detecting the presence of at least one protein encoded by soybean event Gm_CSM63714 in a sample derived from the progeny seed or plant grown therefrom.


Methods of determining the zygosity of a soybean plant, plant part, plant seed, or plant cell comprising soybean event Gm_CSM63714 are provided. One example of such a method comprises: a) contacting a sample comprising DNA derived from the soybean plant, plant part, plant seed, or plant cell with a primer set capable of producing a first amplicon diagnostic for the presence of soybean event Gm_CSM63714 and a second amplicon diagnostic for the wild-type soybean genomic DNA not comprising soybean event Gm_CSM63714; b) performing a nucleic acid amplification reaction; and c) detecting the first amplicon and the second amplicon. The presence of both amplicons indicates that the plant, plant part, seed or cell is heterozygous for soybean event Gm_CSM63714. The presence of only the first amplicon indicates that the plant, plant part, seed, or cell is homozygous for soybean event Gm_CSM63714. An illustrative example of a primer set that can be used is a primer set comprising SEQ ID NO:14, SEQ ID NO:15 and SEQ ID NO:20.


Another method of determining the zygosity of a soybean plant, plant part, plant seed, or plant cell comprising soybean event Gm_CSM63714 is provided. The method comprises: a) contacting a sample comprising DNA derived from the soybean plant, plant part, plant seed, or plant cell with a probe set comprising at least a first probe that specifically hybridizes to soybean event Gm_CSM63714, and at least a second probe that specifically hybridizes to soybean genomic DNA that was disrupted by insertion of the heterologous DNA of soybean event Gm_CSM63714 but does not hybridize to soybean event Gm_CSM63714; and b) hybridizing the probe set with the sample under stringent hybridization conditions. Detecting hybridization of only the first probe under the hybridization conditions is diagnostic for a soybean plant, plant part, seed or plant cell homozygous for soybean event Gm_CSM63714. Detecting hybridization of both the first probe and the second probe under the hybridization conditions is diagnostic for a soybean plant, plant part, seed, or plant cell heterozygous for soybean event Gm_CSM63714. An illustrative example of a probe set that can be used is a probe set comprising SEQ ID NO:16 and SEQ ID NO:21.


DNA constructs are provided. One example of such a DNA construct is a DNA construct comprising a first expression cassette, a second expression cassette, a third expression cassette, and a fourth expression cassette. The first expression cassette comprises in operable linkage: i) ubiquitin (UB3) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) a chloroplast transit peptide coding sequence of APG6 (Albino and Pale Green 6) from Arabidopsis thaliana, iii) a codon-optimized dicamba monooxygenase coding sequence (DMO) from Stenotrophomonas maltophilia, and iv) a 3′ UTR sequence of the aluminum-induced Sali3-2 protein from Medicago truncatula. The second expression cassette comprises in operable linkage: i) a promoter and an intron sequence derived from multiple promoter and intron sequences from Arabidopsis thaliana, ii) a codon-optimized phosphinothricin N-acetyltransferase (PAT) coding sequence from Streptomyces viridochromogene, and iii) a 3′ UTR of a small heat shock protein (Hsp20) from Medicago truncatula. The third expression cassette comprises in operable linkage: i) polyubiquitin (UBQ10) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7) from Sphingobium herbicidovorans, and iii) a 3′ UTR sequence of a putative protein from Medicago truncatula. The fourth expression cassette comprises in operable linkage i) promoter, leader, and intron sequences derived from multiple promoter, leader and intron sequences from Arabidopsis thaliana, ii) a codon-optimized coding sequence of the triketone dioxygenase (TDO) from Oryza sativa, and iii) a 3′ UTR sequence derived from multiple 3′ UTR sequences from Zea mays. For example, the DNA construct can comprise SEQ ID NO:9. The DNA construct can further comprise at the 5′ or 3′ end of the construct: a) at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98; and/or b) at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99.


Another DNA construct is provided. The DNA construct comprises a first expression cassette, a second expression cassette, a third expression cassette, and a fourth expression cassette. The first expression cassette comprises a dicamba monooxygenase coding sequence, the second expression cassette comprises a phospinothricin N-acetyltransferase (PAT) coding sequence the third expression cassette comprises an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7) capable of degrading 2,4-D, the fourth expression cassette comprises a triketone dioxygenase (TDO) coding sequence. The DNA construct further comprises at the 5′ or 3′ end of said construct (i) at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98; and/or (ii) at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99.


A further DNA construct is provided. The construct comprises a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:9. The DNA construct comprises at the 5′ or 3′ end of said construct (i) at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98; and/or (ii) at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99.


Any of the DNA constructs described herein can comprise at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98 at the 5′ end of the construct and at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99 at the 3′ end of the construct. Any of the DNA constructs described herein can comprise at the 5′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:58-77 and SEQ ID NOs:100-139. Any of the DNA constructs described herein can comprise at the 3′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:78-97 and SEQ ID NOs:140-179.


Soybean plants, plant seeds, plant parts, or plant cells comprising any of the DNA constructs described herein are provided.


A method of improving tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, and any combination thereof in a soybean plant is provided. The method comprises: a) inserting any of the DNA constructs described herein into the genome of a soybean cell; b) generating a soybean plant from the soybean cell; and c) selecting a soybean plant comprising the DNA construct. The selecting can comprise treating the soybean cell or plant with an effective amount of at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, and any combination thereof. The benzoic acid auxin can comprise dicamba, the pheoxy auxin comprise 2,4-D, the glutamine synthetase inhibitor can comprise glufosinate, and the β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. For example, the 3-triketone HPPD inhibitor can comprise mesotrione.


Also provided is a soybean plant, plant seed, plant part, or plant cell tolerant to herbicides with at least three different herbicide modes of action at a single genomic location. The soybean plant, plant seed, plant part or plant cell comprises any of the DNA constructs described herein.


Also provided is a soybean plant, plant seed, plant part, or plant cell tolerant to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and any combination thereof. The soybean plant, plant seed, plant part, or plant cell comprises any of the DNA constructs provided herein.


The benzoic acid auxin can comprise dicamba, the phenoxy auxin can comprise 2,4-D, the glutamine synthetase inhibitor can comprise glufosinate, and the β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. For example, the β-triketone HPPD inhibitor can be mesotrione.


Any of the soybean seeds, plants, plant parts, or cells can be obtained by any of the methods of improving tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, and any combination thereof in a soybean plant provided herein.


Any of the soybean plants, plant seeds, plant parts, or plant cells can be tolerant to at least an additional herbicide. For example, the at least an additional herbicide can comprise glyphosate.


A method of producing a progeny soybean plant comprising soybean event Gm_CSM63714 is provided. The method comprises: a) sexually crossing a first soybean plant that comprises soybean event Gm_CSM63714 with itself or a second soybean plant; b) collecting one or more seeds produced from the cross; c) growing one or more seeds to produce one or more progeny plants; and d) selecting at least a first progeny plant or seed comprising soybean event Gm_CSM63714. Inbred and hybrid soybean plants and seeds comprising soybean event Gm_CSM63714 that are produced by the method are also provided.


Nonliving soybean plant material and nonregenerable soybean plant material are also provided. The material can comprise any of the recombinant DNA molecules or any of the DNA constructs described herein.


Also provided is nonliving soybean plant material or nonregenerable soybean plant material comprising soybean event Gm_CSM63714, a representative sample of seed comprising the soybean event soybean event Gm_CSM63714 having been deposited under ATCC Accession No. PTA-127099.


Commodity products are also provided. An example of such a commodity product is a commodity product comprising any of the recombinant DNA molecules or any of the DNA constructs described herein. The commodity product can be produced from a transgenic soybean plant, plant part, plant seed, or plant cell comprising the soybean event Gm_CSM63714. The commodity product can comprise for example, whole or processed seeds; viable or nonviable seeds; viable plant parts (such as roots and leaves); viable plant cells; processed plant parts; processed plant tissues; dehydrated plant tissues; dehydrated plant parts; frozen plant tissues; frozen plant parts; food for human consumption such as soy oil, soy milk, soy flour, soy grits, soy protein, soy protein concentrate, hydrolyzed vegetable protein, textured soy protein, lecithin, curd, tofu, vegetable soybean (edamame), soy sprouts, soy film (yuba), roasted soybeans, miso, tempeh, soy sauce, or natto; plant parts processed for animal feed such as soy meal; soy fiber; biodiesel; bio-composite building materials such as particleboard, laminated plywood, or lumber products; soy oil-based solvents; soy oil-based industrial lubricants; soy ink; soy candles; soy crayons; soy-based hydraulic fluid; or soy-based foams.


A method of producing a commodity product is provided. The method comprises: a) obtaining a transgenic soybean plant, plant part, or plant seed comprising soybean event Gm_CSM63714; and b) producing a commodity product from the transgenic soybean plant, plant part, or plant seed.


A method of controlling, preventing, or reducing the development of herbicide-tolerant weeds is provided. The method comprises cultivating in a crop growing environment a soybean plant comprising transgenes that provide tolerance to herbicides with at least three different herbicide modes of action at a single genomic location. The at least three different herbicide modes of action can be selected from the group consisting of inhibition of glutamine synthetase, inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD), phenoxy auxins, and benzoic acid auxins.


Also provided is a method for controlling, preventing, or reducing the development of herbicide-tolerant weeds is provided. The method comprises: a) cultivating in a crop growing environment a soybean plant comprising any of the DNA constructs described herein for providing tolerance to herbicides with at least three different herbicide modes of action at a single genomic location; and b) applying to the crop growing environment at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof, wherein the soybean plant is tolerant to the at least one herbicide. The soybean plant can further comprise at least one additional transgene for an additional herbicide mode of action. For example, the at least one additional transgene can be EPSPS for conferring tolerance to glyphosate. The EPSPS transgene can comprise a polynucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO:57.


A method of reducing loci for soybean breeding by inserting transgenes at a single genomic location for tolerance to at least three different classes of herbicides is provided. The transgenes can be inserted as a single molecularly linked transgenic insert. The single molecularly linked transgenic insert can provide a commercial level of tolerance to at least one herbicide for each herbicide mode of action.


Further soybean plants, plant cells, plant parts, and plant seeds are provided. The soybean plants, plant cells, plant parts, and plant seeds comprise a recombinant DNA construct integrated in chromosome 13. The recombinant DNA construct confers tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and combinations of any thereof. The recombinant DNA construct is integrated in a position of said chromosome flanked by at least 50 contiguous nucleotides of SEQ ID NO:11 and 50 contiguous nucleotides of SEQ ID NO:12. The benzoic acid auxin can comprise dicamba, the phenoxy auxin can comprise 2,4-D, the glutamine synthetase inhibitor can comprise glufosinate, and the β-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. For example, the β-triketone HPPD inhibitor can be mesotrione. The at least 50 contiguous nucleotides of SEQ ID NO: 11 can comprise one or more nucleotide sequences selected from SEQ ID NOs:58-77. The at least 50 contiguous nucleotides of SEQ ID NO: 12 can comprise one or more nucleotide sequences selected from SEQ ID NOs:78-97.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates the sequence of the soybean event Gm_CSM63714. Horizontal lines correspond to the positions of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:11, and SEQ ID NO:12 relative to SEQ ID NO:10. The horizontal arrows (SEQ ID NO:14 and SEQ ID NO:15) represent the approximate positions of an illustrative primer pair that can be used to detect soybean event Gm_CSM63714. The horizontal line labeled SEQ ID NO:16 represents the approximate position of an illustrative DNA probe that can be used to detect soybean event Gm_CSM63714. “RB” refers to the Agrobacterium T-DNA right border; “LB” refers to the Agrobacterium T-DNA left border. “P” represents a promoter element; “L” represents a leader (5′ UTR) element; “I” represents an intron element; “CTP” represents a chloroplast transit peptide element; “T” represents a 3′ UTR. “DMO” represents a dicamba monooxygenase coding element; “PAT” represents a phosphinothricin N-acetyltransferase coding element; “FT-Tv7” represents a dioxygenase variant coding element; and “TDO” represents a triketone dioxygenase coding element. The horizontal line labeled SEQ ID NO:13 represents the relative location or position of the wild-type soybean genome where the transgenes (SEQ ID NO:9) were inserted. The dashed line represents a 40-nucleotide deletion in the soybean genome at the site of transgene (SEQ ID NO:9) insertion.



FIG. 2 illustrates the approximate timing for creation, greenhouse and field testing, molecular characterization, and selection the soybean event Gm_CSM63714.





BRIEF DESCRIPTION OF THE SEQUENCES

SEQ ID NO:1 is a 30-nucleotide sequence representing the 5′ junction region of the soybean genomic DNA and the integrated transgene insert. SEQ ID NO:1 corresponds to nucleotide positions 986-1,015 of SEQ ID NO:10.


SEQ ID NO:2 is a 30-nucleotide sequence representing the 3′ junction region of the integrated transgene insert and the soybean genomic DNA. SEQ ID NO:2 corresponds to nucleotide positions 11,182-11,211 of SEQ ID NO:10.


SEQ ID NO:3 is a 60-nucleotide sequence representing the 5′ junction region of the soybean genomic DNA and the integrated transgene insert. SEQ ID NO:3 corresponds to nucleotide positions 971-1,030 of SEQ ID NO:10.


SEQ ID NO:4 is a 60-nucleotide sequence representing the 3′ junction region of the integrated transgene insert and the soybean genomic DNA. SEQ ID NO:4 corresponds to nucleotide positions 11,167-11,226 of SEQ ID NO:10.


SEQ ID NO:5 is a 100-nucleotide sequence representing the 5′ junction region of the soybean genomic DNA and the integrated transgene insert. SEQ ID NO:5 corresponds to nucleotide positions 951-1,050 of SEQ ID NO:10.


SEQ ID NO:6 is a 100-nucleotide sequence representing the 3′ junction region of the integrated transgene insert and the soybean genomic DNA. SEQ ID NO:6 corresponds to nucleotide positions 11,147-11,246 of SEQ ID NO:10.


SEQ ID NO:7 is a 1,050-nucleotide sequence representing the 5′ genomic flank region of the soybean genomic DNA and 50 bp of the integrated transgene insert. SEQ ID NO:7 corresponds to nucleotide positions 1-1,050 of SEQ ID NO:10.


SEQ ID NO:8 is a 1,050-nucleotide sequence representing 50 bp of the 3′ junction region of the integrated transgene insert and the 3′ genomic flank region of the soybean genomic DNA. SEQ ID NO:8 corresponds to nucleotide positions 11,147-12,196 of SEQ ID NO:10.


SEQ ID NO:9 is a 10,196-nucleotide sequence corresponding to the transgene insert of soybean event Gm_CSM63714. SEQ ID NO:9 corresponds to nucleotide positions 1,001-11,196 of SEQ ID NO:10.


SEQ ID NO:10 is a 12,196-nucleotide sequence corresponding to the contig nucleotide sequence of the 5′soybean genomic DNA sequence (SEQ ID NO:11), the transgene insert in event Gm_CSM63714 (SEQ ID NO:9), and the 3′ soybean genomic DNA sequence (SEQ ID NO:12).


SEQ ID NO:11 is a 1,000-nucleotide sequence representing the 5′ flanking soybean genomic DNA up to the transgene insert (SEQ ID NO:9). SEQ ID NO:11 corresponds to nucleotide positions 1-1,000 of SEQ ID NO:10.


SEQ ID NO:12 is a 1,000-nucleotide sequence representing the 3′ flanking soybean genomic DNA after the transgene insert (SEQ ID NO:9). SEQ ID NO:12 corresponds to nucleotide positions 11,197-12,196 of SEQ ID NO:10.


SEQ ID NO:13 is a 2,040-nucleotide sequence representing wild-type soybean genomic DNA at the location where the transgenic sequence (SEQ ID NO:9) was inserted in event Gm_CSM63714. A 40-nucleotide fragment of SEQ ID NO:13 (nucleotides 1,001-1,040) was deleted in event Gm_CSM63714 due to insertion of the T-DNA.


SEQ ID NO:14 is a 30-nucleotide sequence corresponding to a thermal amplification primer referred to as SQ21524 used in event-specific assay and zygosity assay to detect soybean event Gm_CSM63714 DNA in a sample, and is identical to the nucleotide sequence corresponding to positions 11,075-11,104 of SEQ ID NO:10.


SEQ ID NO:15 is a 27-nucleotide sequence corresponding to a thermal amplification primer referred to as SQ51589 used in event-specific assay and zygosity assay to detect soybean event Gm_CSM63714 DNA in a sample, and is identical to the reverse complement of the nucleotide sequence corresponding to positions 11,201-11,227 of SEQ ID NO:10.


SEQ ID NO:16 is a 16-nucleotide sequence corresponding to a probe referred to as PB10269 used in event-specific assay and zygosity assay to detect soybean event Gm_CSM63714 DNA in a sample, and is identical to the nucleotide sequence corresponding to positions 11,108-11,123 of SEQ ID NO:10.


SEQ ID NO:17 is a 20-nucleotide sequence corresponding to a thermal amplification primer referred to as SQ546 used as an internal control for the event assay for soybean event Gm_CSM63714 and hybridizes to a region of the soybean genome.


SEQ ID NO:18 is a 20-nucleotide sequence corresponding to a thermal amplification primer referred to as SQ549 used as an internal control for the event assay for soybean event Gm_CSM63714 and hybridizes to a region of the soybean genome.


SEQ ID NO:19 is a 16-nucleotide sequence corresponding to a probe referred to as PB50207 used as an internal control for the event assay for soybean event Gm_CSM63714 and hybridizes to a region of the soybean genome.


SEQ ID NO:20 is a 26-nucleotide sequence corresponding to a thermal amplification primer referred to as SQ52071 used in a zygosity assay for soybean event Gm_CSM63714 DNA in a sample and hybridizes to a region of the soybean genome. It corresponds to positions 949-974 of SEQ ID NO:10.


SEQ ID NO:21 is a 16-nucleotide sequence corresponding to a probe referred to as PB50681 used in a zygosity assay for soybean event Gm_CSM63714 DNA in a sample, and hybridizes to a region of the soybean genome that was deleted by T-DNA insertion.


SEQ ID NOs:22-43 are the nucleotide sequences for the genetic elements in the transgenic insert of soybean event Gm_CSM63714 and are further described in Table 1 hereinbelow.


SEQ ID NOs:44-45 are the nucleotide and amino acid sequences of Cas12a of Lachnospiraceae bacterium ND2006, respectively (LbCas12a, also known as LbCpf1).


SEQ ID NO:46 is the amino acid sequence for LbCas12a_V1 (G532R/K595R).


SEQ ID NO:47 is the amino acid sequence for LbCas12a_V2 (G532R/K538V/Y542R).


SEQ ID NO:48 is the amino acid sequence for Cas12a of Francisella_novicida (FnCas12a).


SEQ ID NO:49 is the nucleotide sequence for the gRNA repeat for LbCas12a.


SEQ ID NO:50 is the nucleotide sequence for the gRNA repeat for FnCas12a.


SEQ ID NO:51 is the nucleotide sequence for the gRNA gRNA_5F-65.


SEQ ID NO:52 is the nucleotide sequence for the gRNA gRNA_TI-605.


SEQ ID NO:53 is the nucleotide sequence for the gRNA gRNA_TI-934.


SEQ ID NO:54 is the nucleotide sequence for the gRNA gRNA_TI-946.


SEQ ID NO:55 is the nucleotide sequence for the gRNA gRNA_3F-41.


SEQ ID NOs:56-57 are the codon-optimized coding sequence and amino acid sequence of the aroA gene (also known as 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS)) from Agrobacterium CP4 strain, respectively.


SEQ ID NOs:58-77 are 50-nucleotide sequences in the 5′ flank genomic sequence of event Gm_CSM63714.


SEQ ID NOs:78-97 are 50-nucleotide sequences in the 3′ flank genomic sequence of event Gm_CSM63714.


SEQ ID NO:98 is a 5,000-nucleotide sequence representing soybean genomic DNA that flanks the transgenic insert at the 5′ end of the insert. Nucleotides 4,001-5,000 of SEQ ID NO:98 are identical to nucleotides 1-1,000 of SEQ ID NO: 11. The remaining nucleotides of SEQ ID NO: 98 (nucleotides 1-4,000) are based on the genomic sequence of the Williams 82 soybean cultivar.


SEQ ID NO:99 is a 5,000-nucleotide sequence representing soybean genomic DNA that flanks the transgenic insert at the 3′ end of the insert. Nucleotides 1-1,000 of SEQ ID NO:99 are identical to nucleotides 1-1000 of SEQ NO: 12. The remaining nucleotides of SEQ ID NO:99 (nucleotides 1,001-5,000) are based on the genomic sequence of the Williams 82 soybean cultivar.


SEQ ID NOs:100-139 are additional 50-nucleotide sequences in the 5′ flank genomic sequence of event Gm_CSM63714 based on the genomic sequence of the Williams 82 soybean cultivar.


SEQ ID NOs:140-179 are additional 50-nucleotide sequences in the 3′ flank genomic sequence of event Gm_CSM63714 based on the genomic sequence of the Williams 82 soybean cultivar.


DETAILED DESCRIPTION OF THE INVENTION

The following definitions, descriptions, and methods are provided to better define the invention and to guide those of ordinary skill in the art in the practice of the invention. Unless otherwise noted, terms are to be understood according to conventional usage by those of ordinary skill in the relevant art.


Herbicide tolerance is an important agronomic trait for effective weed control to maintain favorable crop growing conditions and crop yields, and is achieved by engineering of herbicide tolerance transgenes in crop plants using modern plant biotechnology techniques. Soybean event Gm_CSM63714 provides tolerance to five different herbicide chemistries through different modes of action for weed control and herbicide-resistant weed management.


Soybean event Gm_CSM63714 is provided. The event Gm_CSM63714 was produced by Agrobacterium-mediated transformation of soybean seed-derived embryo explants with a DNA construct harboring two T-DNAs. The first T-DNA comprises four transgene cassettes, encoding a dicamba monooxygenase (DMO), a phosphinothricin N-acetyltransferase (PAT), an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant (FT_Tv7, also referred to as FT_T.1), and a triketone dioxygenase (TDO), respectively, for conferring tolerance to dicamba (3,6-dichloro-2-methoxybenzoic acid), glufosinate (2-amino-4-(hydroxymethylphosphinyl) butanoic acid), 2,4-D (2,4-dichlorophenoxyacetic acid), and β-triketone herbicides (inhibitors of HPPD) such as mesotrione (2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione), respectively. The second T-DNA comprises two transgene cassettes, one encoding an aminoglycoside (3″) adenylyltransferase (aadA) for selection of transformed soybean cells using spectinomycin/streptomycin as the selection, and the other encoding a sucrose phosphorylase (splA) from Agrobacterium tumefaciens (GenBank Accession AE009432) and functioning as a marker gene for identification of the presence of the linked selectable marker.


Plant transformation techniques, such as Agrobacterium-mediated or biolistic transformation, can be used to insert foreign DNA (also known as transgenic DNA) randomly into a chromosome in a plant cell to produce a genetically engineered plant cell, also referred to as a “transgenic” or “recombinant” cell. Using these transformation techniques, many individual cells can be transformed, each resulting in a unique “transgenic event” or “event” due to the random insertion of the foreign DNA into the genome. A transgenic plant can then be regenerated from each individual transgenic cell. This results in every cell of the transgenic plant containing the uniquely inserted transgenic event as a stable part of its genome. The transgenic plant can then be used to produce progeny plants, each containing the unique transgenic event. The term “transgenic” refers to a plant, plant part, plant cell, seed, progeny plant, or DNA molecule, construct, or sequence comprising a transgene—e.g., a “transgenic cell” refers to a cell comprising a transgene.


Soybean event Gm_CSM63714 was produced and identified by a complex research and development process. This process included: (i) design and selection of DNA constructs comprising four transgene cassettes based on design and testing of individual transgene cassettes with combinations of different expression elements, followed by design and testing of different combinations of individual transgene cassettes with different positions and orientations relative to each other; (ii) transformation of thousands of soybean cells with the DNA constructs that comprised the four expression cassettes; (iii) regeneration of a large population of transgenic plants each containing a unique transgenic event; and (iv) rigorous multi-year construct and event selection involving molecular characterization of the large number of transgenic events, greenhouse and field trials for herbicide tolerance efficacy and agronomic performance at different locations and in different geographies for thousands of events through tens of thousands of plants. Soybean event Gm_CSM63714 was thus produced and selected as a uniquely superior event useful for broad-scale agronomic commercial purposes. FIG. 2 illustrates the approximate timing for creation, greenhouse and field testing, molecular characterization, and selection the soybean event Gm_CSM63714.


Detailed molecular characterization was conducted on the transgenic events. Event Gm_CSM63714 was selected based on stringent molecular criteria, as well as other selection criteria such as herbicide tolerance efficacy and agronomic performance. The results from such molecular analyses confirmed that: (1) event Gm_CSM63714 contains a single T-DNA insertion with one copy of the transgenic insert comprising the four expression cassettes; (2) no additional elements from the transformation construct were present other than the four expression cassettes between the left and right borders of the first T-DNA, such as the transformation construct backbone sequence or the second T-DNA containing the aadA/sp/A cassettes; (3) the transgenic DNA was inserted in an intergenic region, far away from any endogenous genes or repeat regions; (4) the transgenic event produced the correct sized transcripts and proteins for the four transgenes by northern hybridization and western hybridization analyses, respectively. Furthermore, DNA sequence analyses were performed to: (1) determine the 5′ and 3′ transgenic insert-to-plant genome junctions; (2) confirm the organization of the elements within the insert; and (3) verify the complete nucleotide sequence of the inserted transgenic DNA (SEQ ID NO:9). In addition, primers and probes were designed, and thermal amplification assays were developed for producing specific amplicons diagnostic for the presence of event Gm_CSM63714 in a sample. As used herein, the 5′ and 3′ designations in reference to the junction, direction and side of the transgenic event insertion is relative to the 5′ to 3′ direction of the transgene, with the 5′ junction and genomic sequence being upstream of the transgene, and the 3′ junction and genomic sequence being downstream of the transgene.


As used herein, an “expression cassette” or “cassette” or “transgene cassette” is a recombinant DNA molecule or sequence comprising a combination of distinct elements for expressing an RNA and/or protein encoded by the coding sequence of a transgene in a transformed plant cell or transformed plant comprising the transgene. As provided herein, an “expression cassette” or “cassette” or “transgene cassette” includes one or more regulatory element(s) operably linked to a coding or transcribable DNA sequence. The regulatory elements can include a promoter, a leader, 5′ untranslated region (5′ UTR), intron and/or a 3′ untranslated region (3′ UTR) region. The “expression cassette” or “cassette” or “transgene cassette” is recombinant and heterologous with respect to the transformed plant cell genome. For purposes of the present disclosure, such an “expression cassette” or “cassette” or “transgene cassette” is a recombinant DNA molecule or sequence that encodes a protein for conferring tolerance to at least one class of herbicides as described herein. Table 1 provides a list of the genetic elements contained in the four transgene cassettes in the transgenic insert (SEQ ID NO:9) of soybean event Gm_CSM63714.


Insertion of the transgenic DNA into the genome of the soybean plant is accomplished by plant transformation methods known in the art and creates a new transgenic genomic DNA sequence, known as a “transgenic event” or an “event.” The DNA sequence of the event consists of the inserted foreign DNA (referred to as “transgenic insert”) and the genomic DNA adjacent to, or “flanking,” the transgenic insert on either side of the insertion location. As used herein, the term “flanking” in reference to a transgenic event refers to the plant genomic sequence(s) adjacent to the transgenic DNA insertion in the genome of a transformed plant, plant part, plant tissue, or plant cell comprising the transgenic event on the 5′ and/or 3′ end(s) of the transgenic event insertion. Likewise, “flanking DNA” refers to a length of genomic DNA sequence adjacent to the transgenic DNA insertion in the genome of the transformed event on the 5′ and/or 3′ end(s) of the insertion. A “5′ flank”, therefore, means the soybean genomic DNA sequence adjacent to and upstream (or on the 5′ end) of the transgenic DNA insertion. For example, a “5′ flank” can include the soybean genomic DNA sequence immediately adjacent to and upstream (on the 5′ end) of the transgenic insertion, or any soybean genomic DNA sequence upstream (on the 5′ end) of the transgenic insertion that is not immediately adjacent to the transgenic insertion but is within about 5000 nucleotides, within about 3000 nucleotides, or within about 1000 nucleotides upstream of the transgenic insertion. Likewise, a “3′ flank” means the soybean genomic DNA sequence adjacent to and downstream (or on the 3′ end) of the transgenic insert. For example, a “3′ flank” can include the soybean genomic DNA sequence immediately adjacent to and downstream (on the 3′ end) of the transgenic insertion, or any soybean genomic DNA sequence downstream (on the 3′ end) of the transgenic insertion that is not immediately adjacent to the transgenic insertion but is within about 5000 nucleotides, within about 3000 nucleotides, or within about 1000 nucleotides downstream of the transgenic insertion. The DNA sequence of an event is unique to and specific for the event and can be readily identified when compared to other DNA sequences, such as that of other events or untransformed soybean genomic DNA. Soybean event Gm_CSM63714 has the new and unique DNA sequence provided as SEQ ID NO:10, which comprises a contiguous sequence comprising the 5′ soybean genomic flanking sequence provided as SEQ ID NO:11, the transgenic insert sequence provided as SEQ ID NO:9, and the 3′ soybean genomic flanking sequence provided as SEQ ID NO:12 (FIG. 1). Soybean event Gm_CSM63714 is thus a DNA molecule that is an integral part of the chromosome of transgenic soybean cells and plants comprising the event and as such is static and may be passed on to progeny cells and plants. As is described further in the Examples hereinbelow, various gene editing tools exist that would permit modification of the transgenic insert and/or the flanking genomic DNA of soybean event Gm_CSM63714, such as by deletion, insertion, transposition, or substitution of nucleic acid sequence(s), the event is still uniquely characterized by the presence of heterologous DNA at the particular position in the genome occupied by soybean event Gm_CSM63714 relative to flanking portions of the native soybean genome.









TABLE 1







Elements and Description of Soybean Event Gm_CSM63714











SEQ
Position in




ID
SEQ ID


Element
NO
NO: 10
Description





5′ Flank sequence
11
  1-1000
Soybean genomic DNA sequence flanking the 5′ end of





the transgenic insert.


Right border region
22
1001-1071
Right border sequence from Agrobacterium tumefaciens.





SEQ ID NO: 22 is the full-length T-DNA right border





sequence and is 285 nucleotides long. However, since a





portion of this sequence was truncated at the time of the





insertion into the soybean genomic DNA, only





nucleotides 215-285 of SEQ ID NO: 22 are present in





SEQ ID NO: 10.


Intervening sequence 1

1072-1110
Sequence used in DNA cloning.


P-At.Ubq3
23
1111-1651
Promoter sequence of a ubiquitin (UB3) protein from






Arabidopsis thaliana.



L-At.Ubq3
24
1652-1740
5′ UTR leader sequence of a ubiquitin (UB3) protein





from Arabidopsis thaliana.


I-At.Ubq3
25
1741-2118
Intron sequence of a ubiquitin (UB3) protein from






Arabidopsis thaliana.



TS-At.APG6
26
2119-2322
APG6 (Albino and Pale Green 6) chloroplast transit





peptide sequence from Arabidopsis thaliana.


CR-STEma.DMO
27
2323-3345
Codon-optimized sequence encoding a variant of





dicamba monooxygenase (DMO) from






Stenotrophomonas maltophilia.



Intervening sequence 2

3346-3364
Sequence used in DNA cloning.


T-Mt.Sali3-2
28
3365-3864
3′ UTR sequence of aluminum-induced Sali3-2 from






Medicago truncatula.



Intervening sequence 3

3865-3942
Sequence used in DNA cloning.


P-At.GSP579
29
3943-4442
Promoter sequence derived from multiple Arabidopsis






thaliana promoter sequences.



I-At.GSI102
30
4443-4752
Intron sequence derived from multiple Arabidopsis






thaliana intron sequences.



Intervening sequence 4

4753-4758
Sequence used in DNA cloning.


CR-STRvi.Pat
31
4759-5310
Codon-optimized coding sequence of the





phosphinothricin N-acetyltransferase (PAT) from






Streptomyces viridochromogenes.



Intervening sequence 5

5311-5318
Sequence used in DNA cloning.


T-Mt.Hsp20
32
5319-5818
3′ UTR sequence of a small heat shock protein (Hsp20)





from Medicago truncatula.


Intervening sequence 6

5819-5901
Sequence used in DNA cloning.


P-At.Ubq10
33
5902-6730
Promoter sequence of a polyubiquitin gene (UBQ10)





from Arabidopsis thaliana.


L-At.Ubq10
34
6731-6797
5′ UTR leader sequence of a polyubiquitin gene





(UBQ10) from Arabidopsis thaliana.


I-At.Ubq10
35
6798-7103
Intron sequence of a polyubiquitin gene (UBQ10) from






Arabidopsis thaliana.



Intervening sequence 7

7104-7109
Sequence used in DNA cloning.


CR-SPHhe.FT_Tv7
36
7110-7997
Codon-optimized sequence encoding an alpha-





ketoglutarate-dependent non-heme iron dioxygenase





variant from Sphingobium herbicidovorans.


Intervening sequence 8

7998-8005
Sequence used in DNA cloning.


T-Mt.AC139600v16
37
8006-8505
3′ UTR sequence of a putative protein from Medicago






truncatula.



Intervening sequence 9

8506-8643
Sequence used in DNA cloning.


P-At.GSP576
38
8644-9101
Promoter sequence derived from multiple Arabidopsis






thaliana promoter sequences.



L-At.GSP576
39
9102-9143
5′ UTR leader sequence derived from multiple






Arabidopsis thaliana 5′ UTR sequences.



I-At.GSI17
40
9144-9443
Intron sequence derived from multiple Arabidopsis






thaliana intron sequences.



Intervening sequence 10

9444-9478
Sequence used in DNA cloning.


CR-Os.TDO
41
 9479-10534
Codon-optimized sequence encoding triketone





dioxygenase from Oryza sativa.


Intervening sequence 11

10535-10564
Sequence used in DNA cloning.


T-Zm.GST7
42
10565-10864
3′ UTR sequence derived from multiple Zea mays 3′





UTR sequences.


Intervening sequence 12

10865-10964
Sequence used in DNA cloning.


Left border region
43
10965-11196
Left border sequence from Agrobacterium tumefaciens.





SEQ ID NO: 43 is the full-length T-DNA left border





sequence and is 442 nucleotides long. However, since a





portion of this sequence was truncated at the time of the





insertion into the soybean genomic DNA, only





nucleotides 1-232 of SEQ ID NO: 43 are present in SEQ





ID NO: 10.


3′ Flank sequence
12
11197-12196
Soybean genomic DNA sequence flanking the 3′ end of





the transgenic insert.









Progeny of the original transformed cell and plant that comprise soybean event Gm_CSM63714 are provided. Such progeny may be produced by selfing of a soybean plant comprising the soybean event Gm_CSM63714, or by sexual cross or outcrossing between a soybean plant comprising soybean event Gm_CSM63714 and another plant that does or does not contain the event, or by any other method known in the art including any plant cell or tissue culture method, wherein the progeny includes the soybean event Gm_CSM63714. The other plant may be a transgenic plant comprising the same and/or different event(s) or may be a non-transgenic plant, and each parental plant in a cross or outcross may be the same or different germplasm or breeding line. Soybean event Gm_CSM63714 is passed from the original parent through each generation to the progeny. A “transgenic plant” or “plant”, therefore, can be the original transformant plant regenerated from the transformed plant cell and comprising the transgenic DNA and event, or a progeny plant of the original transformant plant, which may be separated from the transformant by one or more generations, that retains the transgenic DNA and event at the same specific location and sequence context in the plant's genome. The transformant or progeny plant may be homozygous or heterozygous for event Gm_CSM63714. In addition, a “transgenic plant” may comprise a plant having the transgenes stably inserted into the genome of at least one cell of the plant (i.e., soybean event Gm_CSM63714 in at least one cell of the plant), and the plant may be chimeric or non-chimeric with respect to the transgenes and/or event. A transgenic plant is chimeric with respect to a transgene if not all cells of the plant comprise the transgenes.


The present disclosure describes introduction of event Gm_CSM63714 into soybean, and thus the term “soybean event Gm_CSM63714” is used to refer to the event herein. However, those of skill in the art will understand that event Gm_CSM63714 could be introduced into other varieties or related soybean species by crosses, such as Glycine soja and Glycine tomentella.


Soybean event Gm_CSM63714 provides to soybean cells, plants, plant parts, seeds and progeny that comprise the event tolerance to benzoic acid auxin herbicides such as dicamba which functions by increasing plant growth rate, leading to senescence and cell death; inhibitors of glutamine synthetase such as glufosinate; phenoxy auxins such as 2,4-dichlorophenoxyacetic acid (2,4-D), which mimics the action of the plant growth regulator auxin and causes uncontrolled growth and eventually death in susceptible plants; and β-triketone herbicides such as mesotrione.


Soybean event Gm_CSM63714 is characterized as a single copy insertion into one locus in the soybean genome, resulting in two new loci or junction sequences (e.g. sequences set forth in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7 and SEQ ID NO:8) spanning portions of the inserted DNA and the soybean genomic DNA that are not known to appear or exist naturally in the soybean genome or other transgenic soybean events, i.e., they are unique to event Gm_CSM63714. SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5 and SEQ ID NO:7 span the 5′ junction of the soybean genomic sequence and the transgenic DNA insert, and SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8 span the 3′ junction. These junction sequences are useful in detecting the presence of the event Gm_CSM63714 in soybean cells, seed, plants, plant parts, progeny, and plant products, such as soybean commodity products. Polynucleotide or DNA molecular probes and/or primer pairs are described herein for use in identifying the presence of these various junction sequences in biological samples containing or derived from, or suspected of containing or being derived from, soybean cells, seeds, plants, plant parts, progeny, or commodity product that contains the event Gm_CSM63714.


As used herein, the term “derived” or “derived from” in reference to a particular DNA molecule, amplicon or sequence in relation to a soybean plant, plant part, seed, progeny, cell and/or soybean plant product, such as a commodity product, means that the DNA molecule, amplicon or sequence is taken, purified, isolated, or made, directly or indirectly, from such soybean plant, plant part, seed, progeny, cell and/or soybean plant product, such as a commodity product. Alternatively, the term “derived” or “derived from” in reference to a soybean plant product, such as a commodity product, in relation to soybean plant, plant part, seed, progeny, or cell, means that the soybean plant product is taken, purified, isolated, or made, directly or indirectly, from such soybean plant, plant part, seed, progeny, or cell.


“Capable of being detected” refers to the ability of a particular DNA molecule, segment or sequence to be detected in a sample, such as by amplification and determining its presence, size or sequence such as by DNA sequence analysis, and/or binding of a probe to the target DNA molecule, segment or sequence.


A “sample” is intended to refer to any composition comprising or derived from, either directly or indirectly, a biological sample, source, or material. The sample may generally comprise soybean DNA and/or substantially or completely pure, purified, or isolated soybean DNA. A “biological sample” contains biological materials, including but not limited to DNA obtained or derived from, either directly or indirectly, the genome of a soybean cell(s), tissue(s), seed(s), plant(s), plant part(s) and/or soybean plant product(s), such as a commodity product(s). Such soybean cell(s), tissue(s), seed(s), plant(s), plant part(s) and/or soybean plant product(s), such as a commodity product(s), may comprise soybean event Gm_CSM63714, or DNA molecule(s) and/or DNA segment(s) comprising soybean event Gm_CSM63714. In some embodiments, a sample or biological sample may comprise soybean cell(s), soybean tissue(s), soybean seed(s), soybean plant(s), soybean plant part(s) and/or soybean plant product(s), whose cells or cellular membranes have been fractured (e.g., disrupted or opened) to release the contents of the soybean cell(s) including genomic DNA or proteins and/or make the contents of the soybean cell(s) including genomic DNA or proteins accessible or usable for assays or testing. “Directly” refers to directly obtaining DNA by a skilled artisan from the soybean genome by fracturing soybean cells (or by obtaining samples of soybean that contain fractured soybean cells) and exposing or using the genomic DNA or protein from soybean cells for the purposes of detection. “Indirectly” refers to obtaining by a skilled artisan a target or specific reference DNA (e.g., a novel and unique junction segment(s) described herein as being diagnostic for the presence of the event Gm_CSM63714) in a particular sample, by means other than by obtaining directly via fracturing of soybean cells or obtaining a sample of soybean that contains fractured soybean cells. Such indirect means include, but are not limited to, amplification of a DNA segment that contains a DNA sequence targeted by a particular probe(s) and/or primer set(s) designed to bind with specificity to or near the target sequence, or amplification of a DNA segment comprising all or part of a target sequence that can be measured and characterized (e.g., measured by migration or separation from other segments of DNA and/or identification in an effective matrix, such as an agarose or acrylamide gel or the like, or characterized by direct sequence analysis of the amplicon(s), or cloning of the amplicon(s) into a vector(s) and direct sequencing of the inserted amplicon(s) present within such vector(s)).


As used herein, the term “recombinant” refers to a non-naturally occurring DNA, protein, combination, or organism that would not normally be found or exist in nature, and is created by human intervention. As used herein, a “recombinant DNA molecule” is a DNA molecule comprising a combination of DNA molecules that would not naturally occur together and is the result of human intervention. Two or more elements of such combination of DNA sequences may be operably linked to one another. For example, a recombinant DNA molecule may comprise a combination of at least two DNA molecules heterologous with respect to each other, such as a DNA molecule that comprises a coding sequence operably linked to a heterologous promoter and/or other regulatory expression element(s), and/or a transgene and a heterologous plant genomic DNA adjacent to the transgene, and/or a DNA molecule that is artificially synthesized and comprises a polynucleotide sequence that deviates from any polynucleotide sequence that would normally exist in nature. A recombinant DNA molecule may comprise all or part of a junction sequence of the genome of the event and all or part of the transgenic insert of the genome of the event, and/or may comprise a recombinant or heterologous DNA fragment of soybean event Gm_CSM63714. An example of a recombinant DNA molecule is a DNA molecule comprising at least one polynucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9 and SEQ ID NO:10. As used herein, a “recombinant” in reference to a plant, plant part, seed, plant cell, or progeny is a plant, plant part, seed, plant cell or progeny that would not normally exist in nature, is the result of human intervention, and contains a transgenic DNA molecule stably integrated into the genome of the plant, plant part, seed, plant cell, or progeny. As a result of such genomic insertion, the recombinant or transgenic plant, plant part, seed, plant cell, or progeny is something new and distinctly different from any related wild-type or naturally occurring plant, plant part, seed, plant cell or progeny. An example of a recombinant plant is a soybean plant containing the soybean event Gm_CSM63714.


As used herein, the term “transgene” refers to a DNA molecule artificially incorporated into an organism's genome as a result of human intervention, such as by plant transformation methods. A transgene may be heterologous to the organism. The term “transgenic insert” as used herein refers to the foreign or heterologous DNA inserted by plant transformation techniques into the soybean genome to produce soybean event Gm_CSM63714. The sequence for the transgenic insert of soybean event Gm_CSM63714 is provided as SEQ ID NO:9.


As used herein, the term “heterologous” in reference to a combination of two or more DNA sequences or elements means that the two or more DNA sequences or elements do not normally exist together as such combination in nature without human intervention. For example, a DNA molecule may be from a first species or a recombinant DNA molecule, and inserted into the genome of a second species. The DNA molecule would thus be heterologous to the genome and the organism. As used herein, the term “heterologous” in reference to a DNA molecule, construct, sequence or protein in relation to a plant, microorganism, plant cell or plant genome means that the DNA molecule, construct, sequence or protein does not exist in nature as part of such a plant, microorganism, plant cell or plant genome, and/or does not exist in the same physical or genomic location, context or orientation as part of such a plant, microorganism, plant cell or plant genome in nature, without human intervention.


As used herein, the term “chimeric” refers to a single DNA molecule produced by fusing a first DNA molecule to a second DNA molecule, where neither first nor second DNA molecule would normally be found in that configuration fused to the other. The chimeric DNA molecule is thus a new DNA molecule not normally found in nature. An example of a chimeric DNA molecule is a DNA molecule comprising at least one sequence selected from SEQ ID NO:1-10.


As used herein, the term “isolated” in reference to a molecule means that the molecule is at least partially separated from other molecules that are normally associated with it in its native or natural state. In some embodiments, the term “isolated” refers to a DNA molecule that is at least partially separated from the nucleic acids or polynucleotide or DNA sequence(s) that normally flank and are covalently linked to the sequence of the DNA molecule in its native or natural state. An “isolated” DNA molecule may have a DNA sequence corresponding to a portion of the genome of a plant cell without other genomic DNA sequence(s) that normally flank and are covalently linked to the DNA sequence in nature. Such an “isolated” DNA molecule may comprise all or part of a transgene and/or transgenic event, which may comprise all or part of soybean event Gm_CSM63714 or the transgenes or expression cassettes described herein. Nucleic acid sequences or elements, such as a coding sequence, intron sequence, 5′ UTR, promoter sequence, 3′ UTR, and the like, that are naturally found within the DNA of the genome of an organism are not considered to be “isolated” so long as the element is within the genome of the organism and at the location within the genome in which it is naturally found. However, each of these elements, and subparts of these elements, would be “isolated” within the scope of this disclosure so long as the element or subpart is not within the genome of the organism, and at the location within the genome of the organism, in which it is naturally found. An “isolated” DNA molecule may be any recombinant DNA molecule or amplification product or amplicon, and/or may comprise any DNA sequence removed from its natural or biological state and covalently fused to another DNA molecule or sequence with which it is not associated in nature. Such an isolated DNA molecule could be created by the use of biotechnology techniques, such as by making a recombinant DNA or integrating a foreign or heterologous DNA molecule into the chromosome of a cell, plant, or seed. Thus, any DNA molecule comprising a transgenic, recombinant, chimeric or artificial nucleotide sequence, transgene or expression cassette would be considered to be an “isolated” DNA molecule since these sequences are not naturally occurring, regardless of whether the sequence, transgene or expression cassette is present within a plasmid, vector or construct used to transform plant cells, within the genome of a plant, plant part, plant tissue, plant cell or progeny, or is present in detectable amounts in tissues, progeny, biological samples or commodity products derived from a plant, plant part, plant tissue, progeny or plant cell. A recombinant DNA molecule or sequence, or any fragment derived therefrom, comprising all or part of a transgene or junction sequence of the soybean event Gm_CSM63714 would therefore also be considered to be “isolated.” An “isolated” DNA molecule may be extracted or purified from a transgenic plant(s), plant part(s), plant cell(s) and/or tissue(s), or may be present in a homogenate, extract or lysate from any such transgenic plant(s), plant part(s), plant cell(s) and/or tissue(s), or may be produced as an amplicon or amplification product from plant genomic DNA and/or extracted or purified DNA from transgenic plant(s), plant part(s), plant cell(s) and/or tissue(s), or a homogenate, extract or lysate from plant(s), plant part(s), plant cell(s) and/or tissue(s). For the purposes of this disclosure, any transgenic polynucleotide or DNA sequence, i.e., the nucleotide sequence of the DNA inserted into the genome of a plant or bacterium, or present in an extrachromosomal vector, would be considered to be an “isolated” nucleotide or DNA sequence whether it is present within the plasmid or similar structure used to transform the cells, within the genome of the plant or bacterium, or present in detectable amounts in tissues, progeny, biological samples or commodity products derived from the plant or bacterium. An “isolated” DNA molecule is a chemical or biochemical molecule, regardless of whether the molecule is referred to as a nucleic acid, a nucleic acid sequence, a polynucleotide sequence, a DNA sequence, a nucleic acid molecule, a polynucleotide molecule, a DNA molecule, or the like. An “isolated” molecule can provide industrial applicability when present in a plant cell or in a plant genome or when present outside of a plant cell, and therefore, provides and exhibits (and is intended to provide and exhibit) utility regardless of where the molecule is located. As used herein, the term “correspond” or “corresponding”, or the like, when used in the context of a nucleotide position, mutation, insertion and/or substitution in any given polynucleotide (e.g., SEQ ID NO:9) with respect to a reference polynucleotide sequence (e.g., SEQ ID NO:10) refers to the position(s) of the polynucleotide residue(s) in the given sequence that has identity to the residue(s) in the reference nucleotide sequence when the given polynucleotide is aligned to the reference polynucleotide sequence using a global or local sequence alignment algorithm.


DNA molecules, fragments, and their corresponding DNA sequences, as well as methods of detection are provided. As used herein, the terms “DNA”, “DNA molecule” and “nucleic acid molecule” refer to a deoxyribonucleic acid (DNA) molecule. A DNA molecule may be of genomic or synthetic origin and/or comprise a recombinant or heterologous DNA molecule or sequence. A DNA molecule may be described by convention from the 5′ (upstream) end to the 3′ (downstream) end. As used herein, the term “DNA sequence” refers to the polynucleotide sequence of a DNA molecule, i.e. the sequence of consecutive nucleotides in the DNA molecule. As used herein in reference to nucleotides of a polynucleotide or DNA sequence or molecule, the terms “consecutive” and “contiguous” are interchangeable and synonymous and refer to the 5′ to 3′ order of nucleotides in a polynucleotide or DNA sequence, strand or molecule without any gap or interruption between them. The nomenclature used is that required by Title 37 of the United States Code of Federal Regulations § 1.822 and set forth in the tables in WIPO Standard ST.25 (1998), Appendix 2, Tables 1 and 3. By convention, DNA sequences and fragments thereof are disclosed with reference to the 5′ to 3′ direction of only one strand of the two complementary DNA sequence strands of a DNA molecule. By implication and intent, the complementary sequences of the sequences provided here (the sequences of the complementary strand), also referred to in the art as the reverse complementary or reverse complement sequences, are within the scope of the present disclosure and are expressly intended to be within the scope of the subject matter claimed. As used herein references to SEQ ID NOs:1-10 and fragments thereof include and refer to the sequence of the complementary strand and fragments thereof.


Also provided is a nucleic acid molecule comprising a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8% or at least 99.9% identical to the full length of any one of SEQ ID NOs:1-12.


For example, a nucleic acid molecule is provided comprising a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8% or at least 99.9% identical to the full length of SEQ ID NO:10 or to the full length of SEQ ID NO: 9.


A DNA molecule, or a fragment derived therefrom, can also be extracted from plant(s), plant part(s), seed(s), progeny or plant cell(s), or a homogenate, extract or lysate from plant(s), plant part(s), plant cell(s) or seed(s) or progeny, or can be produced as an amplicon from extracted, purified or isolated DNA from plant part(s), plant cell(s) and/or tissue(s), progeny, or a homogenate, extract or lysate from plant(s), plant part(s), plant cell(s), progeny and/or seeds, which may further comprise soybean event Gm_CSM63714.


As used herein, the term “percent sequence identity” or “% sequence identity” refers to the percentage of identical nucleotides or amino acids in a linear polynucleotide or polypeptide sequence of a reference (“query”) sequence (or its complementary strand) as compared to a test (“subject”) sequence (or its complementary strand) when the two sequences are optimally aligned (with appropriate nucleotide or amino acid insertions, deletions, or gaps totaling less than 20 percent of the reference sequence over the window of comparison). Optimal alignment of sequences for aligning a comparison window are well known to those skilled in the art and may be conducted by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the search for similarity method of Pearson and Lipman, and by computerized implementations of these algorithms such as GAP, BESTFIT, FASTA, and TFASTA available as part of the Sequence Analysis software package of the GCG® Wisconsin Package® (Accelrys Inc., San Diego, Calif.), MEGAlign (DNAStar Inc., 1228 S. Park St., Madison, Wis. 53715), and MUSCLE (version 3.6) (Edgar, “MUSCLE: multiple sequence alignment with high accuracy and high throughput” Nucleic Acids Research 32(5):1792-7 (2004)) for instance with default parameters. An “identity fraction” for aligned segments of a test sequence and a reference sequence is the number of identical components that are shared by the two aligned sequences divided by the total number of components in the portion of the reference sequence segment being aligned, that is, the entire reference sequence or a smaller defined part of the reference sequence. Percent sequence identity is represented as the identity fraction multiplied by 100. The comparison of one or more sequences may be to a full-length sequence or a portion thereof, or to a longer sequence. Soybean plants, progeny, seeds, cells, plant parts and commodity products comprising a detectable amount of a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO:9 are within the scope of the present disclosure.


As used herein, the term “fragment” refers to a smaller piece or sequence of a larger or whole DNA molecule or sequence. For example, a fragment of any one of SEQ ID NOs:1-12 and SEQ ID NOs:98-99 may include a sequence that is at least about 10 consecutive nucleotides, at least about 11 consecutive nucleotides, at least about 12 consecutive nucleotides, at least about 13 consecutive nucleotides, at least about 14 consecutive nucleotides, at least about 15 consecutive nucleotides, at least about 16 consecutive nucleotides, at least about 17 consecutive nucleotides, at least about 18 consecutive nucleotides, at least about 19 consecutive nucleotides, at least about 20 consecutive nucleotides, at least about 21 consecutive nucleotides, at least about 22 consecutive nucleotides, at least about 23 consecutive nucleotides, at least about 24 consecutive nucleotides, at least about 25 consecutive nucleotides, at least about 30 consecutive nucleotides, at least about 35 consecutive nucleotides, at least about 40 consecutive nucleotides, at least about 45 consecutive nucleotides, at least about 50 consecutive nucleotides, at least about 60 consecutive nucleotides, at least about 70 consecutive nucleotides, at least about 80 consecutive nucleotides, at least about 90 consecutive nucleotides, at least about 100 consecutive nucleotides, at least about 150 consecutive nucleotides, at least about 200 consecutive nucleotides, at least about 250 consecutive nucleotides, at least about 300 consecutive nucleotides, at least about 400 consecutive nucleotides, or at least about 500 consecutive nucleotides of the larger, whole or complete DNA molecule or sequence.


For example, a “fragment” of the transgenic insert sequence (SEQ ID NO: 9) of soybean event Gm_CSM63714 can comprise at least about 10, at least about 11, at least about 12, at least about 13, at least about 14, at least about 15, at least about 16, at least about 17, at least about 18, at least about 19, at least about 20, at least about 21, at least about 22, at least about 23, at least about 24, at least about 25, at least about 30, at least about 35, at least about 40, at least about 45, at least about 50, at least about 60, at least about 70, at least about 80, at least about 90, at least about 100, at least about 150, at least about 200, at least about 250, at least about 300, at least about 400, or at least about 500 consecutive nucleotides of SEQ ID NO: 9. In addition, the present disclosure encompasses nucleotide sequences that are at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8% or at least 99.9% identical to SEQ ID NO: 9 or any fragment thereof.


Similarly, a fragment of the 5′ flank (SEQ ID NO:11 or SEQ ID NO:98) or 3′ flank (SEQ ID NO:12 or SEQ ID NO:99) of soybean event Gm_CSM63714 can comprise at least about 10, at least about 11, at least about 12, at least about 13, at least about 14, at least about 15, at least about 16, at least about 17, at least about 18, at least about 19, at least about 20, at least about 21, at least about 22, at least about 23, at least about 24, at least about 25, at least about 30, at least about 35, at least about 40, at least about 45, at least about 50, at least about 60, at least about 70, at least about 80, at least about 90, at least about 100, at least about 150, at least about 200, at least about 250, at least about 300, at least about 400, or at least about 500 consecutive nucleotides of SEQ ID NO:11 or SEQ ID NO:98; or SEQ ID NO:12 or SEQ ID NO:99. In addition, the present disclosure encompasses nucleotide sequences that are at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8% or at least 99.9% identical to SEQ ID NO:11 or 12, or SEQ ID NO:98 or 99, or any fragment of either thereof.


As used herein, the term “about” indicates a value or a range of values which would be understood as an equivalent of a stated value and can be greater or lesser than the value or range of values stated. Each value or range of values preceded by the term “about” is also intended to encompass the embodiment of the stated absolute value or range of values.


The term “or” is used herein to mean “and/or” unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive. Thus the term “and/or” as used herein in a phrase such as “X and/or Y” is intended to include “X and Y”, “X or Y”, “X” (alone), and “Y” (alone). Likewise, the term “and/or” as used in a phrase such as “X, Y, and/or Z” is intended to encompass each of the following embodiments: X (alone); Y (alone); Z (alone); X and Y; X and Z; Y and Z; X, Y, and Z; X, Y, or Z; X or Z; Y or Z; Y or Z.


When used in conjunction with the word “comprising” or other open language, the words “a” and “an” denote “one or more,” unless specifically noted otherwise. The terms “comprise,” “have,” and “include” are open-ended linking verbs. Any forms or tenses of one or more of these verbs, such as “comprises,” “comprising,” “has,” “having,” “includes,” and “including,” are also open-ended. For example, any method that “comprises,” “has,” or “includes” one or more steps is not limited to possessing only those one or more steps and also covers other unlisted steps.


Soybean event Gm_CSM63714 is characterized as a transgenic insertion into a single locus in the soybean genome, resulting in two new junctions (or joining or connection points). The DNA sequence of the region spanning the connection by phosphodiester bond linkage of one end of the transgenic insert to the flanking soybean genomic DNA is referred to herein as a “junction.” In other words, a junction is the connection point or covalent linkage of one end of the transgenic insert and the flanking genomic DNA as one contiguous molecule, and is formed by the insertion of a heterologous nucleic acid molecule into the soybean genomic DNA. One junction is found at the 5′ end of the transgenic insert and the other is found at the 3′ end of the transgenic insert, referred to herein as the 5′ and 3′ junctions, respectively. A “junction sequence” refers to a DNA sequence of any length of consecutive nucleotides that spans the 5′ or 3′ junction of a transgenic event in the plant genome. For a “junction sequence” to be specific to a junction between a transgenic event and a flanking genomic sequence, the junction sequence will generally comprise a sufficient number of consecutive nucleotides at one end of the insertion and a sufficient number of consecutive nucleotides of the flanking genomic sequence. According to some embodiments, a “junction sequence” may comprise (i) at least five (5) consecutive nucleotides, at least ten (10) consecutive nucleotides, at least fifteen (15) consecutive nucleotides, at least twenty (20) consecutive nucleotides, at least twenty five (25) consecutive nucleotides, at least thirty (30) consecutive nucleotides, at least thirty five (35) consecutive nucleotides, at least forty (40) consecutive nucleotides, at least forth five (45) consecutive nucleotides, or at least fifty (50) consecutive nucleotides at one end of the insertion and (ii) at least five (5) consecutive nucleotides, at least ten (10) consecutive nucleotides, at least fifteen (15) consecutive nucleotides, at least twenty (20) consecutive nucleotides, at least twenty five (25) consecutive nucleotides, at least thirty (30) consecutive nucleotides, at least thirty five (35) consecutive nucleotides, at least forty (40) consecutive nucleotides, at least forth five (45) consecutive nucleotides, or at least fifty (50) consecutive nucleotides of the flanking genomic DNA sequence, although it is understood that any length of consecutive nucleotides spanning a junction of a transgenic event in a plant genome may be a junction sequence. Junction sequences of soybean event Gm_CSM63714 are apparent to, and a variety of junction sequences of soybean event Gm_CSM63714 can be determined by one of skill in the art using SEQ ID NO:10. In SEQ ID NO:10, the 5′ junction is at nucleotides 1,000-1,001, and the 3′ junction is at nucleotides 11,196-11,197. Illustrative junction sequences of soybean event Gm_CSM63714 are provided as SEQ ID NOs:1-8. FIG. 1 illustrates the physical arrangement and locations of the illustrative junction sequences, arranged from 5′ to 3′ (left to right), relative to SEQ ID NO:10. The DNA sequence for the transgenic insert of soybean event Gm_CSM63714 is provided as SEQ ID NO:9. The DNA sequence of the transgenic insert and the soybean genomic DNA flanking each side of the transgenic insert is provided as SEQ ID NO:10. The 5′ junction sequences are provided as SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, and SEQ ID NO:7. The 3′ junction sequences are provided as SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, and SEQ ID NO:8. The junction sequences of soybean event Gm_CSM63714 may be present as part of the genome of a plant, seed, plant part, progeny or plant cell containing soybean event Gm_CSM63714, a DNA molecule containing all or part of event Gm_CSM63714. The identification of any one or more of the junction sequences in a DNA molecule or a sample from a plant, plant part, seed, progeny, cell or commodity product indicates that the DNA molecule or plant, plant part, seed, progeny, cell or commodity product contains or comprises event Gm_CSM63714, or was obtained from a soybean plant, plant part, seed, progeny, cell or commodity product containing or comprising event Gm_CSM63714, and is diagnostic for the presence of soybean event Gm_CSM63714.


The junction sequences described herein are diagnostic for the presence of all or part of soybean event Gm_CSM63714. Thus, the identification or detection, directly or indirectly, of one or more of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:10 in a sample or DNA molecule derived from a soybean plant, plant part, seed, progeny, cell, or a commodity product is diagnostic that the soybean plant, plant part, seed, progeny, cell, or a commodity product has or comprises all or part of soybean event Gm_CSM63714. The identification or detection, directly or indirectly, of a 5′ junction sequence and/or a 3′ junction sequence (each as provided or described herein) in a sample or DNA molecule derived from a soybean plant, plant part, seed, progeny, cell, or a commodity product is diagnostic that the soybean plant, plant part, seed, progeny, cell, or a commodity product has or comprises soybean event Gm_CSM63714. The present disclosure thus provides a DNA molecule that comprises at least one of the nucleotide sequences provided as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10. Any segment of DNA derived from transgenic soybean event Gm_CSM63714 that is sufficient to include at least one of the sequences provided as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10 is within the scope of the present disclosure. In addition, any DNA or polynucleotide molecule or sequence comprising a sequence complementary to any of the sequences described herein is also within the scope of the present disclosure.


Polynucleotide molecules are provided, which may be single or double stranded, that can be used either as primers or probes for detecting the presence of DNA comprising all or part of event Gm_CSM63714 in a sample derived from a soybean plant, plant part, seed, progeny, cell, or a commodity product. Such primers or probes are specific for a target polynucleotide sequence and, as such, are useful for the identification of soybean event Gm_CSM63714 polynucleotide by the methods described herein. A primer or probe can hybridize to a target polynucleotide sequence to allow for specific detection or amplification of a polynucleotide molecule that comprises, or is covalently linked and associated with, the target polynucleotide sequence. According to present embodiments, the primers and/or probes may be chosen to identify and distinguish detection of a particular transgenic event and not only the presence of a transgene in a plant genome. The target polynucleotide sequence may comprise all or part of soybean event Gm_CSM63714, a junction sequence and/or flanking genomic DNA. Probes and primers according to the present disclosure may have (i) complete or 100% sequence complementarity (i.e., 100% complementary) to a target polynucleotide sequence or (ii) incomplete sequence complementarity to a target polynucleotide, such as at least 60% complementary, at least 65% complementary, at least 70% complementary, at least 75% complementary, at least 80% complementary, at least 85% complementary, at least 90% complementary, at least 95% complementary, or at least 99% complementary to the target polynucleotide sequence as long as the probe or primer has sufficient complementarity to the target polynucleotide sequence to hybridize to the target polynucleotide sequence under stringent hybridization conditions that are suitable and necessary for use of the probe or primer in the relevant amplification or detection assay, reaction or method. As understood in the art, the percentage complementarity of a primer or probe may be lower if the length of the primer or probe is longer, and depends on the stringency and use. Provided are illustrative polynucleotide molecules that can be used either as primers or probes for detecting the presence of soybean event Gm_CSM63714 in a sample. Detection of the presence of soybean event Gm_CSM63714 may be done by using methods known in the art, such as thermal or isothermal amplification of nucleic acids or nucleic acid hybridization techniques (such as Northern analysis and Southern analysis).


A “probe” is a nucleic acid molecule that is complementary to a strand of a target nucleic acid and is useful in hybridization detection methods. Probes include not only deoxyribonucleic or ribonucleic acids but also polyamides and other probe materials that bind specifically to a target DNA sequence and the detection of such binding can be useful in detecting the presence or absence of the target DNA sequence. A probe may be attached to a conventional detectable label or reporter molecule, such as a radioactive isotope, ligand, chemiluminescent agent, or enzyme. Such a probe is complementary to a strand of a target nucleic acid and, in the case of the present disclosure, to a strand of DNA from event Gm_CSM63714 whether from an event Gm_CSM63714 containing plant or from a sample that includes event Gm_CSM63714 DNA. An illustrative DNA sequence useful as a probe for detecting soybean event Gm_CSM63714 is provided as SEQ ID NO:16.


A “primer” is a DNA molecule or oligonucleotide that is designed for use in specific annealing or hybridization methods that involve an in vitro amplification reaction. A pair of primers may be used with template DNA (such as a sample of soybean event Gm_CSM63714 genomic DNA) in a thermal amplification reaction (such as polymerase chain reaction (PCR)) or any other suitable amplification method known in the art to produce an amplification product or amplicon, where the amplicon produced from such reaction would have a DNA sequence corresponding to sequence of the template DNA located between the two sites where the primers hybridized to the template DNA.


DNA amplification reactions, methods and techniques are known to those skilled in art. DNA amplification can be accomplished by any of the various nucleic acid amplification methods known in the art, including thermal and isothermal amplification methods including the polymerase chain reaction or PCR. Amplification methods are known in the art and are described, inter alia, in U.S. Pat. Nos. 4,683,195 and 4,683,202 and in PCR Protocols: A Guide to Methods and Applications, ed. Innis et al., Academic Press, San Diego, 1990. PCR amplification methods have been developed to amplify up to 22 kb (kilobase) of genomic DNA and up to 42 kb of bacteriophage DNA (Cheng et al., 1994). These methods as well as other methods known in the art of DNA amplification may be used in the practice of the present disclosure. Examples of DNA amplification methods include PCR, Recombinase Polymerase Amplification (RPA) (see for example U.S. Pat. No. 7,485,428), Strand Displacement Amplification (SDA) (see for example, U.S. Pat. Nos. 5,455,166 and 5,470,723), Transcription-Mediated Amplification (TMA) (see for example, Guatelli et al., 1990), Rolling Circle Amplification (RCA) (see for example, Fire and Xu, 1995; Lui, et al., 1996; Lizardi, et al., 1998; U.S. Pat. Nos. 5,714,320 and 6,235,502), Helicase Dependent Amplification (HDA) (see for example Vincent et al., 2004; U.S. Pat. No. 7,282,328), Multiple Displacement Amplification (MDA) (see for example Dean et al., 2002) and Loop-Mediated Isothermal Amplification (LAMP) (see for example Notomi et al., 2000). A sequence of the heterologous DNA insert and/or flanking genomic DNA sequence from soybean event Gm_CSM63714 can be verified or tested by amplifying such DNA molecules from soybean seed containing event Gm_CSM63714 DNA or soybean plants grown from the soybean seed containing event Gm_CSM63714 DNA, using primers derived from the sequences provided herein, followed by standard DNA sequencing of the PCR amplicon or a cloned DNA fragment thereof.


As used herein, an “amplification product” or “amplified DNA” or “amplicon” refers to the nucleic acid or DNA molecule or segment produced by a nucleic acid amplification reaction or method as further described herein, which is directed to a target nucleic acid or DNA molecule that is part of a template nucleic acid molecule. Amplification or amplifying refers to making multiple copies of a target DNA molecule or segment from a template DNA. For example, to determine whether a soybean plant, plant part, seed, progeny or plant cell, resulting from selfing or outcross of a parent comprising soybean event Gm_CSM63714 contains soybean event Gm_CSM63714, DNA may be extracted from the soybean plant tissue sample and subjected to an amplification reaction or method using a pair of primers that are specific for a target sequence that is uniquely associated or part of soybean event Gm_CSM63714, such as, for example, a first primer derived from a genomic DNA sequence in the region flanking the heterologous inserted DNA of soybean event Gm_CSM63714 that is elongated by polymerase 5′ to 3′ in the direction of the inserted DNA, and a second primer derived from the heterologous inserted DNA molecule that is elongated by the polymerase 5′ to 3′ in the direction of the flanking genomic DNA from which the first primer is derived. The amplicon may range in length depending on the length of the intervening polynucleotide or DNA sequence between the two primer target sequences in the template DNA molecule. Alternatively, a primer pair can be derived from the genomic sequence on both sides of the inserted heterologous DNA so as to produce an amplicon that includes the entire insert polynucleotide sequence (e.g., a forward primer targeted to the genomic portion on the 5′ end of SEQ ID NO:10 (i.e. upstream of SEQ ID NO:9) and a reverse primer targeted to the genomic portion on the 3′ end of SEQ ID NO:10 (i.e. downstream of SEQ ID NO:9) that amplifies a DNA molecule comprising the inserted DNA sequence (SEQ ID NO:9) identified herein in the soybean event Gm_CSM63714 genome. The use of the term “amplicon” specifically excludes primer dimers that may be formed in a DNA amplification reaction.


The amplicon described herein may comprise a DNA sequence comprising one or more of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, or a fragment of any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, or SEQ ID NO:10 wherein the fragment is at least 10 nucleotides in length and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10. According to present embodiments, the sequence of an amplicon comprises at least one junction sequence or two junction sequences, such as a 5′ junction sequence and/or a 3′ junction sequences for soybean event Gm_CSM63714. Amplification and detection of such an amplicon is indicative or diagnostic for soybean event Gm_CSM63714.


For practical purposes, one should design primers which produce amplicons of a limited size range, for example, between 100 to 1000 bases. Smaller (shorter polynucleotide length) sized amplicons in general are more reliably produced in thermal amplification reactions, allow for shorter cycle times, and can be easily separated and visualized on agarose gels or adapted for use in endpoint TaqMan®-like assays. Smaller amplicons can be produced and detected by methods known in the art of DNA amplicon detection. In addition, amplicons produced using the primer pairs can be cloned into vectors, propagated, isolated, and sequenced or can be sequenced directly with methods well established in the art. Any primer pair of forward and reverse primers, which may be identical or complementary to part of SEQ ID NO:10, such as SEQ ID NOs:14 and 15, that is useful in a DNA amplification method to produce an amplicon diagnostic for soybean event Gm_CSM63714 or progeny thereof is an aspect of the disclosure. Any single isolated DNA polynucleotide primer molecule comprising at least 15 contiguous nucleotides of SEQ ID NO:10, or its complement that is useful in a DNA amplification method to produce an amplicon diagnostic for soybean event Gm_CSM63714 or progeny thereof is an aspect of the disclosure. Any single isolated DNA polynucleotide primer molecule comprising at least 15 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:12, or its complement that is useful in a DNA amplification method to produce an amplicon diagnostic for plants comprising soybean event Gm_CSM63714 or progeny thereof is an aspect of the disclosure. Any single isolated DNA polynucleotide primer molecule comprising at least 15 contiguous nucleotides of SEQ ID NO:9, or its complement that is useful in a DNA amplification method to produce an amplicon diagnostic for soybean event Gm_CSM63714 or progeny thereof is an aspect of the disclosure.


A primer is typically designed to hybridize specifically to a complementary target DNA strand to form a hybrid between the primer and the target DNA strand. Hybridization or binding of a primer to the complementary target DNA strand is a point of recognition by a polymerase to begin extension of the primer (i.e., polymerization of additional nucleotides into a lengthening nucleotide molecule) using the target DNA strand as a template. Primer pairs refer to use of two primers binding opposite strands of a double stranded nucleotide segment for the purpose of amplifying the polynucleotide segment between the positions targeted for binding by the individual members of the primer pair, typically in a thermal amplification reaction or other conventional nucleic-acid amplification methods. Primer pairs are typically designed to hybridize to different nearby target positions of a template DNA molecule on opposing strands of the template DNA molecule such that the intervening region or sequence between the two primers can be specifically amplified for use or detection through multiple rounds of amplification.


To detect the presence or absence of soybean event Gm_CSM63714, the target positions and/or the intervening region or sequence of a template DNA molecule may comprise at least one junction sequence and/or at least a portion of the insert of soybean event Gm_CSM63714. To detect the absence of soybean event Gm_CSM63714, the target positions and/or the intervening region or sequence of a template DNA molecule may comprise soybean genomic DNA that does not include a junction sequence or any portion of the insert of soybean event Gm_CSM63714. Thus, the presence or absence of an amplicon with a primer pair may be diagnostic of the presence or absence, respectively, of soybean event Gm_CSM63714 in a DNA molecule or sample, or vice versa. This may also be possible with more than one primer pair. For example, a first primer pair may produce a first amplicon if soybean event Gm_CSM63714 is present, and a second primer pair may produce a second amplicon if soybean event Gm_CSM63714 is absent or not present. Alternatively, the size of an amplicon produced in an amplification reaction may also be diagnostic of the presence or absence of soybean event Gm_CSM63714 in a DNA molecule or sample—e.g., a primer pair may produce a first amplicon of a first size if soybean event Gm_CSM63714 is present or a second amplicon of a second size if soybean event Gm_CSM63714 is absent and not present; or a first primer pair may produce a first amplicon of a first size if soybean event Gm_CSM63714 is present, and a second primer pair may produce a second amplicon of a second size if soybean event Gm_CSM63714 is absent or not present. According to some of these embodiments, at least two primer pairs may be used wherein at least one of the primer pairs is used as an internal control and is not associated with soybean event Gm_CSM63714.


According to present embodiments, a primer pair to detect the presence or absence of all or part of soybean event Gm_CSM63714 in a DNA molecule or sample comprises a first primer and a second primer, wherein the first primer is complementary to a 5′ flanking genomic DNA sequence and the second primer is complementary to a sequence within the transgenic insert; or wherein the first primer is complementary to a 5′ flanking genomic DNA sequence and the second primer is complementary to a 3′ flanking genomic DNA sequence; or wherein the first primer is complementary to a sequence within the transgenic insert and the second primer is complementary to a 3′ flanking genomic DNA sequence. Each reference in this paragraph to a primer complementary to a 5′ flanking genomic DNA sequence, a 3′ flanking genomic DNA sequence, or a sequence within the transgenic insert of soybean event Gm_CSM63714 is also intended to potentially include a primer complementary to the reverse complement or opposing strand of the respective 5′ flanking genomic DNA sequence, 3′ flanking genomic DNA sequence, or sequence within the transgenic insert of soybean event Gm_CSM63714.


Illustrative DNA molecules useful as primers are provided as SEQ ID NO:14 and SEQ ID NO:15 and SEQ ID NO:20. The primer pair SEQ ID NO:14 and SEQ ID NO:15 can be useful as a first primer (corresponding to a sequence within the transgenic insert) and a second primer (complementary to a 3′ flanking genomic DNA sequence), wherein each primer has sufficient length of consecutive nucleotides of SEQ ID NO:10 or a sequence complementary to SEQ ID NO:10 to function as DNA primers that, when used together in an amplification reaction with template DNA derived from soybean event Gm_CSM63714, hybridize to opposite strands of the template DNA and produce an amplicon diagnostic for soybean event Gm_CSM63714 DNA in a sample. The primer pair SEQ ID NO:20 (corresponding to a 5′ flanking genomic DNA sequence) and SEQ ID NO:15 (complementary to a 3′ flanking genomic DNA sequence) are useful as a first primer and a second primer, wherein each primer has sufficient length of consecutive nucleotides of a locus within the soybean genome to function as DNA primers that, when used together in a thermal amplification reaction with template DNA, to produce an amplicon indicative or diagnostic for the wild-type DNA for the zygosity of Gm_CSM63714 event DNA in a sample. An amplicon diagnostic for event Gm_CSM63714 comprises a sequence not naturally found in the soybean genome.


A primer may further comprise an oligo tail sequence such as those used in the Kompetitive Allele-Specific PCR (KASP™) method. The allele-specific primers each harbor a unique tail sequence that corresponds with a universal FRET (fluorescence resonant energy transfer) cassette; one labelled with FAM™ dye and the other with HEX™ dye. During thermal cycling, the relevant allele-specific primer binds to the template and elongates, thus attaching the tail sequence to the newly synthesized strand. The complement of the allele-specific tail sequence is then generated during subsequent rounds of PCR, enabling the FRET cassette to bind to the DNA. The FRET cassette is no longer quenched and emits fluorescence.


Methods for designing and using primers and probes are well known in the art. DNA molecules comprising fragments of SEQ ID NOs:1-10 are useful as primers and probes for detecting soybean event Gm_CSM63714 and can readily be designed by one of skill in the art using the sequences provided herein. Such probes and primers are selected to be of sufficient length and sequence complementarity to a target sequence to hybridize specifically to a target sequence under stringency hybridization conditions. Probes and primers may have a complete sequence complementarity or identity with the target sequence, although probes and primers differing from the target sequence in terms of identity or complementarity but retaining the ability to form a stable double-stranded structure under particular hybridization conditions or reaction conditions and to hybridize to the target sequence may be designed by conventional methods.


Any conventional nucleic acid hybridization or amplification method can be used to identify or detect the presence of a target DNA from a transgenic plant, such as soybean event Gm_CSM63714, in a sample. Polynucleotide molecules or DNA molecules, also referred to as “polynucleotide segment or fragment of sufficient length” or “sufficient length of contiguous or consecutive nucleotides” therefore are capable of specifically hybridizing to a target DNA sequence under certain hybridization conditions or reaction conditions. As used herein, the term “of sufficient length” refers to any length that is sufficient to be useful in a detection method of choice. Probes and primers are generally at least about 8 nucleotides, at least about 10 nucleotides, at least about 12 nucleotides, at least about 14 nucleotides, at least about 16 nucleotides, at least about 18 nucleotides, at least about 20 nucleotides, at least about 22 nucleotides, at least about 24 nucleotides, at least about 26 nucleotides, at least about 28 nucleotides, or at least about 30 nucleotides or more in length. Such probes and primers hybridize specifically to a target DNA sequence under stringent hybridization conditions.


As used herein, two nucleic acid molecules are capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double-stranded nucleic acid structure. A nucleic acid molecule is the “complement” of another nucleic acid molecule if they exhibit complete complementarity. As used herein, two nucleic acid molecules exhibit “complete complementarity” and are “completely complementary” if every nucleotide of the first nucleic acid molecule is complementary to every nucleotide of the second nucleic acid molecule when they are aligned. Two molecules are “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low-stringency” conditions. Similarly, the molecules are “complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high-stringency” conditions. Conventional stringency conditions are described by Haymes et al., In: Nucleic Acid Hybridization, A Practical Approach, IRL Press, Washington, DC (1985), and by MR Green and J Sambrook, Molecular cloning: a laboratory manual, 4th Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2012). Departures from complete complementarity are therefore permissible, as long as such departures do not completely preclude the capacity of the molecules to form a double-stranded structure. In order for a nucleic acid molecule to serve as a primer or probe, it need only be sufficiently complementary in sequence to be able to form a stable double-stranded structure under the particular solvent and salt concentrations and other conditions employed.


As used herein, a substantially homologous or complementary sequence in relation to a reference nucleic acid sequence is a nucleic acid sequence that will specifically hybridize to the reference nucleic acid sequence or its complement to which it is being compared under high stringency conditions. As used herein, “stringent hybridization conditions” refers to conditions under which a polynucleotide will hybridize to its target sequence, typically in a complex mixture of nucleic acids, but to essentially no other sequences. “Stringent conditions” or “stringent hybridization conditions” when referring to a polynucleotide probe, refer to conditions under which a probe will hybridize to its target sequence to a detectably greater degree than to other sequences (e.g., at least 2-fold over background). Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures. Generally, stringent conditions are selected to be about 5-10° C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength pH. The Tm is the temperature (under defined ionic strength, pH, and nucleic acid concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (as the target sequences are present in excess, at Tm, 50% of the probes are occupied at equilibrium. Stringent conditions will be those in which the salt concentration is less than about 1.0 M sodium ion, typically about 0.01 to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30° C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60° C. for long probes (e.g. greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. By controlling the stringency of the hybridization and/or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of identity are detected (heterologous probing).


Appropriate stringency conditions which promote DNA hybridization, for example, 6× sodium chloride/sodium citrate (SSC) at about 45° C., followed by a wash of 2×SSC at 50° C., are known to those skilled in the art or can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6. For example, the salt concentration in the wash step can be selected from a low stringency of about 2.0×SSC at 50° C. to a high stringency of about 0.2×SSC at 50° C. In addition, the temperature in the wash step can be increased from low stringency conditions at room temperature, about 22° C., to high stringency conditions at about 65° C. Both temperature and salt may be varied, or either the temperature or the salt concentration may be held constant while the other variable is changed. Regarding the amplification of a target polynucleotide (e.g., by PCR) using a particular amplification primer pair, “stringent conditions” or “stringent hybridization conditions” are conditions that permit the primer pair to hybridize to the target polynucleotide to which a primer having the corresponding wild-type sequence (or its complement) would bind and to produce an identifiable amplification product (the amplicon) having a soybean Gm_CSM63714 event specific region in a DNA thermal amplification reaction. The term “specific for” a target sequence indicates that a probe or primer hybridizes under stringent hybridization conditions only to the target sequence in a sample comprising the target sequence.


A polynucleotide molecule or DNA molecule of the present disclosure, such as a primer or a probe, will specifically hybridize to at least one of the nucleic acid molecule sequences selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to SEQ ID NO:10, or a complete complement of or fragment of any of the foregoing under stringent hybridization conditions, or under moderately stringent hybridization conditions if the sequence of the polynucleotide molecule is not identical to the at least one of the nucleic acid molecules. The hybridization of a nucleic acid molecule, such as a primer or probe, to the target DNA molecule can be detected by any number of methods known to those skilled in the art, which can include, but are not limited to, fluorescent tags, radioactive tags, antibody-based tags, and chemiluminescent tags.


An illustrative DNA molecule or polynucleotide useful as a probe for detecting soybean event Gm_CSM63714 is provided as SEQ ID NO:16. In some embodiments, a DNA molecule that functions as a probe comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a complement of any of the foregoing or a fragment of any of the foregoing. In other embodiments, a DNA molecule comprises a polynucleotide segment of sufficient length to function as a DNA probe specific for at least one of: a) a 5′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714; b) a 3′ junction sequence between the transgenic insert of soybean event Gm_CSM63714 and flanking soybean genomic DNA; c) SEQ ID NO:9; or d) a fragment of SEQ ID NO:9 comprising a sufficient length of contiguous nucleotides of SEQ ID NO:9 to identify the sequence as a fragment of the transgenic insert of Gm_CSM63714 in a sample of DNA.


A diagnostic amplicon produced by the methods described herein may be detected by a plurality of techniques known in the art, such as sequencing, restriction mapping, Southern analysis, or any other suitable polynucleotide or DNA hybridization, blotting, polymerization and/or amplification-based approach or technique. One method is Genetic Bit Analysis (Nikiforov et al., 1994) where a DNA oligonucleotide is designed that overlaps both the adjacent flanking genomic DNA sequence and the inserted DNA sequence—i.e., a junction sequence. The oligonucleotide is immobilized in wells of a microtiter plate. Following PCR of the region of interest (using, for example, one primer in the inserted sequence and one in the adjacent flanking genomic sequence), a single-stranded PCR product can be hybridized to the immobilized oligonucleotide and serve as a template for a single base extension reaction using a DNA polymerase and labeled dideoxynucleotide triphosphates (ddNTPs) specific for the expected next base. Readout may be fluorescent or ELISA-based. A signal indicates presence of the transgene/genomic junction sequence due to successful amplification, hybridization, and single base extension.


Another method is the pyrosequencing technique as described by Winge (2000). In this method, an oligonucleotide is designed that overlaps the adjacent genomic DNA and insert DNA junction. The oligonucleotide is hybridized to single-stranded PCR product from the region of interest (one primer in the inserted sequence and one in the flanking genomic sequence) and incubated in the presence of a DNA polymerase, ATP, sulfurylase, luciferase, apyrase, adenosine 5′ phosphosulfate and luciferin. DNTPs are added individually and the incorporation results in a light signal that is measured. A light signal indicates the presence of the transgene/genomic sequence due to successful amplification, hybridization, and single or multi-base extension.


Fluorescence Polarization as described by Chen et al. (1999) is a method that can be used to detect the amplicon of the present invention. Using this method an oligonucleotide is designed that overlaps the genomic flanking and inserted DNA junction. The oligonucleotide is hybridized to single-stranded PCR product from the region of interest (one primer in the inserted DNA and one in the flanking genomic DNA sequence) and incubated in the presence of a DNA polymerase and a fluorescent-labeled ddNTP. Single base extension results in incorporation of the ddNTP. Incorporation can be measured as a change in polarization using a fluorometer. A change in polarization indicates the presence of the transgene/genomic sequence due to successful amplification, hybridization, and single base extension.


Real-time polymerase chain reaction (PCR) has the ability to monitor the progress of the PCR as it occurs (i.e., in real time). Data is collected throughout the PCR process, rather than at the end of the PCR. In real-time PCR, reactions are characterized by the point in time during cycling when amplification of a target is first detected rather than the amount of target accumulated after a fixed number of cycles. In a real-time PCR assay, a positive reaction is detected by accumulation of a fluorescent signal. The higher the starting copy number of the nucleic acid target, the sooner a significant increase in fluorescence is observed. The cycle threshold (Ct value) is defined as the number of cycles required for the fluorescent signal to cross the threshold (i.e., exceeds background level). Ct levels are inversely proportional to the amount of target nucleic acid in the sample (i.e., the lower the Ct value, the greater the amount of target nucleic acid in the sample).


Taqman® (PE Applied Biosystems, Foster City, CA) is described as a method of detecting and quantifying the presence of a DNA sequence using real-time PCR and is fully understood in the instructions provided by the manufacturer. Briefly, a FRET oligonucleotide probe is designed that overlaps the genomic flanking and insert DNA junction. The FRET probe and PCR primers (one primer in the insert DNA sequence and one in the flanking genomic sequence) are cycled in the presence of a thermal stable polymerase and dNTPs. Hybridization of the FRET probe results in cleavage and release of the fluorescent moiety away from the quenching moiety on the FRET probe. A fluorescent signal indicates the presence of the transgene/genomic sequence due to successful amplification and hybridization.


Molecular beacons have been described for use in sequence detection as described in Tyangi et al. (1996). Briefly, a FRET oligonucleotide probe is designed that overlaps the flanking genomic and insert DNA junction. The unique structure of the FRET probe results in it containing secondary structure that keeps the fluorescent and quenching moieties in close proximity. The FRET probe and PCR primers (one primer in the insert DNA sequence and one in the flanking genomic sequence) are cycled in the presence of a thermostable polymerase and dNTPs. Following successful PCR amplification, hybridization of the FRET probe to the target sequence results in the removal of the probe secondary structure and spatial separation of the fluorescent and quenching moieties. A fluorescent signal results and indicates the presence of the flanking/transgene insert sequence due to successful amplification and hybridization.


Other detection methods known in the art may be used. For example, microfluidics (see, e.g., U.S. Patent Publication No. 2006/068398; U.S. Pat. No. 6,544,734) provide methods and devices that can be used to separate and amplify DNA samples or molecules. Optical dyes can be used to detect and measure specific DNA molecules (see, e.g., WO/05017181). Nanotube devices (see, e.g., WO/06024023) that comprise an electronic sensor for the detection of DNA molecules or nanobeads that bind specific DNA molecules can then be detected. Nanopore sequencing technology, such as that described in Wang et al. (2021), Tyler et al. (2018), or Pearson et al. (2019), can also be used for event detection.


The DNA molecules and corresponding nucleotide sequences provided herein are therefore useful for, among other things, identifying soybean event Gm_CSM63714, detecting the presence of DNA derived from the transgenic soybean event Gm_CSM63714 in a sample, and monitoring samples for the presence and/or absence of soybean event Gm_CSM63714 or plant parts derived from soybean plants comprising event Gm_CSM63714.


Provided are proteins that can be used to produce antibodies for detecting the presence of soybean event Gm_CSM63714 in a sample. Such antibodies are specific for one or more of the proteins that are encoded by soybean event Gm_CSM63714. Methods for preparing a polyclonal antibody or a monoclonal antibody are well-known to those skilled in the art, and can be used to make antibodies specific for one or more of the proteins encoded by soybean event Gm_CSM63714. For example, U.S. Pat. No. 7,838,729 and Wang et al. (2016) describe antibodies to DMO; U.S. Pat. No. 9,371,394 describes antibodies to the PAT enzyme. The DNA sequence encoding such proteins is provided in SEQ ID NO:10 and the start positions and stop positions of the coding sequences are indicated in Table 1. The DNA sequence encoding each protein and the protein encoded by the sequence are useful to produce antibodies for detecting the presence of soybean event Gm_CSM63714 by the methods described herein. Detection for the presence of soybean event Gm_CSM63714 may be done by using any protein detection techniques known in the art, such as western blot analysis, immuno-precipitation, enzyme-linked immunosorbent assay (ELISA), antibody attachment to a detectable label or reporter molecule (such as a radioactive isotope, ligand, chemiluminescent agent, or enzyme), or enzymatic action on a reporter molecule. One method provides for contacting a sample with an antibody that binds to the DMO, PAT, FT_Tv7 or TDO protein encoded by soybean event Gm_CSM63714 and then detecting the presence or absence of antibody binding. The binding of such antibody is diagnostic for the presence of one or more proteins encoded by soybean event Gm_CSM63714.


Nucleic acid or protein detection kits for detecting the presence of soybean event Gm_CSM63714 are provided. Variations on such kits can also be developed using the compositions and methods disclosed herein and the methods well known in the art for protein and nucleic acid detection for identification of soybean event Gm_CSM63714. Protein and nucleic acid detection kits can be applied to methods for breeding with plants comprising soybean event Gm_CSM63714. Such kits contain primers and/or probes or antibodies which are specific to soybean event Gm_CSM63714. Such DNA primers and/or probes may comprise fragments of one or more of SEQ ID NOs:1-10, or antibodies specific for a protein encoded by the soybean event Gm_CSM63714. The kits can also contain instructions for using the primers, probes, or antibodies for detecting the presence of soybean event Gm_CSM63714. Kits may optionally also comprise reagents for performing the detection or diagnostic reactions described herein.


One example of a detection kit comprises at least one DNA molecule of sufficient length of contiguous nucleotides of SEQ ID NO:10 to function as a DNA probe useful for detecting the presence or absence of soybean event Gm_CSM63714 in a sample. The DNA derived from transgenic soybean plants comprising event Gm_CSM63714 would comprise a DNA molecule having at least one sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10, a complement of any of the foregoing, or a fragment of any of the foregoing. An illustrative DNA molecule sufficient for use as a probe is one comprising the sequence provided as SEQ ID NO:16. Other probes may be readily designed by one of skill in the art. The probe can include a junction sequence that spans the 5′ or 3′ junction between the soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714.


Another example of a detection kit comprises at least one primer pair that specifically hybridize to a target DNA and amplify a diagnostic amplicon under the appropriate reaction conditions useful for detecting the presence or absence of soybean event Gm_CSM63714 in a sample. A kit that contains DNA primers that are homologous or complementary to any portion of the soybean genomic region as set forth in SEQ ID NO:10 and to any portion of the inserted transgenic DNA as set forth in SEQ ID NO:9 is an object of the present disclosure. The kit may provide an agarose gel-based detection method or any number of methods of detecting the amplicon that are known in the art. Such a method may also include sequencing the amplicon or a fragment thereof. Illustrative DNA molecules sufficient for use as a primer pair are ones comprising the sequences provided as SEQ ID NO:14 and SEQ ID NO:15, and SEQ ID NO:20 and SEQ ID NO:15, respectively, wherein the primer pair SEQ ID NO:14 and SEQ ID NO:15 will produce an amplicon diagnostic for the presence of event Gm_CSM63714 in a sample; and the primer pair SEQ ID NO:20 and SEQ ID NO:15 will produce an amplicon indicative of wild-type DNA, therefore, diagnostic for the absence of event Gm_CSM63714 in a sample. Other primer pairs may be readily designed by one of skill in the art.


Another example of a detection kit comprises at least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714. For example, such a kit may utilize a lateral flow strip comprising reagents activated when the tip of the strip is contacted with an aqueous solution. Illustrative proteins sufficient for use in antibody production are ones encoded by the sequence provided as SEQ ID NO:10, or any fragment thereof. Detection of binding of the at least one antibody to the at least one protein encoded by soybean event Gm_CSM63714 in a sample is diagnostic for the presence of soybean event Gm_CSM63714 in the sample.


The detection kits provided herein are useful for, among other things, identifying soybean event Gm_CSM63714, selecting plant varieties or hybrids comprising soybean event Gm_CSM63714, detecting the presence of DNA derived from the transgenic soybean plant comprising event Gm_CSM63714 in a sample, and monitoring samples for the presence and/or absence of soybean plants comprising event Gm_CSM63714, or plant parts derived from soybean plants comprising event Gm_CSM63714.


Soybean plants, progeny, seeds, cells, and plant parts comprising soybean event Gm_CSM63714 are provided, as well as commodity products produced using these. As used herein, the term “soybean” or “soy” means plant species within Glycine max and all plant varieties belonging to the genus Glycine that can be bred with Glycine max plants, including wild soybean species such as Glycine soja. The term “soybean” is intended to include soybean plants, plant parts, plant cells, plant tissue, seeds, progeny plants, and/or soybean commodity products. These soybean plants, plant parts, plant cells, plant tissues, seeds, progeny plants and commodity products contain or comprise soybean event Gm_CSM63714 or are derived from a transgenic soybean plant, plant part, plant cell, plant tissue, seed, progeny plant or commodity product containing or comprising event Gm_CSM63714. These soybean plants, plant parts, plant cells, plant tissues, seeds, progeny plants and commodity products contain a detectable amount of a polynucleotide or DNA molecule comprising at least one junction sequence and/or heterologous transgenic insert sequence of soybean event Gm_CSM63714, such as a polynucleotide or nucleic acid or DNA molecule having or comprising at least one of the sequences provided as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a polynucleotide comprising at least 16 consecutive nucleotides of SEQ ID NO:1, at least 23 consecutive nucleotides of SEQ ID NO:2, at least 33 consecutive nucleotides of SEQ ID NO:3, at least 31 consecutive nucleotides of SEQ ID NO:4, at least 51 consecutive nucleotides of SEQ ID NO:5, or at least 51 consecutive nucleotides of SEQ ID NO:6, a polynucleotide comprising a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9, and a complete complement of any of the foregoing. In some embodiments, the soybean plant, plant part, plant cell, plant tissue, or seed is further defined as a progeny plant of any generation of a soybean plant comprising soybean event Gm_CSM63714, or a soybean plant part, plant seed, or plant cell derived therefrom.


The soybean plants, plant parts, plant cells, plant tissues, seeds, progeny plants and commodity products express or contain at least one herbicide tolerance gene selected from the group consisting of dicamba monooxygenase (DMO), phosphinothricin N-acetyltransferase (PAT), an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant (FT_Tv7), triketone dioxygenase (TDO), and any combination thereof, and are tolerant to at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone (HPPD inhibitor) such as mesotrione, and any combination thereof.


Also provided are soybean plants, plant seeds, plant parts, and plant cells tolerant to herbicides with at least three different herbicide modes of action, wherein the genes that confer the herbicide tolerance are present at a single genomic location. For example, the soybean plants, plant seeds, plant parts, or plant cells can be tolerant to herbicides with at least four different herbicide modes of action, wherein the genes that confer the herbicide tolerance are present at a single genomic location. To make such a soybean plant, plant seed, plant part, or plant cell, three or more transgenic cassettes containing herbicide tolerance genes can be inserted at a single genomic location within the soybean genome as a contiguous polynucleotide or a single molecularly linked transgenic insert. Alternatively, three or more transgenic cassettes containing herbicide tolerance genes can be inserted at a single genomic location by inserting separate cassettes containing the herbicide tolerance genes at the same location. By “single genomic location” it is meant that the genes, together with any regulatory sequences (e.g., promoters, introns, leader sequences, 5′-UTRs, and/or 3′UTRs, etc.) and/or sequences encoding targeting peptides (e.g., chloroplast transit peptides) are present at a single location on a chromosome, and will be inherited as a single locus. While some intervening sequence may be present between each transgene cassette, the length of the intervening sequence is limited such that the transgenes cassettes are close to one another on the chromosome. For example, the intervening sequence between the transgene cassettes may be 500 nucleotides or fewer in length, 400 nucleotides or fewer in length, 300 nucleotides or fewer in length, 250 nucleotides or fewer in length, 200 nucleotides or fewer in length, or 150 nucleotides or fewer in length. For example, the soybean plant, plant seed, plant part, or plant cell can comprise any of DNA constructs described herein, and can exhibit tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins such as dicamba, phenoxy auxins such as 2,4-D, glutamine synthetase inhibitors such as glufosinate, β-triketone HPPD inhibitors such as mesotrione, and any combination thereof.


The present disclosure provides soybean plants, progeny, seeds, plant cells, and plant parts such as microspores, pollen, anthers, ovules, ovaries, flowers, pods, embryos, stems, leaves, roots, and calluses derived from a transgenic soybean plant comprising soybean event Gm_CSM63714. A representative sample of seed comprising soybean event Gm_CSM63714 has been deposited according to the Budapest Treaty for the purpose of enabling the present disclosure. The ATCC repository has assigned the Accession No. PTA-127099 to the seed comprising soybean event Gm_CSM63714.


A microorganism is provided. The microorganism comprises a polynucleotide molecule having the nucleotide sequence of SEQ ID NO:9, or a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4% at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:9. An example of such a microorganism is an Agrobacterium cell. Another example of such a microorganism is an E. coli cell.


A plant cell is provided comprising a polynucleotide molecule as described herein. For example, a plant cell is provided having a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and a nucleic acid molecule comprising a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9 present in its genome.


Plant cells and microorganisms of the present disclosure are useful in many industrial applications, including but not limited to: (i) use as research tools for scientific inquiry or industrial research; (ii) use in culture for producing endogenous or recombinant carbohydrate, lipid, nucleic acid, enzymes or protein products or small molecules that may be used for subsequent scientific research or as industrial products; and (iii) for the plant cells of the present disclosure, use with modern plant tissue culture techniques to produce transgenic plants or plant tissue cultures that may then be used for agricultural research or production. The production and use of such transgenic plant cells utilize modern microbiological techniques and human intervention to produce a man-made, unique plant cell. In this process, a recombinant DNA is inserted into a plant cell's genome to create a transgenic plant cell that is separate and unique from naturally occurring plant cells. This transgenic plant cell can then be cultured much like bacteria and yeast cells using modern microbiology techniques and may exist in an undifferentiated, unicellular state. The new plant cell's genetic composition and phenotype is a technical effect created by the integration of a heterologous DNA into the genome of the cell.


Provided are method of using a plant cell, such as transgenic plant cells. These include (i) methods of producing transgenic cells by integrating a recombinant DNA into the genome of the cell and then using this cell to derive additional cells possessing the same heterologous DNA; (ii) methods of culturing cells that contain recombinant DNA using modern microbiology techniques; (iii) methods of producing and purifying endogenous or recombinant carbohydrate, lipid, nucleic acid, enzymes or protein products from cultured cells; and (iv) methods of using modern plant tissue culture techniques with transgenic plant cells to produce transgenic plants or transgenic plant tissue cultures.


Plants, progeny, seeds, cells, and plant parts may contain one or more additional desirable trait(s). Such desirable traits may be transgenic traits, native traits, or traits produced by other methods such as genome editing, base editing, prime editing or other conventional mutagenesis methods. Desirable traits may be combined with soybean event Gm_CSM63714 by, for example, crossing a soybean plant comprising soybean event Gm_CSM63714 with another soybean plant containing the additional trait(s), or transgenic events. Such traits or transgenic events include, but are not limited to, increased insect resistance, increased water use efficiency, increased yield performance, increased drought resistance, increased disease resistance, increased seed quality, improved nutritional quality, hybrid seed production, and/or increase herbicide tolerance, in which the trait is measured with respect to a soybean plant lacking such transgenic trait. For example, the Gm_CSM63714 event could be stacked by breeding or by site directed introgression with other events known in the art including, but not limited to, A2704-12 (Liberty Link® for glufosinate herbicide tolerance), A2704-21 (Liberty Link® for glufosinate herbicide tolerance), A5547-127 (Liberty Link® for glufosinate herbicide tolerance), A5547-35 (Liberty Link® for glufosinate herbicide tolerance), CV127 (Cultivance for sulfonylurea herbicide tolerance), DAS44406-6 (for glufosinate, glyphosate and 2,4-D herbicide tolerance), DAS81419 (for glufosinate tolerance and Lepidopteran resistance), DP356043 (Optimum GAT™ for glyphosate and sulfonylurea herbicide tolerance), FG72 (for glyphosate and isoxaflutole herbicide tolerance), FG72×A5547-127 (Liberty Link® GT27™ for glufosinate, glyphosate and isoxaflutole herbicide tolerance), GMB151 (for isoxaflutole herbicide tolerance), GTS 40-3-2 (Roundup Ready™ for glyphosate herbicide tolerance), GU262 (Liberty Link™ for glufosinate herbicide tolerance, and antibiotic resistance), MON87708 (Genuity® Roundup Ready™ 2 Xtend™ for glyphosate and dicamba herbicide tolerance), MON89788 (Genuity® Roundup Ready 2 Yield™ for glyphosate herbicide tolerance), SYHT0H2 (Herbicide-Tolerant Soybean Line for glufosinate and mesotrione herbicide tolerance), W62 (Liberty Link™ for glufosinate herbicide tolerance), and W98 (Liberty Link™ for glufosinate herbicide tolerance), MON87701 (for Lepidopteran insect resistance), MON87751 (for Lepidopteran insect resistance), DAS81419×DAS44406 (Conkesta Enlist E3™ for glufosinate, glyphosate and 2,4-D herbicide tolerance, and Lepidopteran insect resistance), MON87701×MON89788 (Intacta™ Roundup Ready™ 2 Pro for glyphosate herbicide tolerance and Lepidopteran insect resistance), MON87751×MON87701×MON87708×MON89788 (for glyphosate and dicamba herbicide tolerance, and Lepidopteran insect resistance) to provide herbicide tolerance and/or to control Lepidopteran pests. The Gm_CSM63714 event could also be stacked by breeding or by site directed introgression with other transgenic soybean events known in the art including, but not limited to, DP305423 (Treus™, Plenish™ for sulfonylurea herbicide tolerance, and modified oil/fatty acid), MON87705 (Vistive Gold™ for glyphosate herbicide tolerance and modified oil/fatty acid), MON87712 (for glyphosate herbicide tolerance and enhanced photosynthesis/yield), MON87769 (for glyphosate herbicide tolerance and modified oil/fatty acid), and HB4 (Verdeca HB4 Soybean for drought stress tolerance) to provide tolerance to herbicides and/or modified oils, enhanced photosynthesis/yield, or drought tolerance. The Gm_CSM63714 event could also be stacked by breeding or by site directed introgression with genome edited events known in the art including, but not limited to, high-oleic soybean trait, and high oleic low linolenic (HOLL) soybean trait.


The plants described herein can be used to produce progeny or offspring that comprise soybean event Gm_CSM63714. Such progeny may include any plant, seed, and cell and/or regenerable plant part comprising soybean event Gm_CSM63714 inherited or derived from an ancestor or parental soybean plant(s), at least one of which comprises a DNA molecule having or comprising at least one polynucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a polynucleotide comprising at least 16 consecutive nucleotides of SEQ ID NO:1, at least 23 consecutive nucleotides of SEQ ID NO:2, at least 33 consecutive nucleotides of SEQ ID NO:3, at least 31 consecutive nucleotides of SEQ ID NO:4, at least 51 consecutive nucleotides of SEQ ID NO:5, or at least 51 consecutive nucleotides of SEQ ID NO:6, or a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9.


Soybean plants, progeny, and seed may be homozygous or heterozygous for the event Gm_CSM63714 and the transgenes of event Gm_CSM63714. Progeny may be grown from seeds produced by a soybean plant comprising or containing event Gm_CSM63714 and/or from seeds produced by a plant fertilized with pollen from a soybean plant comprising or containing event Gm_CSM63714 (i.e., fertilized with pollen comprising or containing event Gm_CSM63714). Plants or progeny may also be obtained by tissue culture and regeneration methods from a protoplast, cell, embryo or reproductive or somatic tissue derived from a soybean plant comprising or containing soybean event Gm_CSM63714.


Progeny plants may be self-pollinated (also known as “selfing”) to generate a true breeding line of plants, i.e., plants homozygous for the soybean event Gm_CSM63714 DNA. Alternatively, progeny plants may be outcrossed, i.e., bred with another plant, to produce a varietal or a hybrid seed or plant. The other plant may be transgenic or non-transgenic. A varietal or hybrid seed or plant of the present disclosure may thus be derived by crossing a first parent that lacks the specific and unique DNA of event Gm_CSM63714 with a second parent comprising event Gm_CSM63714, resulting in a hybrid comprising the specific and unique DNA of event Gm_CSM63714. Each parent can be a hybrid or an inbred/variety, so long as the cross or breeding results in a plant or seed of the present disclosure, i.e., a seed having at least one allele comprising the specific and unique DNA of event Gm_CSM63714 and/or at least 16 consecutive nucleotides of SEQ ID NO:1, at least 23 consecutive nucleotides of SEQ ID NO:2, at least 33 consecutive nucleotides of SEQ ID NO:3, at least 31 consecutive nucleotides of SEQ ID NO:4, at least 51 consecutive nucleotides of SEQ ID NO:5, or at least 51 consecutive nucleotides of SEQ ID NO:6, or a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO:9.


Sexually crossing one plant with another plant, i.e., cross-pollinating, may be accomplished or facilitated by human intervention, for example: by human hands collecting the pollen of one plant and contacting this pollen with the style or stigma of a second plant; by human hands and/or human actions removing, destroying, or covering the stamen or anthers of a plant (e.g., by manual intervention or by application of a chemical gametocide) so that natural self-pollination is prevented and cross-pollination would have to take place in order for fertilization to occur; by human placement of pollinating insects in a position for “directed pollination” (e.g., by placing beehives in orchards or fields or by caging plants with pollinating insects); by human opening or removing of parts of the flower to allow for placement or contact of foreign pollen on the style or stigma; by selective placement of plants (e.g., intentionally planting plants in pollinating proximity); and/or by application of chemicals to precipitate flowering or to foster receptivity (of the stigma for pollen).


Two different transgenic plants of the same or different genetic backgrounds may thus be crossed to produce inbred or hybrid offspring plants, plant parts and/or seeds that contain two independently segregating transgenes or events wherein at least one of those transgenes or events comprises or is contained within soybean event Gm_CSM63714. For example, transgenic plants comprising soybean event Gm_CSM63714 can be crossed with other transgenic soybean plants to produce a plant having the characteristics of both transgenic parents.


Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation. Descriptions of other breeding methods that are commonly used for different traits and crops are known in the art and can be found in one of several references, e.g., Fehr, in Breeding Methods for Cultivar Development, Wilcox J. ed., American Society of Agronomy, Madison WI (1987).


A plant part is provided. As used herein, a “plant part” refers to any part of a plant that is comprised of material directly from or derived from a plant comprising soybean event Gm_CSM63714. Plant parts include but are not limited to microspores, pollen, anthers, ovules, ovaries, flowers, pods, embryos, stems, leaves, roots, and calluses, in whole or part. Plant parts may be viable or nonviable, regenerable and/or non-regenerable.


Commodity products that are produced from plants comprising soybean event Gm_CSM63714 are provided. The commodity products contain a detectable amount of DNA comprising a DNA sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, or a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO:9. As used herein, a “commodity product” refers to any composition or product which is comprised of material from plant, seed, cell, or plant part comprising soybean event Gm_CSM63714. Commodity products may be viable or non-living plant material, that is, a material that is not living and derived from a plant, seed, cell, or plant part comprising soybean event Gm_CSM63714. Nonviable commodity products include but are not limited to nonviable seeds, whole or processed seeds, processed plant tissues or plant parts, dehydrated plant tissues or parts, frozen plant tissues or parts, food for human consumption (such as soy oil, soy milk, soy flour and grits, soy protein, soy protein concentrate, hydrolyzed vegetable protein, textured soy protein, lecithin, curd, tofu, vegetable soybean (edamame), soy sprout, soy film (yuba), roasted soybeans, miso, tempeh, soy sauce, natto), plant parts processed for animal feed such as soy meal, soy fiber, biodiesel, bio-composite building materials (such as particleboard, laminated plywood and lumber products), soy oil based solvents and industrial lubricants, soy ink, soy candle and crayon, soy-based hydraulic fluid, and soy-based foams. Viable commodity products include but are not limited to viable seeds, viable plant parts (such as root and leaf) and viable plant cells. A plant comprising event Gm_CSM63714 can thus be used to manufacture any commodity product typically acquired from a soybean plant. Any such commodity product that is derived from the plants comprising event Gm_CSM63714 may contain at least a detectable amount of the specific and unique DNA corresponding to event Gm_CSM63714, and specifically may contain a detectable amount of a polynucleotide having a nucleotide sequence of at least 16 consecutive nucleotides of SEQ ID NO:1, at least 23 consecutive nucleotides of SEQ ID NO:2, at least 33 consecutive nucleotides of SEQ ID NO:3, at least 31 consecutive nucleotides of SEQ ID NO:4, at least 51 consecutive nucleotides of SEQ ID NO:5, or at least 51 consecutive nucleotides of SEQ ID NO:6, or a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO:9. Any standard method of detection for polynucleotide molecules may be used, including methods of detection disclosed herein.


A plant tolerant to herbicides may be produced by sexually crossing a plant comprising event Gm_CSM63714 with another plant and thereby producing seed, which is then grown into progeny plants. These progeny plants may be analyzed using diagnostic methods to select for progeny plants that comprise event Gm_CSM63714 DNA or for progeny plants tolerant to the herbicides benzoic acid auxins such as dicamba, glutamine synthetase inhibitors such as glufosinate, phenoxy auxins such as 2,4-D, β-triketones such as mesotrione, and any combination thereof. The other plant used may or may not be transgenic. The progeny plant and/or seed produced may be varietal or hybrid seed.


A plant tolerant to herbicides may be produced by selfing a plant comprising event Gm_CSM63714 comprising a polynucleotide having the nucleotide sequence of SEQ ID NOs:1-10, at least 16 consecutive nucleotides of SEQ ID NO:1, at least 23 consecutive nucleotides of SEQ ID NO:2, at least 33 consecutive nucleotides of SEQ ID NO:3, at least 31 consecutive nucleotides of SEQ ID NO:4, at least 51 consecutive nucleotides of SEQ ID NO:5, or at least 51 consecutive nucleotides of SEQ ID NO:6, and a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO:9, and thereby producing seed, which is then grown into progeny plants. These progeny plants may then be analyzed using diagnostic methods to select for progeny plants that comprise event Gm_CSM63714 DNA, or for progeny plants tolerant to the herbicides such as dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor such as mesotrione, and any combination thereof.


Soybean event Gm_CSM63714 contains four expression cassettes that together provide tolerance to benzoic acid auxins such as dicamba; phenoxy auxins such as 2,4-D; inhibitors of glutamine synthetase such as glufosinate; and β-triketone HPPD inhibitors such as mesotrione.


As used herein, inhibitors of glutamine synthetase include, but are not limited to, phosphinothricin, glufosinate, glufosinate salts, glufosinate-ammonium, glufosinate-sodium, glufosinate-P, L-glufosinate-ammonium, and L-glufosinate-sodium.


As used herein, synthetic auxins include, but are not limited to, benzoic acid herbicides, phenoxy acid herbicides, arylpicolinate herbicides, and pyridinyloxy acid herbicides. Examples of a benzoic acid herbicides include, but are not limited to, dicamba (3,6-dichloro-2-methoxybenzoic acid), dicamba salts, dicamba-butotyl, dicamba-diglycolamine salt, dicamba-dimethylammonium, dicamba-diethanolammonium, dicamba-isopropylammonium, dicamba-potassium, dicamba-sodium, and dicamba-trolamine. Examples of phenoxy acid herbicides include, but are not limited to, 2,4-D (2,4-dichlorophenoxyacetic acid), 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-choline, 2,4-D-dimethylammonium, 2,4-D-diolamin, 2,4-D-ethyl, 2,4-D-2-ethylhexyl, 2,4-D-isobutyl, 2,4-D-isoctyl, 2,4-D-isopropyl, 2,4-D-isopropylammonium, 2,4-D-potassium, 2,4-D-sodium, 2,4-D-triisopropanolammonium, 2,4-D-trolamine, clomeprop, dichlorprop, fenoprop, MCPA (2-methyl-4-chlorophenoxyacetic acid), MCPA-butotyl, MCPA-dimethylammonium, MCPA-2-ethylhexyl. MCPA-isopropylammonium, MCPA-potassium, MCPA-sodium, MCPA-thioethyl, 2,4-DB, MCPB (4-(4-chloro-2-methylphenoxy)butanoic acid), MCPB-methyl, MCPB-ethyl-sodium, and mecoprop. Examples of arylpicolinate herbicides include, but are not limited to, halauxifen, halauxifen-methyl, and florpyrauxifen-benzyl. Examples of pyridinyloxy acid herbicides include, but are not limited to, triclopyr, fluroxypyr, aminopyralid, and picloram.


As used herein, β-triketone HPPD inhibitors include, but are not limited to benzobicyclon (BBC), tefuryltrione, sulcotrione, mesotrione, and tembotrione.


FT_Tv7 degrades phenoxy auxins such as 2,4-D, and thus soybean containing event Gm_CSM63714 exhibits tolerance to 2,4-D. In addition, FT_Tv7 is also capable of degrading aryloxyphenoxypropionate (AOPP) inhibitors of acetyl CoA carboxylase (ACCase), including the “fop” family of herbicides. Examples of AOPP herbicide inhibitors of ACCase include, but are not limited to clodinafop, clodinafop-ethyl, clodinafop-propargyl, cyhalofop, cyhalofop-butyl, diclofop, diclofop-methyl, diclofop-P, diclofop-P-methyl, fenoxaprop, fenoxaprop-P, fenoxaprop-P-ethyl, fenthiaprop, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, fluroxypyr, haloxyfop, haloxyfop-etotyl, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-methyl, isoxapyrifop, metamifop, propaquizafop, quizalofop, quizalafop-ethyl, quizalofop-P, quizalafop-P-ethyl, quizalafop-P-tefuryl, and trifop. Accordingly, in plants that are not naturally tolerant to such herbicides (e.g., maize), in addition to conferring tolerance to phenoxy auxin herbicides such as 2,4-D, FT_Tv7 also confers tolerance to AOPP herbicides. Additionally, in plants that are naturally tolerant to AOPP or fop herbicides, or that have been selected or engineered to be tolerant to AOPP or fop herbicides, FT_Tv7 may provide an enhanced level of tolerance to these herbicides. The ability of FT_Tv7 and related alpha-ketoglutarate-dependent non-heme iron dioxygenase variants to degrade both phenoxy auxins such as 2,4-D and AOPP herbicides is further described in U.S. Pat. No. 10,023,874, the disclosure of which is incorporated herein by reference in its entirety.


As used herein, “herbicide tolerant” or “herbicide tolerance” or “tolerance” means the ability to be wholly or partially unaffected by the presence or application of one of more herbicide(s), for example to resist the toxic effects of an herbicide when applied. A cell, seed, or plant is “herbicide tolerant” or has “improved tolerance” if it can maintain at least some normal growth or phenotype in the presence of one or more herbicide(s). A trait is an herbicide tolerance trait if its presence can confer improved tolerance to an herbicide upon a cell, plant, or seed as compared to the wild-type or control cell, plant, or seed. Crops comprising an herbicide tolerance trait can continue to grow in the presence of the herbicide and may be minimally affected by the presence of the herbicide. A protein confers “herbicide tolerance” if expression of the protein can confer improved tolerance to an herbicide upon a cell, plant, or seed as compared to the wild-type or control cell, plant, or seed. Examples of herbicide tolerance proteins are dicamba monooxygenase, phosphinothricin N-acetyltransferase, the alpha-ketoglutarate-dependent non-heme iron dioxygenase variant FT_Tv7 and triketone dioxygenase. Herbicide tolerance may be complete or partial insensitivity to a particular herbicide and may be expressed as a percent (%) tolerance or insensitivity to a particular herbicide.


As used herein “herbicide injury” or “injury” refers to injury to a plant because of the application of one or more herbicides. The “injury rate” or “percent injury” refers to the percentage of leaf area of a plant exhibiting damage such as necrosis (brown or dead tissue), chlorosis (yellow tissue or yellow spotting) and malformation (misshapen leaves or plant structures, epinasty or twisting of stem, cupping of leaves) caused by herbicide application based on visual evaluation. It is measured on a scale of 0 to 100, where “0” representing no crop injury and “100” denoting complete crop injury (death).


For soybean plants containing or comprising soybean event Gm_CSM63714, the plant will have decreased injury after application of one or more of: a synthetic auxin (such as dicamba or 2,4-D); a β-triketone HPPD inhibitor (such as mesotrione); or an inhibitor of glutamine synthetase (such as glufosinate). For example, soybean plants containing or comprising soybean event Gm_CSM63714 will have less than about 5% injury, less than about 10% injury, less than about 15% injury, or less than about 20% injury following application of a synthetic auxin such as dicamba or 2,4-D, a β-triketone HPPD inhibitor such as mesotrione, or a glutamine synthetase inhibitor such as glufosinate, as compared to otherwise identical soybean plants that do not contain soybean event Gm_CSM63714.


As used herein, a “weed” is any undesired plant. A plant may be considered generally undesirable for agriculture or horticulture purposes (for example, Amaranthus species) or may be considered undesirable in a particular situation (for example, a crop plant of one species in a field of a different species, also known as a volunteer plant). Weeds are commonly known in the art and vary by geography, season, growing environment, and time. Lists of weed species are available from agricultural and scientific societies and efforts (such as the Weed Science Society of America, the Canadian Weed Science Society, the Brazilian Weed Science Society, the International Weed Science Society, and the International Survey of Herbicide Resistant Weeds), government agencies (such as the United States Department of Agriculture and the Australia Department of the Environment and Energy), and industry and farmer associations. Major troublesome weeds in soybean production include waterhemp (Amaranthus tuberculatus), ragweed (Ambrosia spp.), common lambsquarters (Chenopodium album), morning glory species (Ipomoea spp.), horseweed/marestail (Erigeron canadensis), palmer amaranth (Amaranthus palmeri), pigweed (Amaranthus spp.), velvetleaf (Abutilon theophrasti Medik.), common cocklebur (Xanthium strumarium), foxtail (Setaria spp.), crabgrass (Digitaria spp.), barnyard grass (Echinochloa crus-galli), Johnsongrass (Sorghum halepense), and thistles (Cirsium spp.) (Heap 2021; Shoup et al, 2016)


Methods for controlling weeds in an area for soybean cultivation are provided. The methods comprise applying at least one herbicide selected from the group consisting of (i) inhibitors of glutamine synthetase such as glufosinate; (ii) benzoic auxins such as dicamba; (iii) phenoxy auxins such as 2,4-D; (iv) β-triketone HPPD inhibitors such as mesotrione; and (v) any combination thereof, where seeds or plants comprising soybean event Gm_CSM63714 are planted in the area before, at the time of, or after applying the herbicide and the herbicide application prevents or inhibits weed growth and does not injure the soybean plants comprising event Gm_CSM63714, or has about less than about 5-20% injury. The plant growth area may or may not comprise weed seeds or plants at the time of herbicide application. The herbicide(s) used in the methods described herein can be applied alone, in sequential with or in combination with one or more herbicide(s) during the growing season. The herbicide(s) used in the methods described herein can be applied in combination with one or more herbicide(s) temporally (for example, as a tank mixture or in sequential applications), spatially (for example, at different times during the growing season including before and after soybean seed planting), or both. For example, a method for controlling weeds is provided that consists of planting seed comprising soybean event Gm_CSM63714 in an area and applying an herbicidally effective amount over the growing season of one or more of dicamba, glufosinate, 2,4-D and mesotrione alone or in any combination with another herbicide, for the purpose of controlling weeds in the area with no injury or less than about 5-20% injury to the plants containing soybean event Gm_CSM63714. Such application of herbicide(s) may be pre-planting (any time prior to planting seed comprising soybean event Gm_CSM63714, including for burn-down purposes, that is application to emerging or existing weeds prior to seed plant), pre-emergence (any time after seed comprising soybean event Gm_CSM63714 is planted and before plants comprising soybean event Gm_CSM63714 emerge), or post-emergence (any time after plants comprising soybean event Gm_CSM63714 emerge). Multiple applications of one or more herbicides, or a combination of herbicides together or individually, may be used over a growing season, for example, two applications (such as a pre-planting application and a post-emergence application, or a pre-emergence application and a post-emergence application) or three or more applications (such as a pre-planting application and two post-emergence applications).


Herbicide application in practicing the methods described herein may be at the recommended commercial rate or any fraction or multiple thereof, such as twice the recommended commercial rate. Herbicide rates may be expressed as pounds acid equivalent per acre (lb ae/acre), pounds active ingredient per acre (lb ai/acre) or pounds active ingredient per hectare (lb ai/ha), depending on the herbicide and the formulation. The use of acres in the herbicide application rates as provided herein is merely instructive; herbicide application rates in the equivalent dosages to any rate provided herein may be used for areas larger or smaller than an acre. The herbicide application comprises at least one herbicide selected from the group consisting of (i) inhibitors of glutamine synthetase such as glufosinate; (ii) benzoic acid auxins such as dicamba; (iii) phenoxy auxins such as 2,4-D; and (iv) β-triketone HPPD inhibitors such as mesotrione. The plant growth area may or may not comprise weed plants at the time of herbicide application. An herbicidally effective amount of glutamine synthetase inhibitors for use in the area for controlling weeds ranges from about 0.1 lb ae/acre to as much as about 10 lb ae/acre over a growing season (for example, glufosinate could be applied at a rate of about 0.4 lb ai/acre to about 1.6 lb ai/acre). An herbicidally effective amount of a benzoic acid herbicide for use in the area for controlling weeds ranges from about 0.1 lb ae/acre to as much as about 16 lb ae/acre over a growing season (for example, dicamba could be applied at a rate of about 0.5 lb ae/acre to about 2.0 lb ae/acre). An herbicidally effective amount of a phenoxy auxin herbicide for use in the area for controlling weeds ranges from about 0.1 lb ae/acre to as much as about 16 lb ae/acre over a growing season (for example, 2,4-D could be applied at a rate of about 0.5 lb ae/acre to about 4.0 lb ae/acre). An herbicidally effective amount of β-triketone HPPD inhibitors for use in the area for controlling weeds ranges from about 0.5 lb ae/ac to about 12 lb ae/ac over a growing season (for example, mesotrione could be applied at a rate of about 0.09 lb ae/acre to about 0.36 lb ae/acre).


Methods for controlling volunteer soybean comprising soybean event Gm_CSM63714 in an area for crop cultivation are provided. The methods comprise applying one or more herbicides effective on soybean event Gm_CSM63714 in the area for crop cultivation and having a mode of action other than benzoic auxins, phenoxy auxins, inhibitors of glutamine synthetase, and P-triketone HPPD inhibitors. Illustrative examples of such herbicides are atrazine, bronioxynil (3,5-di-bromo-4-hydroxybenzonitrile), clopyralid, pyrithiobac, isoxaflutole, topramezone, fluometuron, trifloxysulfuron, monosodium methyl arsenate (MSMA), inhibitors of protoporphyrinogen oxidase (PPO) (such as saflufenacil, flumioxazin, and sulfentrazone), and combinations of any thereof, wherein the herbicide application prevents growth of volunteer soybean comprising event Gm_CSM63714. For example, to control volunteer soybean comprising event Gm_CSM63714 in a corn cultivation field, topramezone, atrazine, clopyralid or isoxaflutole can be applied preemergence and/or postemergence. To control volunteer soybean comprising event Gm_CSM63714 in a cotton cultivation field, fluometuron can be applied preemergence, and trifloxysulfuron, pyrithiobac or monosodium methyl arsenate (MSMA) can be applied postemergence.


Methods for producing plants and seeds comprising soybean event Gm_CSM63714 are provided. Plants may be bred using any method known in the art. A progeny soybean plant comprising the event Gm_CSM63714 may be produced, for example, by selfing a parent plant or line comprising the event Gm_CSM63714, wherein such parent plant or line is homozygous or hemizygous for the event Gm_CSM63714, or by crossing a first parent plant or line comprising the event Gm_CSM63714, wherein such parent plant or line is homozygous or hemizygous for the event Gm_CSM63714, with a second parent plant or line having a different genotype or germplasm than the first parent line, wherein the second parent plant or line may or may not contain or comprise the event Gm_CSM63714. As described further herein, soybean event Gm_CSM63714 comprises four independent expression cassettes or transgenes encoding a dicamba monooxygenase (DMO), a phosphinothricin N-acetyltransferase (PAT), an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant (FT_Tv7), and triketone dioxygenase (TDO), respectively. According to some embodiments, the transgenic soybean plant(s) comprising the event Gm_CSM63714 is/are tolerant to benzoic auxins such as dicamba, phenoxy auxins such as 2,4-D, inhibitors of glutamine synthetase such as glufosinate, β-triketone HPPD inhibitors such as mesotrione, or any combination thereof, relative to a non-transgenic control plant. Transgenic soybean plants used in these methods may be homozygous or heterozygous for the transgenes. Progeny plants produced by these methods may be varietal or hybrid plants; may be grown from seeds produced by soybean event Gm_CSM63714 containing plant and/or from seeds produced by a plant fertilized with pollen from a soybean event Gm_CSM63714 containing plant; and may be homozygous or heterozygous for the transgenes and/or event Gm_CSM63714. Progeny plants may be subsequently self-pollinated to generate a true breeding line of plants, i.e., plants homozygous for the transgene, or alternatively may be out-crossed, e.g., bred with another unrelated plant, to produce a varietal or a hybrid seed or plant.


As used herein, the terms “line”, “breeding line”, “genotype” or “germplasm” are used interchangeably to refers to a group of plants that show little or no genetic variation between individuals for at least one trait. Such “line”, “breeding line”, “genotype” or “germplasm” can be created by self-pollination for several generations, selection, or vegetative propagation from a single parent using tissue or cell culture techniques. As used herein, the terms “cultivar” and “variety” are synonymous and refer to a line used for commercial production.


The production of double haploids may also be used to produce soybean plants and seeds homozygous for event Gm_CSM63714 DNA in a breeding program. Double haploids are produced by the doubling of a set of chromosomes (1 N) from a heterozygous plant to produce a completely homozygous individual. For example, see Wan, et al., (1989) and U.S. Pat. No. 7,135,615. This can be advantageous because the process omits the generations of selfing needed to obtain a homozygous plant from a heterozygous source. One way of producing haploid and double haploid soybean plant comprising event Gm_CSM63714 is through anther culture of flowers comprising event Gm_CSM63714 (Khan et al., 2010). Other methods such as natural polyembryony, induction with irradiated pollen, crosses with polyploid plants or wild species, unfertilized ovule and microspore culture can also be applied to produce haploid and double haploid soybean plants comprising event Gm_CSM63714.


Seed and progeny plants made by the methods described herein comprise soybean event Gm_CSM63714. Application of one or more herbicide for which soybean event Gm_CSM63714 confers tolerance may be used to select progeny that comprise soybean event Gm_CSM63714. Alternatively, progeny may be analyzed using diagnostic methods to select for plants or seeds comprising soybean event Gm_CSM63714.


Soybean transgenic events are known to one of skill in the art; for example, a list of such traits is provided by the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) and can be found on their website at www.aphis.usda.gov. Two or more transgenic events may thus be combined in a progeny seed or plant by crossing two parent plants each comprising one or more transgenic event(s), collecting progeny seed, and selecting for progeny seed or plants that contain the two or more transgenic events; these steps may then be repeated until the desired combination of transgenic events in a progeny is achieved. Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation.


Methods of detecting the presence of DNA derived from a soybean plant, plant part, plant cell, or seed comprising soybean event Gm_CSM63714 in a sample are provided. One method comprises (i) extracting a sample comprising DNA from at least one soybean plant, plant part, plant cell, or seed; (ii) contacting the sample with at least one primer that is capable of producing DNA sequence specific to event Gm_CSM63714 DNA under conditions appropriate for DNA sequencing; (iii) performing a DNA sequencing reaction; and then (iv) confirming that the nucleotide sequence comprises a nucleotide sequence specific for event Gm_CSM63714, of the transgenic insert comprised therein, such as one selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10.


Another method comprises (i) extracting a sample comprising DNA from at least one soybean plant, plant part, plant cell, or seed; (ii) contacting the sample with a primer pair that is capable of producing an amplicon from event Gm_CSM63714 DNA under conditions appropriate for DNA amplification; (iii) performing a DNA amplification reaction; and then (iv) detecting the amplicon molecule and/or confirming that the nucleotide sequence of the amplicon comprises a nucleotide sequence specific for event Gm_CSM63714, such as one selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, and SEQ ID NO:10. The amplicon should be one that is specific for event Gm_CSM63714, and comprises the junction at nucleotide positions 1000-1001, and/or nucleotide positions 11,196-11,197 of SEQ ID NO:10, such as an amplicon that comprises SEQ ID NO:1, or SEQ ID NO:2, or SEQ ID NO:3, or SEQ ID NO:4, or SEQ ID NO:5, or SEQ ID NO:6, or SEQ ID NO:7, or SEQ ID NO:8, or SEQ ID NO:9, or SEQ ID NO:10. The detection of a nucleotide sequence specific for event Gm_CSM63714 in the amplicon is determinative and/or diagnostic for the presence of the soybean event Gm_CSM63714 specific DNA in the sample. An illustrative primer pair that is capable of producing an amplicon from event Gm_CSM63714 DNA under conditions appropriate for DNA amplification is provided as SEQ ID NO:14 and SEQ ID NO:15. Other primer pairs may be readily designed by one of skill in the art to produce an amplicon diagnostic for soybean event Gm_CSM63714, wherein such a primer pair comprises at least one primer within the genomic region flanking the insert and a second primer within the insert, provided that any primer pair could be designed and used that produces an amplicon comprising a junction sequence and/or all or part of the insert or transgene sequence. Detection of an amplicon could be based on any suitable method, such as sequencing, determining fragment size or migration of the amplicon in a matrix or gel, or a hybridization-based method.


Another method of detecting the presence of DNA derived from a soybean plant, plant part, plant cell, or seed comprising soybean event Gm_CSM63714 in a sample consists of (i) extracting a sample comprising DNA from at least one soybean plant, plant part, plant cell, or seed; (ii) contacting the sample with a DNA probe specific for event Gm_CSM63714 DNA; (iii) allowing the probe and the DNA in the sample to hybridize under stringent hybridization conditions; and then (iv) detecting hybridization between the probe and the target DNA in the sample. An example of the sequence of a DNA probe that is specific for event Gm_CSM63714 is provided as SEQ ID NO:16. Other probes may be readily designed by one of skill in the art. Detection of probe hybridization to the DNA in the sample is diagnostic for the presence of soybean event Gm_CSM63714 specific DNA in the sample. Absence of hybridization is alternatively diagnostic of the absence of soybean event Gm_CSM63714 specific DNA in the sample.


Methods for determining the zygosity of the event and transgene with genomic DNA derived from at least one soybean plant, plant part, plant cell or seed comprising soybean event Gm_CSM63714 in a sample are provided. One method consists of (i) extracting a sample comprising DNA from at least soybean plant, plant part, plant cell or seed; (ii) contacting the sample with a first primer pair that is capable of producing a first amplicon diagnostic for event Gm_CSM63714; (iii) contacting the sample with a second primer pair that is capable of producing a second amplicon diagnostic for wild-type genomic DNA not comprising event Gm_CSM63714; (iv) performing a DNA amplification reaction; and then (v) detecting the amplicons, wherein the presence of only the first amplicon is diagnostic of a homozygous event Gm_CSM63714 DNA in the sample, the presence of both the first amplicon and the second amplicon is diagnostic of a soybean plant heterozygous for event Gm_CSM63714, and the presence of only the second amplicon is diagnostic for the absence of event Gm_CSM63714 DNA in the sample. Illustrative sets of primer pairs are presented as SEQ ID NO:14 and SEQ ID NO:15, which produce an amplicon diagnostic for event Gm_CSM63714; and SEQ ID NO:20 and SEQ ID NO:15, which produce an amplicon diagnostic for wild-type soybean genomic DNA not comprising event Gm_CSM63714. A set of probes can also be incorporated into such an amplification method to be used in a real-time PCR format using the primer pair sets described above. An illustrative set of probes are presented as SEQ ID NO:16 (diagnostic for the amplicon for the event Gm_CSM63714) and SEQ ID NO:21 (diagnostic for the amplicon for wild-type soybean genomic DNA not comprising event Gm_CSM63714).


Another method for determining zygosity consists of (i) extracting a sample comprising DNA from at least one soybean plant, plant part, plant cell or seed; (ii) contacting the sample with a probe set which contains at least a first probe that specifically hybridizes to event Gm_CSM63714 DNA and at least a second probe that specifically hybridizes to soybean genomic DNA that was disrupted by insertion of the heterologous DNA of event Gm_CSM63714 and does not hybridize to event Gm_CSM63714 DNA; (iii) hybridizing the probe set with the sample under stringent hybridization conditions, wherein detecting hybridization of only the first probe under the hybridization conditions is diagnostic for a homozygous soybean plant, plant part, plant cell or seed for event Gm_CSM63714 DNA in the sample; wherein detecting hybridization of both the first probe and the second probe under the hybridization conditions is diagnostic for a heterozygous soybean plant, plant part, plant cell or seed for event Gm_CSM63714 in the sample; and detecting hybridization of only the second probe under the hybridization conditions is diagnostic for the absence of event Gm_CSM63714 DNA in the sample.


Yet another method for determining zygosity consists of (i) extracting a sample comprising DNA from at least one soybean plant, plant part, plant cell or seed; (ii) contacting the sample with a first primer pair that is capable of producing a first amplicon diagnostic for event Gm_CSM63714; (iii) contacting the sample with a second primer pair that is capable of producing a second amplicon of an internal standard known to be single-copy and homozygous in the soybean plant; (iv) contacting the sample with a probe set which contains at least a first probe that specifically hybridizes to the first amplicon, and at least a second probe that specifically hybridizes to the second amplicon; (v) performing a DNA amplification reaction using real-time PCR and determining the cycle thresholds (Ct values) of the first and second amplicons; (vi) calculating the difference (ΔCt) between the Ct value of the first amplicon and the second amplicon; and (vii) determining zygosity, wherein a ΔCt of about zero (0) indicates homozygosity of the event or inserted T-DNA, and a ΔCt of about one (1) indicates heterozygosity of the event or inserted T-DNA. Heterozygous and homozygous events are differentiated by a ΔCt value unit of approximately one (1). Given the normal variability observed in real-time PCR due to multiple factors such as amplification efficiency and ideal annealing temperatures, the range of “about one (1)” is defined as a ΔCt of 0.75 to 1.25, and the range of “about zero (0)” is defined as a ΔCt of −0.25 to 0.25 (or of 0.0 to 0.25 if the ΔCt is measured as an absolute value). Primer pairs and probes for the above method for determining zygosity can amplify and detect amplicons from the transgene or event DNA and the internal DNA standard.


A DNA construct is provided comprising a first expression cassette, a second expression cassette, a third expression cassette and a fourth expression cassette, wherein the first expression cassette comprises in operable linkage i) ubiquitin (UB3) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) a chloroplast transit peptide coding sequence of APG6 (Albino and Pale Green 6) from Arabidopsis thaliana, iii) a codon-optimized dicamba monooxygenase coding sequence (DMO) from Stenotrophomonas maltophilia for conferring dicamba tolerance, and iv) a 3′ UTR sequence of the aluminum-induced Sali3-2 protein from Medicago truncatula; the second expression cassette comprises in operable linkage i) promoter and an intron sequences derived from multiple promoter and intron sequences from Arabidopsis thaliana, ii) a codon-optimized phosphinothricin N-acetyltransferase (PAT) coding sequence from Streptomyces viridochromogene for conferring tolerance to glutamine synthetase inhibitors, and iii) a 3′ UTR of a small heat shock protein (Hsp20) from Medicago truncatula; the third expression cassette comprises in operable linkage i) polyubiquitin (UBQ10) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) a codon-optimized alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7, also referred to as FT_T.1) from Sphingobium herbicidovorans for conferring tolerance to phenoxy auxins such as 2,4-D, and iii) a 3′ UTR sequence of a putative protein from Medicago truncatula, and the fourth expression cassette comprises in operable linkage i) promoter, leader, and intron sequences derived from multiple promoter, leader and intron sequences from Arabidopsis thaliana, ii) a codon-optimized coding sequence of the triketone dioxygenase (TDO) from Oryza sativa for conferring tolerance to β-triketone HPPD inhibitors such as mesotrione, and iii) a 3′ UTR sequence derived from multiple 3′ UTR sequences from Zea mays. The nucleotide sequences of the four expression cassettes were comprised in SEQ ID NO:9 and SED ID NO:10 of soybean event Gm_CSM63714. Expression of the DMO, PAT, FT_Tv7 and TDO in transgenic plants confers tolerance to herbicides with at least four different modes of action. For example, plants, plant parts, plant cells or seeds containing or comprising soybean event Gm_CSM63714 are tolerant to dicamba (a benzoic acid herbicide), glufosinate (a glutamine synthetase inhibitor), 2,4-D (a phenoxy herbicide), and mesotrione (a β-triketone HPPD inhibitor).


Any of the DNA constructs or transgenic inserts described herein can further comprise at its 5′ or 3′ end at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98, or at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99. Alternatively, any of the DNA constructs or transgenic inserts described herein can further comprise at its 5′ or 3′ end at least 100 contiguous nucleotides, at least 150 contiguous nucleotides, at least 200 contiguous nucleotides, at least 250 contiguous nucleotides, at least 300 contiguous nucleotides, at least 350 contiguous nucleotides, at least 400 contiguous nucleotides, at least 450 contiguous nucleotides, or at least 500 nucleotides of SEQ ID NO: 11 or SEQ ID NO: 98, or at least 100 contiguous nucleotides, at least 150 contiguous nucleotides, at least 200 contiguous nucleotides, at least 250 contiguous nucleotides, at least 300 contiguous nucleotides, at least 350 contiguous nucleotides, at least 400 contiguous nucleotides, at least 450 contiguous nucleotides, or at least 500 nucleotides of SEQ ID NO: 12 or SEQ ID NO: 99.


SEQ ID NOs.:11 and 12 are 1,000 nucleotide sequences representing soybean genomic DNA that flanks the transgenic insert at the 5′ and 3′ ends of the insert in soybean event Gm_CSM63714, respectively. SEQ ID NO:11 and SEQ ID NO:12 have been validated by sequencing, as further described in Example 5 hereinbelow. SEQ ID NOs:98 and 99 are 5,000 nucleotide sequences representing soybean genomic DNA that flanks the transgenic insert at the 5′ and 3′ ends of the insert, respectively. Nucleotides 4,001-5,000 of SEQ ID NO:98 are identical to nucleotides 1-1,000 of SEQ ID NO: 11. The remaining nucleotides of SEQ ID NO: 98 (nucleotides 1-4,000) are based on the genomic sequence of the Williams 82 soybean cultivar (Schmutz et al., 2010). Similarly, nucleotides 1-1000 of SEQ ID NO: 99 are identical to nucleotides 1-1,000 of SEQ NO: 12. The remaining nucleotides of SEQ ID NO: 99 (nucleotides 1,001-5,000) are based on the genomic sequence of the Williams 82 soybean cultivar.


The at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98 at the 5′ end of the DNA construct or transgenic insertion may be immediately adjacent to and upstream (on the 5′ end) of the transgenic insertion, or may not be immediately adjacent to, but further upstream (on the 5′ end) and within about 5000 nucleotides, within about 3000 nucleotides, or within about 1000 nucleotides of the transgenic insertion. Likewise, the at least 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99 at the 3′ end of the DNA construct or transgenic insertion may be immediately adjacent to and downstream (on the 3′ end) of the transgenic insertion, or may not be immediately adjacent to but further downstream (on the 3′ end) and within about 5000 nucleotides, within about 3000 nucleotides, or within about 1000 nucleotides of the transgenic insertion. Illustrative examples of sequences comprising 50 contiguous nucleotides of SEQ ID NO:11 are provided in SEQ ID NOs:58-77. Illustrative examples of 50 contiguous nucleotides of SEQ ID NO:12 are provided in SEQ ID NOs:78-97. Illustrative examples of 50 contiguous nucleotides of SEQ ID NO:98 are provided in SEQ ID NOs: 100-139. Illustrative examples of 50 contiguous nucleotides of SEQ ID NO:99 are provided in SEQ ID NOs: 140-179. However, any sequence comprising at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO: 98, or at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO: 99 is within the scope of the present disclosure.


In addition, a DNA construct comprising a first expression cassette, a second expression cassette, a third expression cassette, and a fourth expression cassette is provided. The first expression cassette comprises a dicamba monooxygenase coding sequence, the second expression cassette comprises a phospinothricin N-acetyltransferase (PAT) coding sequence, the third expression cassette comprises an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7) capable of degrading 2,4-D, and the fourth expression cassette comprises a triketone dioxygenase (TDO) coding sequence. The DNA construct further comprises at the 5′ and/or 3′ end of the construct (i) at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO:98; and/or (ii) at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO:99.


A further DNA construct is provided. The DNA construct comprises a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO: 9. The DNA construct further comprises at the 5′ and/or 3′ end of the construct (i) at least 50 contiguous nucleotides of SEQ ID NO: 11 or 98; and/or (ii) at least 50 contiguous nucleotides of SEQ ID NO: 12 or 99.


For example, any of the DNA constructs can comprise at the 5′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:58-77 and SEQ ID NOs:100-139. Alternatively or in addition, any of the DNA constructs can comprise at the 3′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:78-97 and SEQ ID NOs:140-179.


Soybean plants, plant cells, plant parts, and plant seeds comprising any of the DNA constructs described herein are also provided.


Also provided are soybean plants, plant cells, plant parts, and plant seeds comprising a recombinant DNA construct integrated in chromosome 13, wherein the recombinant DNA construct confers tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and combinations of any thereof. The recombinant DNA construct is integrated in a position of said chromosome flanked by at least 50 contiguous nucleotides of SEQ ID NO:11 98 and 50 contiguous nucleotides of SEQ ID NO:12 or 99. The benzoic acid auxin can comprise dicamba; the phenoxy auxin can comprise 2,4-D; the glutamine synthetase inhibitor comprises glufosinate; and the 0-triketone HPPD inhibitor can be selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and combinations of any thereof. The at least 50 contiguous nucleotides of SEQ ID NO: 11 or 98 can comprise one or more nucleotide sequences selected from SEQ ID NOs:58-77 or SEQ ID NOs:100-139, and the at least 50 contiguous nucleotides of SEQ ID NO: 12 or 99 can comprise one or more nucleotide sequences selected from SEQ ID NOs:78-97 or SEQ ID NOs:140-179.


Methods of improving tolerance to herbicides are provided. The methods consist of i) inserting a DNA construct comprising a first expression cassette, a second expression cassette, a third expression cassette and a fourth expression cassette, as described herein, into the genome of a plant cell, ii) generating a plant from the plant cell; and iii) selecting a regenerated transgenic plant comprising the DNA construct. Transgenic plants produced by the methods comprise a unique combination of four transgene expression cassettes in terms of orientation and positive relative to each other, each with a unique combination of expression elements for optimal expression of the transgenes. Furthermore, transgenic plants produced by the methods as described herein acquire tolerance to herbicides with four different herbicide modes of action. Selecting the regenerated plant comprising the DNA construct may be done using DNA or protein detection methods as described herein. Alternatively or additionally, selecting may comprise treating the transgenic plant or plant cell with an effective amount of at least one herbicide selected from the group consisting of benzoic acid auxins such as dicamba, phenoxy auxins such as 2,4-D, inhibitors of glutamine synthetase such as glufosinate, β-triketone HPPD inhibitors such as mesotrione, and any combination thereof.


Methods of controlling, preventing, or reducing the development of herbicide-tolerant weeds are provided. The methods comprise: a) cultivating in a crop growing environment a soybean plant comprising a DNA construct or transgenes of the present disclosure or event Gm_CSM63714 that provide tolerance to herbicides with at least three different herbicide modes of action at a single genomic location, and b) applying to the crop growing environment at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor such as mesotrione, and any combination thereof, wherein the soybean plant is tolerant to the at least one herbicide. The at least three different herbicide modes of action are selected from inhibition of glutamine synthetase, benzoic acid auxins, phenoxy auxins, and inhibition of HPPD. All four of these different herbicide modes of action can be provided by the DNA construct or transgenes. For example, soybean plants grown from the seeds comprising the DNA construct or transgenes of the present disclosure, or event Gm_CSM63714 are tolerant to dicamba, 2,4-D, glufosinate, mesotrione, or any combination thereof.


The soybean plants, plant seeds, plant parts, or plant cells may further comprise at least one additional transgene (such as the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene from Agrobacterium CP4 strain or another EPSPS that confers tolerance to glyphosate) for additional herbicide mode(s) of action. An illustrative EPSPS coding sequence and its corresponding amino acid sequence from Agrobacterium CP4 strain are provided as SEQ ID NO:56 and SEQ ID NO:57, respectively.


The herbicide(s) used in the methods described herein can be applied alone, sequentially with or in combination with one or more herbicide(s) during the growing season. The herbicide(s) used in the methods described herein can be applied in combination with one or more herbicide(s) temporally (for example, as a tank mixture or in sequential applications), spatially (for example, at different times during the growing season including before and after soybean seed planting), or both. For example, a method for controlling the development of herbicide resistance in weeds is provided that consists of planting seed comprising soybean event Gm_CSM63714 in an area and applying an herbicidally effective amount over the growing season of one or more of benzoic acid auxins such as dicamba, phenoxy auxins such as 2,4-D, inhibitors of glutamine synthetase such as glufosinate, and β-triketone HPPD inhibitors such as mesotrione alone or in any combination with another herbicide, for the purpose of controlling the development of herbicide resistance in weeds in the area. Such application of herbicide(s) may be pre-planting (any time prior to planting seed comprising soybean event Gm_CSM63714, including for burn-down purposes, that is application to emerging or existing weeds prior to seed plant), pre-emergence (any time after seed comprising soybean event Gm_CSM63714 is planted and before plants comprising soybean event Gm_CSM63714 emerge), or post-emergence (any time after plants comprising soybean event Gm_CSM63714 emerge). Multiple applications of one or more herbicides, or a combination of herbicides together or individually, may be used over a growing season, for example, two applications (such as a pre-planting application and a post-emergence application, or a pre-emergence application and a post-emergence application) or three or more applications (such as a pre-planting application and two post-emergence applications).


Also provided are methods of reducing loci for soybean breeding by inserting multiple transgenes at a single genomic location to provide four different modes of action for herbicide tolerance. Soybean event Gm_CSM63714 contains or comprises a transgenic insert comprising four independent transgene cassettes: a first expression cassette encoding a dicamba monooxygenase coding sequence (DMO), a second expression cassette encoding a phosphinothricin N-acetyltransferase (PAT), a third expression cassette encoding an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant (FT_Tv7), and a fourth expression cassette encoding a triketone dioxygenase (TDO). These four transgene cassettes were inserted at a single genomic location as a contiguous polynucleotide or DNA molecule or single molecularly linked transgenic insert, and provide a commercial level of tolerance to at least one herbicide for each herbicide mode of action in a field, such as dicamba, glufosinate, 2,4-D, mesotrione, and any combination thereof. The nucleotide sequences of the four expression cassettes are comprised in SEQ ID NO:9 and SED ID NO:10. As used herein, the term “commercial level” in reference to an herbicide refers to the recommended commercial rate (1×) for herbicide application for a specific herbicide. For example, a 1× rate of dicamba is 1 lb/acre pre-emergence and 0.5 lb/acre post-emergence; a 1× rate of 2,4-D is 1 lb/acre post-emergence; a 1× rate of glufosinate is 0.8 lb/acre; and a 1× rate of mesotrione is 0.18 lb/acre pre-emergence, and 0.09 lb/acre post-emergence. As used herein, “commercial level tolerance” refers to tolerance to one or more herbicides at the recommended commercial rates or higher as a result of transgene expression from one or more of the four expression cassettes in plants comprising event Gm_CSM63714.


Soybean event Gm_CSM63714 with the unique characteristics such as s single insertion site, stable integration and expression of the DMO, PAT, FT_Tv7 and TDO transgenes, consistent and superior combinations of efficacy, including herbicide tolerance and agronomic performance, in and across multiple environment conditions in different geographies can be bred or introgressed into elite lines or varieties as a single locus by conventional breeding methods, and maintained over subsequent generations following Mendelian inheritance of single locus. Therefore, the methods of the present disclosure allow for rapid trait integration of the multiple transgenes on segregating material, saving time and resources in a breeding program and enabling rapid development of lines, compared to cases where the individual transgenes are inserted into two or more loci, necessitating tedious and laborious multiple crosses over multiple generations to select for plants comprising the multiple genes. The newly introgressed or integrated DNA molecule or polynucleotide of event Gm_CSM63714 comprising SEQ ID NO:9 and/or SEQ ID NO:10 will maintain the expression characteristics of the transgenes, and the genomic flanking sequences and chromosomal location, where it will confer tolerance to the at least one herbicide for each herbicide mode of action in a field, such as dicamba, glufosinate, 2,4-D, or mesotrione, and any combination thereof.


DEPOSIT INFORMATION

A deposit of a representative sample of soybean seed comprising event Gm_CSM63714 has been made on Aug. 10, 2021 according to the Budapest Treaty with the American Type Culture Collection (ATCC) Patent Repository having an address at 10801 University Boulevard, Manassas, Va., 20110, USA. The ATCC Patent Deposit Designation (accession number) for seeds comprising soybean event Gm_CSM63714 is Accession No. PTA-127099. Access to the deposits will be available during the pendency of the application to the Commissioner of Patents and Trademarks and persons determined by the Commissioner to be entitled thereto upon request. Upon issuance of the patent, all restrictions upon availability to the public will be irrevocably removed. The deposit will be maintained in the depository for a period of thirty (30) years, or five (5) years after the last request, or for the effective life of the patent, whichever is longer, and will be replaced as necessary during that period.


EXAMPLES

The following examples are included to more fully describe the invention. Summarized are the construction and testing of 72 transformation constructs containing single gene cassettes for tolerance to dicamba, glufosinate, 2,4-D, and mesotrione, the construction and testing of six different transformation constructs containing all four of these gene cassettes, the production and testing of over 25,760 unique transformation events, and the analysis of thousands of individual plants over multiple seasons through rigorous molecular characterization, efficacy and agronomic testing both in a controlled environment and in field trials, leading to the creation, identification, and ultimate selection of the soybean event Gm_CSM63714.


The Examples illustrate certain embodiments of the present disclosure. It should be appreciated by those of skilled in the art that many modifications can be made in the specific examples which are disclosed and still obtain a similar result. Certain agents which are both chemically and physiologically related may be substituted for the agents described herein while achieving the same or similar results. All such substitutions and modifications apparent to those skilled in the art are deemed to be within the scope of the invention.


Example 1: Expression Cassette Testing, Construct Design, Plant Testing and Construct Selection

This example describes the design of six different expression constructs for tolerance to dicamba, glufosinate, 2,4-D, and mesotrione herbicides through a vector stack, the production of 25,760 unique soybean events, and testing and molecular analysis of the resulting transgenic soybean plants for selection of the lead construct.


Transgene expression and performance in transgenic plants may be influenced by many factors. These include but are not limited to: 1) the expression elements used to drive the expression of the transgene in the expression cassette, and their interactions among themselves and with the transgene; 2) the relative position and orientation of different expression cassettes when the transgenic insert comprises multiple expression cassettes, each carrying a different transgene conferring a distinct trait; and 3) the genomic location of the transgenic insertion, also known as positional effect. A commercially useful multi-gene transgenic event requires that each of the transgenes in the transgenic insert expresses in the manner necessary for that trait to be successful, i.e., optimal transgene expression and performance across different tissues and developmental stages, in various germplasms, and under different growth conditions.


For these reasons, it is often necessary to create and screen a large number of constructs and transformation events in order to identify a construct (the lead construct), and then an event (the lead event), which demonstrates optimal expression and performance of the transgenes without phenotypic and agronomic off-types such as yield drag. Prior to such studies, it is not possible to determine whether a particular beneficial event phenotype or performance can be obtained.


In an initial proof-of-concept and early development stage study, over several years and multiple growing seasons, a total of 72 different constructs each containing single gene cassette of DMO, PAT, FT_Tv7 or TDO with different expression element combinations were designed. Genes encoding protein variants for TDO and FT_Tv7 were also tested. In addition, one DMO and PAT double stack construct, one DMO, PAT and TDO triple stack construct, forty-one DMO, PAT and FT_Tv7 triple stack constructs, and four DMO, PAT, FT_Tv7 and TDO quad stack constructs were designed. The individual gene cassettes in these constructs contained different expression element combinations and varied in relative positions and orientations of the transgene cassettes. These vectors were constructed and transformed into soybean seed-derived dry excised explants through Agrobacterium-mediated transformation using methods known in the art. Thousands of transformed plants were regenerated and tested in the greenhouse and in field trials for optimal protein expression through measurement of protein levels by ELISA, and for trait efficacy through herbicide spray treatment. Based on these results, top performing individual expression cassettes were identified, each containing individual transgenes driven by combinations of expression elements. From these individual expression cassettes, six different constructs were designed, each containing four expression cassettes (encoding DMO, PAT, FT_Tv7, and TDO, respectively). These six constructs contained different expression cassette combinations, varying by expression elements, protein coding sequence for TDO and FT, relative position and orientation of the transgene cassettes.


The six four-expression cassette constructs were cloned into plant transformation vectors, and introduced into soybean seed-derived dry excised explants through Agrobacterium-mediated transformation using methods known in the art. The transformation vectors harbored two T-DNAs, a first T-DNA molecule which was bordered by a first right border DNA sequence (RB) and a first left border DNA sequence (LB) linked to a second T-DNA molecule which is bordered by a second right border DNA sequence and a second left border DNA sequence. The two T-DNA molecules were positioned in the DNA construct to have an orientation with respect to each other consisting of LB-second T-DNA-RB-RB-first T-DNA-LB, wherein the first RB and second RB are linked. The first T-DNA contained four expression cassettes encoding DMO, PAT, FT_Tv7, and TDO, respectively for conferring herbicide tolerance. The second T-DNA contained two expression cassettes, one encoding aadA targeted to the chloroplast for selection of transgenic events resistant to spectinomycin and/or streptomycin, and one encoding sucrose phosphorylase (GenBank Accession AE009432) under the control of a seed specific promoter to function as a marker for identification of the presence of the selectable marker. A total of 25,760 unique transformation events were produced, each made by a random insertion of the transgenic insert into the soybean genome. R0 plants were subsequently regenerated from the transgenic events. Rooted plants with normal phenotype were transferred to soil for growth and further assessment.


Out of the 25,760 R0 plants generated, 22,834 were analyzed for desirable molecular characteristics. These include: 1) the transgenic insert is single copy and intact; 2) no transformation vector backbone sequence is present; and 3) the two T-DNAs are not linked (and therefore can be segregated in a later generation). Plants with the desirable molecular characteristics and sufficient seed set were advanced for herbicide tolerance efficacy testing.


As shown in Table 2, a total of 288 unique events containing a single copy of the intact transgenic insert without the presence of the transformation vector backbone, and lack of the second T-DNA sequence were advanced to R1 nursery for R1 seed production. Events with unacceptable segregation or that were unable to produce sufficient seeds were discarded. As a result, a total of 224 homozygous events were assessed in the greenhouse for herbicide tolerance. The plants were sprayed with 1.5 pound/acre (lb/acre) of 2,4-D at V3 stage, followed by a tank mix of 1.06 lb/acre of glufosinate and 1 lb/acre of dicamba at V6 stage, followed by 0.19 lb/acre of mesotrione at R1 stage, and were assessed visually for injury 7 days after each treatment, with 0% representing no injury and 100% representing complete plant death. Events with >35% injury were discarded. A few additional events were also dropped due to capacity limitations. From the greenhouse spray results, a total of 68 events were advanced to first season field trials.









TABLE 2







Summary of events from the six transformation constructs














# R1 Events
# Events




# Events
Avanced to
Advanced to



# R0
Advanced to
Greenhouse
1st Season


Construct
Events
R1 Nursery
Testing
Field Trials














GmHT4-1
4886
50
41
17


GmHT4-2
4247
47
41
18


GmHT4-3
4685
54
47
15


GmHT4-4
4751
43
34
18


GmHT4-5
2678
37
28
0


GmHT4-6
4513
57
33
0


Total
25760
288
224
68









Example 2: Field Trials

Field trials were conducted over multiple seasons/years and across many locations in different geographies to evaluate the performance of the constructs/events, and for selecting the best performing construct/event. The field trials comprised efficacy trials for herbicide tolerance, and agronomic trials for yield performance of the events. The performance of many individual plants for each event in each field trial was analyzed as a set. Each event was thus represented by many individual plants. This allowed the performance of each event to be analyzed under many different conditions, in different locations and geographies, and for a variety of properties. Field trials were conducted on homozygous plants to assess trait efficacy for tolerance to commercial rates of dicamba, glufosinate, 2,4-D and mesotrione herbicides, and agronomic performance.


First Season Field Trials

A total of 68 events from four constructs were tested in the first season field trials in North America (see Table 2). In the efficacy trials, the events were evaluated for tolerance to dicamba, glufosinate, 2,4-D and mesotrione. Herbicide treatments are summarized in Table 3 and consisted of dicamba at 2 lb/acre (2×) pre-emergence, 1 lb/acre (2×) at V3 and R1 stages; mesotrione at 0.36 lb/acre (2×) pre-emergence, 0.18 lb/acre (2×) at V3 and R1 stages; 2,4-D at 2 lb/acre (2×) at V3 and R1 stages; and glufosinate at 1.6 lb/acre (2×) at V3 and V6 stages. All applications were single chemistries. Plant height, flowering time, maturity and yield data were collected.









TABLE 3







Herbicide treatments in the first season field trials










Treatment Stage and Rate (pound/acre)














Herbicide
Pre-emergence
V3
V6
R1

















Dicamba
2
1

1



Glufosinate

1.6
1.6




2,4-D

2

2



Mesotrione
0.36
0.18

0.18










In the agronomy trials, the same events were evaluated for plant height, flowering time, maturity, and yield performance (presented as bushel per acre). Fields were maintained weed-free by hand hoeing or by use of conventional herbicides.


The agronomy and efficacy trials were conducted using a Group Unbalanced Block Design (GUBD2). The efficacy trials included nine locations with three replications and five treatment blocks. These consisted of an untreated block along with blocks for herbicide treatments at 2×maximum application rates as prescribed on herbicide labels. Turbo TeeJet Induction (TTI) nozzles were used for all herbicide treatments. The agronomy trials were conducted at 18 locations with two replications. Plots were two rows of twelve feet in length, with a 30-inch row spacing and a three-foot alley. Trial maintenance was designed to optimize grain yield. Herbicide-treated event plots were compared to untreated event plots. Visual injury data were collected for the efficacy trials approximately seven days after post-emergent herbicide applications or 14 days after pre-emergent applications.


All data from both agronomy and efficacy trials were subject to analysis of variance and means separated at LSD (Least Significant Difference) at alpha 0.05. Statistical analysis was automated using ASReml software for mixed model fitting. Events were prioritized for further testing based on yield performance and crop injury. In the efficacy trials, yield of herbicide treated events was compared to that of the untreated events. In the agronomy trials, yield of events was compared to that of the untransformed (wild-type) control plants. Typically, events were not advanced for further testing if the yield was significantly negative at p value≤0.05 compared to the yield of untreated controls after herbicide treatment, or to the yield of the wild-type controls.


The results of the efficacy and agronomy trials for the individual events of the four constructs are summarized in Table 4. A black box indicates a significantly negative performance of the event for the treatment, whereas a grey box indicates no significant difference when compared to the wild-type or untreated control. Yield (bu/A or bushel/acre) refers to yield performance measured in bushel per acre compared to the wild-type control in the agronomy trials. Yield-Dicamba, Yield-Glufosinate, Yield-2,4-D, or Yield-Mesotrione refers to yield in bushel per acre after dicamba, glufosinate, 2,4-D, or mesotrione application compared to the untreated controls, respectively. Dicamba Injury, Glufosinate Injury, 2,4-D Injury or Mesotrione Injury refers to % injury after the respective herbicide application compared to the untreated controls. While none of the events showed high levels of injury following individual herbicide treatments, more than half of the events showed reduced yield (bushel/acre or lb/A) compared to the controls. Based on the first season field trial results, all events from constructs GmHT4-1 and GmHT4-2 were dropped, and seven events from construct GmHT4-3 and eight events from construct GmHT4-4 were advanced to the second season field trials.


Second Season Field Trials

In the second season field trials conducted in South America, the events were evaluated for tolerance to dicamba, glufosinate, 2,4-D, and mesotrione in efficacy trials. Seven events from construct GmHT4-3 and eight events from construct GmHT4-4 were advanced from the first season trial. However, since the second season field trial started before the first season field trial results were obtained, all 33 events from constructs GmHT4-3 and GmHT4-4 were planted, and therefore tested in the second season trials. Herbicide treatments are summarized in Table 3 above. All applications were single chemistries. The efficacy trial was conducted across six locations using a Group Unbalanced Block Design (GUBD2), with three replications and five treatment blocks. These consisted of an untreated block along with blocks for herbicide treatments at 2×maximum application rates as prescribed in herbicide labels. Turbo TeeJet Induction (TTI) nozzles were used for all herbicide treatments. Herbicide-treated event plots were compared to untreated event plots. The agronomy trial was conducted across twelve locations and events were compared to the untransformed control.


Plots were four rows of four meters in length, with a 0.525-meter row spacing and a one-meter alley. Trial maintenance was designed to optimize grain yield. Visual injury data was collected for the efficacy trials approximately seven days after post-emergent herbicide applications or 14 days after pre-emergent applications.


All data from both agronomic and efficacy trials were subject to analysis of variance and means separated at LSD at alpha 0.05. Statistical analysis was automated using ASReml software for mixed model fitting. Events were prioritized for further testing based on yield performance and crop injury. In the efficacy trials, yield of herbicide treated events were compared to that of the untreated events. In the agronomy trials, yield of events was compared to that of the untransformed (wild-type) control plants.


The results of the second season efficacy and agronomy trials for the individual events of the two constructs are summarized in Table 5. A dark box indicates a significantly negative performance of the event for the treatment, whereas a grey box indicates no significant difference when compared to the wild-type or untreated control. A white box indicates that the event was not assessed in this trial. The results of the efficacy trial were consistent with the results of the first season trials, i.e., none of the events tested showed significant injury following individual herbicide treatments. One event for construct GmHT4-3 and two events for construct GmHT4-4 showed significant yield reduction compared to the wild-type controls in the agronomic trials. Yield (bu/A) refers to yield performance measured in bushel per acre compared to the wild-type control in the agronomy trials. Yield-Dicamba, Yield-Glufosinate, Yield-2,4-D, or Yield-Mesotrione refers to yield in bushel per acre after dicamba, glufosinate, 2,4-D, or mesotrione application compared to the untreated controls, respectively. Similarly, Dicamba Injury, Glufosinate Injury, 2,4-D Injury, or Mesotrione Injury refers to % injury after the respective herbicide application compared to the untreated controls.


Based on composite data from the first and second season field trials and the in-depth molecular characterization of the events, seven events from each of the constructs GmHT4-3 and GmHT4-4 were advanced to the third season field trials.


Third and Fourth Season Field Trials

The third and fourth season field trials were conducted in North America and in South America, respectively. The third season field trials contained 7 events for construct GmHT4-3 and 7 events for construct GmHT4-4, and followed the same trial design, individual herbicide application method, rates and development stages, and statistical analysis method as in the first season field trials. The fourth season field trials contained 5-7 events for construct GmHT4-3 (five events in the efficacy trials, and 7 events in the agronomic trials) and 7 events for construct GmHT4-4, and followed the same trial design, individual herbicide application method, rates and development stages, and statistical analysis method as in the second season field trials. In both the third and the fourth season trials, data were collected for emergence, vigor, date of first flower, plant height, maturity, and yield. In addition, visual injury data were collected for the efficacy trials approximately seven days after post-emergent herbicide applications or fourteen days after pre-emergent applications.


In the third season efficacy trials, all events demonstrated tolerance to individual herbicide applications, most with less than 10% injury when compared to the untreated controls, although some events had >10% injury, especially at the V3 stage. One of the events for construct GmHT4-3 (GmHT4-3-3) was not tested due to lack of sufficient seeds. The results of the efficacy trials are summarized in Table 6. Mean Yield refers to cross-location yield in bushel per acre for the event, untreated, or treated with dicamba, glufosinate, 2,4-D, or mesotrione.









TABLE 6







Summary of event performance in the third season efficacy trials













Untreated
Dicamba
Gufosinate
2,4-D
Mesotrione



















Mean
Mean

Mean

Mean

Mean



Construct
Event
Yield
Yield
p_Value
Yield
p_Value
Yield
p_Value
Yield
p_Value




















GmHT4-3
GmHT4-3-1
56.2
54.2
0.10
54.8
0.26
56.4
0.89
55.7
0.70



GmHT4-3-2
57.9
56.5
0.28
56.6
0.35
58.7
0.54
58.5
0.63



GmHT4-3-3












GmHT4-3-4
59.0
56.0
0.02
55.9
0.02
58.3
0.60
58.0
0.45



GmHT4-3-5
58.9
54.9
0.00
54.9
0.00
58.3
0.60
57.2
0.17



GmHT4-3-6
59.2
56.6
0.05
58.0
0.35
58.3
0.51
58.4
0.58



GmHT4-3-7
59.9
57.4
0.06
57.3
0.06
59.0
0.50
58.6
0.33


GmHT4-4
GmHT4-4-1
58.7
58.0
0.62
57.3
0.29
55.1
0.00
58.8
0.94



GmHT4-4-2
60.8
60.6
0.89
59.2
0.22
57.7
0.02
61.5
0.61



(Gm_CSM63714)



GmHT4-4-3
61.6
60.6
0.45
59.0
0.05
59.7
0.14
59.1
0.06



GmHT4-4-4
60.6
61.0
0.76
59.4
0.37
57.5
0.02
60.1
0.70



GmHT4-4-5
61.2
59.5
0.19
60.6
0.65
57.8
0.01
59.4
0.17



GmHT4-4-6
62.2
57.8
0.00
59.4
0.08
57.7
0.00
59.6
0.08



GmHT4-4-7
60.4
60.3
0.91
58.3
0.10
56.5
0.00
60.0
0.74









The performance for the 7 events from each of constructs GmHT4-3 and GmHT4-4 in the agronomic trials is summarized in Table 7. Mean Yield refers to cross location yield in bushel per acre for the event. The results demonstrate that the presence of the transgenic insert had no negative impact on these events, which had comparable yield compared to the wild-type control.









TABLE 7







Summary of event performance in the third season agronomic trials










Construct
Event
Mean Yield
p_Value





GmHT4-3
GmHT4-3-1
52.8
0.08



GmHT4-3-2
54.1
0.18



GmHT4-3-3
53.5
0.12



GmHT4-3-4
53.0
0.09



GmHT4-3-5
52.6
0.07



GmHT4-3-6
55.5
0.37



GmHT4-3-7
54.8
0.26


GmHT4-4
GmHT4-4-1
53.4
0.12



GmHT4-4-2
56.5
0.55



(Gm_CSM6371



GmHT4-4-3
56.0
0.46



GmHT4-4-4
57.4
0.76



GmHT4-4-5
56.3
0.51



GmHT4-4-6
56.0
0.46



GmHT4-4-7
54.5
0.22


Untransformed control

58.4









To compare the field trial data and obtain more precise estimate on the performance of different constructs and transgenic events, a statistical meta-analysis was performed using the aggregate of all plants for each of the seven events for GmHT4-3, and each of the seven events for GmHT4-4 in the multi-season, multi-location field trial data. Table 8 provides the meta-analysis results for yield for the 14 events from the two constructs in the agronomy trials. Mean Yield refers to yield in bushel per acre for the event, or for the untransformed control (wild-type). Table 9 summarizes the meta-analysis results for yield in the efficacy trials. Mean Yield refers to yield in bushel per acre for the event, untreated, or treated with dicamba, glufosinate, 2,4-D, or mesotrione. Plants comprising the soybean event GmHT4-4-2 out-performed other events in these trials. Based on the results of meta-analysis and the molecular profile from the molecular analysis of each event, GmHT4-4-2 was selected as the commercial event and was named Gm_CSM63714.









TABLE 8







Meta-analysis of yield from agronomic field trials












Mean



Construct
Event
Yield
p_Value





GmHT4-3
GmHT4-3-1
59.7
0.03



GmHT4-3-2
61.6
0.44



GmHT4-3-3
61.2
0.86



GmHT4-3-4
60.3
0.24



GmHT4-3-5
60.6
0.50



GmHT4-3-6
61.0
0.96



GmHT4-3-7
61.1
0.96


GmHT4-4
GmHT4-4-1
61.0
0.94



GmHT4-4-2
63.4
0.00



(Gm_CSM63714)



GmHT4-4-3
62.7
0.01



GmHT4-4-4
62.6
0.02



GmHT4-4-5
62.6
0.02



GmHT4-4-6
61.7
0.32



GmHT4-4-7
62.2
0.08


Untransformed control

61.1
















TABLE 9







Meta-analysis of yield from efficacy field trials













Untreated
Dicamba
Gufosinate
2,4-D
Mesotrione



















Mean
Mean

Mean

Mean

Mean



Construct
Event
Yield
Yield
p_Value
Yield
p_Value
Yield
p_Value
Yield
p_Value




















GmHT4-3
GmHT4-3-1
60.4
59.4
0.33
59.1
0.20
62.4
0.05
60.4
0.95



GmHT4-3-2
61.5
61.3
0.85
60.8
0.54
63.2
0.14
62.3
0.47



GmHT4-3-3
61.3
59.7
0.19
59.8
0.21
64.4
0.01
61.0
0.79



GmHT4-3-4
62.6
60.5
0.06
59.8
0.02
62.9
0.82
61.3
0.25



GmHT4-3-5
62.2
60.5
0.08
61.6
0.51
63.5
0.20
61.1
0.28



GmHT4-3-6
62.1
61.3
0.47
61.0
0.35
63.2
0.34
62.1
0.98



GmHT4-3-7
62.8
60.9
0.11
61.9
0.48
63.0
0.85
63.0
0.81


GmHT4-4
GmHT4-4-1
61.6
63.1
0.11
60.9
0.53
60.3
0.21
61.6
0.95



GmHT4-4-2
64.5
64.3
0.84
63.8
0.52
62.6
0.11
64.0
0.64



(Gm_CSM63714)



GmHT4-4-3
64.5
64.2
0.77
63.5
0.33
62.4
0.04
63.0
0.14



GmHT4-4-4
63.8
65.5
0.16
64.1
0.82
61.4
0.04
64.2
0.74



GmHT4-4-5
64.6
63.6
0.43
64.2
0.76
61.6
0.01
62.9
0.16



GmHT4-4-6
65.7
64.3
0.27
63.7
0.11
62.2
0.00
64.2
0.21



GmHT4-4-7
64.6
65.2
0.60
63.5
0.36
61.4
0.01
63.8
0.50









System Trials

In addition to assessing the events for tolerance to individual herbicides at 2×commercial rates as described in the preceding sections of this Example, system trials were designed to evaluate crop tolerance to 1×commercial rates of individual herbicides and herbicide tank mix combinations similar to those potentially used by growers.


Four events from GmHT4-3 and three events from GmHT4-4 were tested. The trial was conducted at four North American locations using a Group Unbalanced Block Design (GUBD2) with two replications and twenty treatments. These consisted of an untreated block along with nineteen blocks for herbicide treatments (Table 10). Herbicide applications were at V3, V6 and R1 growth stages. Turbo TeeJet Induction (TTI) nozzles were used for all herbicide treatments. Herbicide-treated event plots were compared to untreated event plots.


Plots were two rows of twelve feet in length, with a three-foot alley with 30-inch row spacing and seeded at 235 seeds per plot. Trial maintenance was designed to optimize grain yield. Data was collected for emergence, vigor, date of first flower, plant height, maturity, and yield. In addition, visual injury data was collected for the efficacy trials approximately seven days after postemergent herbicide applications. Statistical analysis was automated using ASReml software for mixed model fitting.


Table 10 provides a summary of herbicide treatments and the corresponding plant development stages of such treatments. Treatment 1 is the untreated control. The herbicide application rate is presented as pound/acre (lb/acre) unless otherwise noted. Mean Yield (bushels/acre) of the events with different herbicide treatments in the system trials is summarized in Table 11. The soy event GmHT4-4-2 (Gm_CSM63714) performed very well with all of the herbicide treatments and showed significantly positive yield with dicamba applications (Treatment 4). Event GmHT4-3-6 showed significant reduced yield with the herbicide combination of dicamba+mesotrione+glufosinate.









TABLE 10







Herbicide treatments and plant growth stages in the system trials













Herbicide






(Commercial
Application Rate
Application


Treatment
Rate
Product Name)
(pound/acre)
Stage
















1

None






2
1X
Dicamba (Xtendimax)
0.5
V3




2,4-D (Enlist One)
1




Glufosinate (Liberty 280ASL)
0.8

V6




Mesotrione (Callisto 480SC)
0.09


R1


3
1X
Glufosinate (Liberty 280ASL)
0.8
V3




Mesotrione (Callisto 480SC)
0.09




Dicamba (Xtendimax)
0.5

V6




2,4-D (Enlist One)
1


4
1X
Dicamba (Xtendimax)
0.5
V3

R1


5
1X
Glufosinate (Liberty 280ASL)
0.8
V3

R1


6
1X
2,4-D (2,4-D Amine )
1
V3

R1


7
1X
2,4-D (Enlist One)
1
V3

R1


8
1X
Mesotrione (Callisto 480SC)
0.09
V3

R1


9
1X
Dicamba (Xtendimax)
0.5
V3

R1




Glufosinate (Liberty 280ASL)
0.8


10
1X
Dicamba (Xtendimax)
0.5
V3

R1




2,4-D (Enlist One)
1


11
1X
Dicamba (Xtendimax)
0.5
V3

R1




Mesotrione (Callisto 480SC)
0.09


12
1X
Glufosinate (Liberty 280ASL)
0.8
V3

R1




2,4-D (Enlist One)
1


13
1X
2,4-D (Enlist One)
1
V3

R1




Mesotrione (Callisto 480SC)
0.09


14
1X
Glufosinate (Liberty 280ASL)
0.8
V3

R1




Mesotrione (Callisto 480SC)
0.09


15
1X
Dicamba (Xtendimax)
0.5
V3

R1




Mesotrione (Callisto 480SC)
0.09




Glufosinate (Liberty 280ASL)
0.8


16
1X
Dicamba (Xtendimax)
0.5
V3

R1




Mesotrione (Callisto 480SC)
0.09




2,4-D (Enlist One)
1


17
1X
Dicamba (Xtendimax)
0.5
V3

R1




Mesotrione (Callisto 480SC)
0.09




Glufosinate (Liberty 280ASL)
0.8


18
1X
2,4-D (Enlist One)
1
V3

R1




Mesotrione (Callisto 480SC)
0.09




Glufosinate (Liberty 280ASL)
0.8
















TABLE 11





Performance of events in system trials

















GnHT4-3











GmHT4-3-2
GmHT4-3-3
GmHT4-3-6














Treatment

Mean

Mean

Mean



Number
Treatment
Yield
p_Value
Yield
p_Value
Yield
p_Value





1
Untreated
59.3

59.2

60.8


2
Quad 1
59.3
0.98
60.4
0.56
61.3
0.79


3
Quad 2
57.9
0.50
58.8
0.85
60.8
0.98


4
Dicamba
61.6
0.26
60.4
0.56
61.6
0.68


5
Glufosinate
57.5
0.37
58.1
0.61
58.2
0.20


6
2,4-D Amine
62.8
0.09
58.0
0.58
58.6
0.28


7
2,4-D Choline
60.9
0.45
61.8
0.20
60.2
0.79


8
Mesotrione
57.3
0.32
61.2
0.33
61.6
0.70


9
Dic + Gluf
56.6
0.17
56.7
0.23
60.1
0.73


10
Dic + 2,4-D
60.4
0.59
61.2
0.33
59.9
0.66


11
Dic + Meso
59.8
0.79
59.5
0.88
61.9
0.58


12
2,4-D + Gluf
59.2
0.94
58.3
0.67
59.4
0.49


13
2,4-D + Meso
61.0
0.42
59.6
0.82
60.5
0.90


14
Meso + Gluf
56.8
0.23
58.7
0.81
58.2
0.23


15
Dic + Meso + Gluf
57.7
0.44
57.7
0.47
56.5
0.04


16
Dic + Meso + 2,4-D
57.6
0.40
58.9
0.91
60.0
0.70


17
Dic + 2,4-D + Gluf
59.2
0.97
59.9
0.71
57.3
0.09


18
2,4-D + Meso + Gluf
57.1
0.28
56.3
0.17
59.3
0.46












GmHT4-4












GnHT4-3
GmHT4-4-2





GmHT4-3-7
(Gm_CSM63714)
GmHT4-4-4
GmHT4-4-6















Treatment
Mean

Mean

Mean

Mean



Number
Yield
p_Value
Yield
p_Value
Yield
p_Value
Yield
p_Value





1
58.8

60.0

61.1

60.4


2
60.4
0.45
61.4
0.52
60.8
0.90
61.8
0.49


3
60.1
0.54
63.2
0.13
62.2
0.58
59.6
0.70


4
60.6
0.38
64.7
0.03
60.8
0.90
63.8
0.10


5
56.0
0.16
61.3
0.53
59.6
0.49
59.4
0.62


6
59.9
0.59
60.2
0.94
59.4
0.41
59.4
0.64


7
61.7
0.16
60.3
0.88
61.2
0.97
62.5
0.32


8
59.4
0.79
62.2
0.30
61.6
0.79
63.0
0.21


9
58.2
0.74
63.6
0.09
61.4
0.90
61.2
0.69


10
60.7
0.37
60.1
0.97
61.2
0.96
60.6
0.90


11
59.5
0.75
63.0
0.15
63.6
0.23
64.3
0.06


12
58.7
0.94
59.3
0.73
60.9
0.92
57.6
0.19


13
61.4
0.22
59.8
0.90
61.3
0.90
61.0
0.77


14
57.3
0.45
61.1
0.62
59.6
0.48
59.2
0.55


15
57.4
0.48
60.2
0.94
62.2
0.59
61.7
0.52


16
60.5
0.41
59.2
0.68
60.8
0.90
58.5
0.34


17
58.8
0.97
61.7
0.44
58.5
0.20
61.7
0.51


18
60.9
0.31
56.8
0.12
59.5
0.45
58.7
0.42









Meta analysis was also performed on emergence, plant height, moisture, maturity, and yield for the seven events from each of the constructs GmHT4-3 and GmHT4-4. Emergence is a visual estimation of planted seed that emerged on a scale of 1-9, where 1 indicates that 90 to 100% of the planted seeds emerged, and 9 indicates that 0 to 19% of planted seeds emerged. The results showed that the mean emergence for the transgenic events ranged from 1.1 to 1.5, with a p-value ranging from 0.01 to 0.97, which was not significantly different from the mean of 1.2 for the untransformed control.


Plant height was assessed by measuring in inches the average height of the upper most nodes of representative plants, taken prior to harvest. The mean plant height for the transgenic events ranged from 33.0 to 35.9, with a p-value ranging from 0 to 0.51, which was not significantly different from the mean of 35.5 for the untransformed control.


Moisture refers to the moisture content of harvested grain from a given plot, denoted as percent. The mean moisture content for the transgenic events ranged from 11.7 to 11.9%, with a p-value ranging from 0.02 to 0.97, which was not significantly different from the mean of 11.7 for the untransformed control.


Maturity is the number of days before or after March 1st (South America) or August 31st (North America) when the plot reaches 95% maturity; that is, when 95% of the pods in the plot are brown. The mean maturity for the transgenic events ranged from 28.5 to 30.9, with a p-value ranging from 0 to 0.97, which was not significantly different from the mean of 28.5 for the untransformed control.


Yield is the grain yield expressed in bushels per acre. While the mean yield for the transgenic events ranged from 59.7 to 63.4, the mean for the untransformed control is 61.1. Therefore, the results demonstrate that the transgenic events behaved similarly to the untransformed control. Expression of the transgenes had no significant impact on plant growth and development.


Example 3: Molecular Analysis and Event Selection

Molecular analysis was conducted concurrently with the field trials on events that were advanced. DNA amplification and sequencing were used to confirm the composition and intactness of the insert sequence, insert copy number, absence of Agrobacterium Ti-plasmid backbone sequence and the aadA/sp/A selection cassettes carried on the second T-DNA. The insertion site in the soybean genome of each event was mapped, and it was confirmed that the transgenic insert was not inserted in or close to any endogenous gene or a repeat region. Northern analysis was done to detect and measure mRNA transcripts of the DMO, PAT, FT_Tv7, and TDO genes in transgenic plants for each event. Protein analysis of plants comprising each event was conducted using techniques known in the art. N-terminal protein sequencing of the DMO, PAT, FT_Tv7, and TDO proteins purified from transgenic plants containing each event was done to confirm the recombinant protein sequences. Western blot analysis was conducted on protein extracts to confirm the production of the DMO, PAT, FT_Tv7, and TDO proteins from each transgenic event.


Based on the comprehensive and in-depth molecular characterization for each event in combination with the trait efficacy and agronomy performance over multiple growing seasons, in multiple geographic locations and under a variety of growth conditions, the soybean event Gm_CSM63714 was selected as the commercial event. Table 12 summarizes the results of the extensive and intensive selection process, leading to the identification and selection of the soybean event Gm_CSM63714 as the best event for commercial development. #R0 Event refers to number of events generated for each of the constructs (Step 1). #Event with 1-2 Copy of the Transgenic Insert refers to the number of events for each construct that contained 1-2 copy of the transgenic insert based on molecular characterizations, and thus were advanced to further testing and/or molecular characterization (Step 2). #Event without aadA Cassette refers to the number of events that contained 1-2 copy of the transgenic insert and did not contain the aadA/splA cassettes on the second T-DNA, indicating that the second T-DNA was not linked to the first T-DNA and was segregated away, and therefore, the events did not contain the second T-DNA (Step 3). #R0 Events with Seeds represents the number of R0 events from Step 3 that were able to grow to maturity and harvested with seeds (Step 4). #Advanced to R1 Nursery represents the number of events advanced to R1 nursery for seed production and further testing (Step 5). #Meeting Molecular Criteria refers to the number of events that met all the molecular criteria, such as single copy insert, intactness of the insert sequence, absence of Agrobacterium Ti-plasmid backbone sequence and the second T-DNA, insertion of the transgene not in or close to any endogenous gene or a repeat region, detection of the DMO, PAT FT_Tv7, and TDO protein in transgenic plants for each event, and confirmation of the recombinant protein sequences (Step 6). R2 Efficacy and Nursery represents the number of events showing herbicide tolerance efficacy and were advanced to R2 nursery (Step 7). R3 Field Trials NA Y1 and R4 SA Field Trials indicate the number of R3 and R4 events that were tested in year 1 North American and South American field trials (Step 8 and 9), respectively. R5 Field NA Y2 indicates the number of R5 events that were advanced to year 2 North American field trials (Step 10). Commercial Event indicates the final event that was selected as the commercial event, which met all the molecular criteria, and showed consistent efficacy and agronomic performance in all field trials.









TABLE 12







Summary of event selection














Event Selection









Description (Step)
GmHT4-1
GmHT4-6
GmHT4-3
GmHT4-4
GmHT4-5
GmHT4-2
Total

















# R0 Event (1)
4886
4513
4,685
4,751
2678
4247
25760


# Event with 1-2 Copy of
1013
839
943
934
552
921
5202


Transgenic Insert (2)


# Event without aadA
186
151
201
167
105
134
944


Cassette (3)


# R0 Event with Seeds (4)
160
147
158
160
100
125
850


# Advanced to R1 nursery (5)
50
57
54
43
37
47
288


# Meeting Molecular
26
12
37
22
17
27
141


Criteria (6)


R2 Efficacy and Nursery (7)
18
14
20
18
18
18
106


R3 field trials NA Y1 (8)
17

15
18

18
68


R4 SA field trials (9)
17

18
18

17
70


R5 field NA Y2 (10)


7
8


15


Commercial Event



1


1









Example 5: Molecular Characterization of Soybean Event Gm_CSM63714

As described above, soybean event Gm_CSM63714 was identified through comprehensive molecular characterization and event selection processes coupled with field performance testing including trait efficacy and yield. This example describes the extensive molecular characterization upon selection of Gm_CSM63714 as the commercial event, including confirmation of single copy of intact T-DNA at a single locus, absence of Agrobacterium Ti plasmid backbone DNA and the second T-DNA containing the aadA/sp/A selection cassettes; determination of the chromosomal location of the T-DNA insert, confirmation that the T-DNA did not interrupt any known endogenous gene and did not insert into any repeat regions; and identification of the transgene 5′ and 3′ genomic flanking sequences and the wild-type allele sequence. The transgenic insert of soy event Gm_CSM63714 contains the elements and sequences described in Table 1.


DNA sequence analysis of the soybean event Gm_CSM63714 was conducted. Southern hybridization analysis was conducted to confirm that plants of soybean event Gm_CSM63714 contained a single and intact copy of the entire transgenic insert without any transformation vector backbone and the second T-DNA sequence harboring the aadA and splA selection cassettes. The in planta transgenic insert was isolated and sequenced using methods known in the art. The results showed that the inserted in planta T-DNA sequence perfectly matched the expected T-DNA sequence from the transformation vector HT4-4.


DNA flanking the transgenic insert (5′ and 3′ flanking sequences) was also isolated and sequenced using sequence capture, enrichment, sequencing, inverse PCR, and genome walking techniques. The respective 5′ and 3′ junction sequences were subsequently determined. The sequences of the flanking DNA for soybean event Gm_CSM63714 were mapped to the known soybean genome physical assembly. The insertion site sequence information was used for bioinformatic analysis to determine the chromosomal location of the event. The insertion site integrity was determined by PCR across the wild-type allele using primers specific to the flanking regions of soybean event Gm_CSM63714. The wild-type insertion site was used to map the unique site of transgenic integration for soybean event Gm_CSM63714 to the soybean reference genome. Molecular analysis identified a 40-nucleotide deletion at the transgene insertion site, and also confirmed that the inserted T-DNA sequence perfectly matches the intended T-DNA sequence from the transformation vector, with no mutations or truncations. Whole genome sequencing (E-Southern) was performed on materials from multiple generations to confirm the identity of the progeny. Sequence information for the transgenic insert, the 5′ and 3′ flanking sequences, and the 5′ and 3′ junctions are provided herein as SEQ ID NOs:1-10.


RNA analysis of plants comprising the soybean event Gm_CSM63714 was conducted. Northern hybridization was performed on total RNA and mRNA isolated from immature seeds. The results confirmed RNA transcripts corresponding in size to the DMO, PAT, FT_Tv7, and TDO mRNA products in soy event Gm_CSM63714.


Protein analyses of plant comprising soybean event Gm_CSM63714 were also conducted. The N-terminal amino acid sequences of the expressed DMO, PAT, FT_Tv7, and TDO proteins were determined by Edman sequencing and mass spectrometry using immunopurified protein extracts from mature seeds to confirm the authentic N-terminal amino acid sequences. Western blot analysis was conducted on protein extracts from mature seed of soybean event Gm_CSM63714 to confirm the production of a single expected-sized protein for DMO, PAT, FT_Tv7, and TDO, respectively. In addition, ELISA was used to determine protein levels of DMO, PAT, FT_Tv7, and TDO in soybean event Gm_CSM63714 leaves during different developmental stages (V3, R1, and R5), under different growth conditions (greenhouse, growth chamber, and field) and over multiple generations (R1, R3, and R5). The results show that, overall, the DMO, PAT, FT_Tv7, and TDO proteins remained stable across different growth conditions and multiple generations tested.


Example 6: Detection of Soybean Event Gm_CSM63714

This example describes methods useful in identifying or detecting the presence of soybean event Gm_CSM63714. Detection of the event in a sample can be achieved using DNA, RNA, or protein detection techniques. Illustrative detection methods and materials are provided below.


1) Soybean Event Gm_CSM63714 Event-Specific Endpoint Taqman™ Assays

An event-specific endpoint Applied Biosystems™ TaqMan thermal amplification method (Thermo Fisher Scientific) was developed to identify soybean event Gm_CSM63714 in a sample. The DNA primers and probe used in the endpoint assay for this example are shown in Table 13, although it will be appreciated by those of skill in the art that that other primers and probes may also be used.









TABLE 13







Primers and probe for soybean


Gm_CSM63714 event-specific assay











SEQ ID NO.
Name
Type







14
Primer SQ21524
Event-specific



15
Primer SQ51589
Event-specific



16
6FAM ™ probe PB 10269
Event-specific



17
Primer SQ546
Internal control



18
Primer SQ549
Internal control



19
VIC ™ Probe PB50207
Internal control










6-FAM™ is a fluorescent dye product of Applied Biosystems (Foster City, Calif.) and is attached to the DNA probe. For TaqMan MGB (Minor Grove Binder) probes, the 5′ exonuclease activity of Taq DNA polymerase cleaves the probe from the 5′-end, between the fluorophore and quencher. When hybridized to the target DNA strand, quencher and fluorophore are separated enough to produce a fluorescent signal, thus releasing fluorescence. The pair of primers when used with these reaction methods and the probe produce a DNA amplicon that is diagnostic for soybean event Gm_CSM63714. The controls for this analysis should include a positive control containing soybean event Gm_CSM63714, a negative control from a non-transgenic plant, and a negative control that contains no template DNA. Additionally, a control for the PCR reaction should optimally include internal control primers and an internal control probe, specific to a single copy gene in the soybean genome. These assays are optimized for use with the Applied Biosystems GeneAmp® PCR System 9700 (Thermo Fisher Scientific) run at maximum speed, but other equipment may be used.


Examples of PCR reaction components and cycling conditions useful for the event-specific qualitative endpoint TaqMan PCR assay for soybean event Gm_CSM63714 are presented in Table 14 and Table 15. The extracted DNA template was a DNA sample to be analyzed, a negative control (non-transgenic soybean DNA), no template (water) control, or a positive control containing soybean event Gm_CSM63714 DNA.









TABLE 14







Gm_CSM63714 event-specific endpoint TaqMan ™ PCR


reaction components













Stock

Final




Concentration
Volume
Concen-


Step
Reagent
(μM)
(μl)
tration















Reaction Volume

5



1
2 × Master Mix

2.28
1 X


2
Event Specific Primer
100
0.05
0.9 μM



SQ21524


3
Event Specific Primer
100
0.05
0.9 μM



SQ51589


4
Event Specific 6FAM ™
100
0.01
0.2 uM



probe PB10269


5
Internal Control Primer
100
0.05
0.9 μM



SQ546


6
Internal Control Primer
100
0.05
0.9 μM



SQ549


7
Internal Control VIC ™
100
0.01
0.2 μM



Probe PB50207


8
Extracted DNA template

2.5
















TABLE 15







Endpoint TaqMan ™ thermocycler conditions











Step No.
Cycle No.
Settings















1
1
95° C., 20 seconds



2
35
95° C., 3 seconds





60° C., 20 seconds










2) Detection of Soybean Event Gm_CSM63714 Using AntibodiesPG-3″

Another example of detection of soybean event Gm_CSM63714 involves the use of one or more antibodies specific for at least one protein encoded by soybean event Gm_CSM63714. For example, a detection kit comprising at least such antibody can be used. Such a kit may utilize a lateral flow strip comprising reagents activated when the tip of the strip is contacted with an aqueous solution. Illustrative proteins sufficient for use in antibody production are ones encoded by the sequence provided as SEQ ID NO:10, or any fragment thereof.


A protein detection method is developed to determine whether a sample is from a plant, seed, cell, or plant part comprising soybean event Gm_CSM63714. At least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714 is used to detect a protein encoded by soybean event Gm_CSM63714 in a sample. A detection kit comprising one or more antibodies specific for one or more proteins encoded by soybean event Gm_CSM63714 may utilize a lateral flow strip containing reagent activated when the tip of the strip is contacted with an aqueous solution. Samples of soybean tissues may be ground up and protein extracted for analysis using water or an aqueous buffer (for example, phosphate buffered saline containing detergent and bovine serum albumin). Following centrifugation, the aqueous supernatant is analyzed using the ELISA method in a sandwich format on a lateral flow strip containing an absorbent pad. Detection is activated by dipping the tip of the strip into the aqueous solution containing the sample to be tested.


The aqueous solution is carried up the strip by capillary action and solubilizes gold labeled antibodies on the strip. The gold-labeled antibodies are specific for at least one protein encoded by soybean event Gm_CSM63714 and will bind to an epitope on the protein in the sample to form an antibody-antigen complex. The gold labeled antibody-antigen complex is then carried up the strip to a nitrocellulose membrane. The membrane comprises a test line of immobilized antibodies that bind to a second, separate epitope on the protein encoded by soybean event Gm_CSM63714, causing a visible line to appear across the test strip if the protein encoded by soybean event Gm_CSM63714 is present in the sample.


3) Detection of Soybean Event Gm_CSM63714 by Southern Analysis

Another method to detect the presence of soybean event Gm_CSM63714 in a plant sample is Southern analysis as generally understood in the art. One of skill in art, based on the present disclosure and description of soybean event Gm_CSM63714, would understand how to design Southern hybridization probe(s) specific for the event and a second Southern hybridization probe specific for a plant which is null for the event (wild-type). With Southern analysis, a signal detected only from the first Southern hybridization probe will be indicative of a plant positive for soybean event Gm_CSM63714; a signal detected only from the second Southern hybridization probe will be indicative that the DNA was extracted from a plant that is null for the event (wild-type).


Example 7: Zygosity Assays for Soybean Event Gm_CSM63714

This example describes methods useful in determining the zygosity of event Gm_CSM63714. The zygosity assay determines whether a plant comprising soybean event Gm_CSM63714 is heterozygous or homozygous for the event or the wild-type allele. Illustrative detection methods and materials are provided below.


A zygosity assay is developed to determine whether a plant comprising soybean event Gm_CSM63714 is heterozygous or homozygous for the event or the wild-type allele. An amplification reaction assay can be designed using the sequence information provided herein. For example, such a PCR assay would include design of at least three primers: primer-1, primer-2 and primer-3, where primer-1 is specific to soybean genomic DNA on the 3′ flanking DNA of soybean event Gm_CSM63714 (for example, SEQ ID NO:15); primer-2 is specific to soybean event Gm_CSM63714 transgenic insert (for example, SEQ ID NO:14); and primer-3 is specific to the wild-type allele (for example, SEQ ID NO:20). When used as a primer pair in an amplification reaction, primer-1 with primer-2 will produce a PCR amplicon specific for soybean event Gm_CSM63714. When used as a primer pair in an amplification reaction, primer-1 with primer-3 will produce a PCR amplicon specific for wild-type allele. In a PCR reaction performed on soybean event Gm_CSM63714, the respective PCR amplicons generated from primer-1+primer-2 and those generated from primer-1+primer-3 will differ in sequence and size of the amplicon. When the three primers are included in a PCR reaction with DNA extracted from a plant homozygous for soybean event Gm_CSM63714, only the primer-1+primer-2 amplicon (specific for the soybean event Gm_CSM63714) will be generated. When the three primers are included in a PCR reaction with DNA extracted from a plant heterozygous for soybean event Gm_CSM63714, both the primer-1+primer-2 amplicon (specific for the soybean event Gm_CSM63714 insert) and the primer-1+primer-3 amplicon (specific for the wild-type allele or absence of the soybean event Gm_CSM63714 insert) will be generated. When the three primers are mixed together in a PCR reaction with DNA extracted from a plant that is null for soybean event Gm_CSM63714 (that is wild-type), only the primer-1+primer-3 amplicon (specific for the wild-type allele) will be generated. The amplicons produced using the PCR reaction may be identified or distinguished using any method known in the art.


Another zygosity assay for soybean event Gm_CSM63714 is a Tagman™ thermal amplification method. Two fluorescently labeled probes are included in addition to the primers as described in the proceeding section. Probe-1, containing a fluorescent label (for example, the 6-FAM™-labeled SEQ ID NO:16), is specific for soybean event Gm_CSM63714; whereas Probe-2, containing a different fluorescent label (for example, the VIC™-labeled SEQ ID NO:21), is specific for a wild-type soybean plant that is null for soybean event Gm_CSM63714.


When the three primers (SEQ ID NO:14, SEQ ID NO:15, and SEQ ID NO:20) and two probes (SEQ ID NO:16 and SEQ ID NO:21) are mixed together in a PCR reaction with DNA extracted from a plant homozygous for soybean event Gm_CSM63714, a fluorescent signal from the 6FAM™-labeled probe PB10269 (SEQ ID NO:16) is released, which is indicative of and diagnostic for a plant homozygous for soybean event Gm_CSM63714. When the three primers and two probes are mixed together in a PCR reaction with DNA extracted from a plant heterozygous for soybean event Gm_CSM63714, two distinct fluorescent signals are generated, one from the 6FAM™-labeled probe PB10269 (SEQ ID NO:16), and one from the VIC™_labeled probe PB50681 (SEQ ID NO:21). When the three primers and the two probes are mixed together in a PCR reaction with DNA extracted from a wild-type plant which is null for soybean event Gm_CSM63714, a fluorescent signal from the VIC™-labeled probe PB50681 (SEQ ID NO:21) is generated.


Examples of PCR reaction components and cycling conditions useful for TaqMan™ PCR zygosity assay for soybean event Gm_CSM63714 are presented in Table 16 and Table 17. The extracted DNA template was a DNA sample to be analyzed, a negative control (non-transgenic soybean DNA), no template (water) control, or a positive control containing soybean event Gm_CSM63714 DNA.









TABLE 16







Gm_CSM63714 zygosity TaqMan ™ PCR reaction components













Stock

Final




Concentration
Volume
Concen-


Step
Reagent
(μM)
(μl)
tration















Reaction Volume

5



1
18 megohm water

0.05


2
2 × Master Mix

2.28
1 X


3
Event Specific Primer
100
0.05
0.9 μM



SQ21524


4
Event Specific Primer
100
0.05
0.9 μM



SQ51589


5
Event Specific 6FAM ™
100
0.01
0.2 μM



probe PB10269


6
Wild-type allele primer
100
0.05
0.9 μM



SQ52071


7
Wild-type allele VIC ™
100
0.01
0.2 μM



probe PB50681


8
Extracted DNA template

2.5
















TABLE 17







Zygosity TaqMan ™ thermocycler conditions











Step No.
Cycle No.
Settings















1
1
95° C., 20 seconds



2
35
95° C., 3 seconds





60° C., 20 seconds










Another method to detect the presence and zygosity of soybean event Gm_CSM63714 in a plant sample is Southern blot analysis. One of skill in art would understand how to design a first Southern hybridization probe(s) specific for soybean event Gm_CSM63714 and a second Southern hybridization probe specific for a soybean plant which is null for the soybean event Gm_CMS63714 (wild-type). With Southern blot analysis, a signal detected only from the first Southern hybridization probe is indicative a plant homozygous for soybean event Gm_CSM63714; a signal detected from both the first and the second hybridization probes is indicative of a plant heterozygous for soybean event Gm_CSM63714; and a signal detected only from the second Southern hybridization probe indicates that the DNA was extracted from a plant that is null for soybean event Gm_CSM63714 (wild-type).


Example 8: Modification of Soybean Event Gm_CSM63714 with Genome Editing Techniques Using a Single Guide RNA

This example describes how one may alter or excise all or a part of the transgenic insertion present in soybean event Gm_CSM63714, as well as flanking genomic DNA segments, such as by making one or more insertions, deletions, substitutions, or transpositions using genomic editing techniques. For example, such alterations can be made using Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) editing systems comprising a single guide RNA by genome editing methods. Sequences useful in excision of the event Gm_CSM63714 transgenic insertion or expression cassettes within SEQ ID NO:9 or SEQ ID NO:10 can be introduced through genome editing using a variety of methods. In one embodiment, Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) editing systems comprising a CRISPR associated protein and cognate guide RNAs may be used for targeted excision. The CRISPR-associated protein is an RNA guided nuclease and can be selected from a Type I CRISPR-associated protein, a Type II CRISPR-associated protein, a Type III CRISPR-associated protein, a Type IV CRISPR-associated protein, a Type V CRISPR-associated protein, or a Type VI CRISPR-associated protein, such as, but not limited to, Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9 (also known as Csn1 and Csx12), Cas10, Cas 12a (also known as Cpf1), Csy1, Csy2, Csy3, Cse1, Cse2, Csc1, Csc2, Csa5, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, Csf4, CasX, CasY, and Mad7. The CRISPR-associated protein and one or more guide RNAs (gRNA) can be introduced into a plant cell corresponding to soybean event Gm_CSM63714 to target a specific sequence within the transgene insertion locus. In one embodiment, the CRISPR nuclease system cleaves at two identical guide RNA hybridization sites thereby permitting the excision of the intervening sequence. Following DNA cleavage, the genomic sequence can be repaired via a double strand break repair pathway, which may include, for example, non-homologous end-joining (NHEJ), microhomology-mediated end joining (MMEJ), homologous recombination, synthesis-dependent strand annealing (SDSA), single-strand annealing (SSA), or a combination of any thereof, at the genomic target site. One or more guide RNA hybridization sequences can be inserted within the event Gm_CSM63714 transgene insertion locus which can subsequently allow for the excision of the transgene insertion from event Gm_CSM63714 or specific expression cassettes within SEQ ID NO:9 or SEQ ID NO:10.


Sequences corresponding to the 5′ and 3′ flanking genomic sequences of event Gm_CSM63714 (presented as SEQ ID NOs:11 and 12), the 5′ and 3′ junction regions (presented as SEQ ID NOs:1-6) and the transgenic insertion (presented as SEQ ID NO:9) were scanned for potential originator guide RNA recognition sites (OgRRS). As used herein, the term “originator guide RNA recognition site” or “OgRRS” refers to an endogenous DNA polynucleotide comprising a protospacer adjacent motif (PAM) site operably linked to a guide RNA hybridization site (i.e., protospacer sequence). In some embodiments, an OgRRS can be located in the flanking 5′ or 3′ genomic sequence (i.e., in non-transgenic DNA of a junction polynucleotide). In some embodiments, an OgRRS can be located in the 5′ or 3′ junction region (i.e., in both transgenic DNA and non-transgenic DNA of a junction polynucleotide, or spanning transgenic and non-transgenic DNA in a DNA junction polynucleotide). In some embodiments, an OgRRS can be located in the transgenic insert. The OgRRS can be determined based upon the specific CRISPR editing system chosen. For example, Cas9 recognizes a G-rich protospacer-adjacent motif (PAM) that is 3′ to its guide RNA hybridization site whereas Cas12a systems recognize a T-rich protospacer-adjacent motif (PAM) that is 5′ to its guide RNA hybridization site.


The OgRRS sequence is then used to define a cognate guide RNA recognition site (CgRRS) which is inserted into the transgenic insertion locus of event Gm_CSM63714 using a CRISPR editing system. As used herein, the term “cognate guide RNA recognition site” or “CgRRS” refers to a DNA polynucleotide comprising a PAM site operably linked to a guide RNA hybridization site (i.e. protospacer sequence), where the CgRRS is absent from event Gm_CSM63714 comprising the original transgenic locus that is unmodified and where the CgRRS and its corresponding OgRRS can hybridize to a single gRNA. A CgRRS can be located in the flanking 5′ or 3′ genomic sequence (i.e., in non-transgenic DNA of a junction polynucleotide), in the 5′ or 3′ junction region (i.e., in both transgenic DNA and non-transgenic DNA of a junction polynucleotide, or spanning transgenic and non-transgenic DNA in a DNA junction polynucleotide), or in the transgenic insert. A CgRRS comprises the same gRNA target sequence as the corresponding OgRRS. The CgRRS is inserted in a region within the transgenic insertion locus of event Gm_CSM63714 that is on the opposite side of the transgenic insertion, relative to the OgRRS in a manner that will permit the excision of a fragment of DNA corresponding to either the entire transgenic insertion of event Gm_CSM63714, or a fragment within the transgene insert of event Gm_CSM63714 such as an expression cassette or genetic element within the transgene cassette, using a single gRNA. For example, if the OgRRS is located within the 3′ flanking genomic sequence or the 3′ junction region, then the CgRRS can be inserted within the 5′ flanking genomic sequence, or the 5′ junction region, or within the transgene insert such as between expression cassettes or genetic elements within an expression cassette. Insertion of the CgRRS on the opposite side of the transgenic insertion or within the region between expression cassettes, relative to the OgRRS allows for excision of the transgenic insertion or specific expression cassette(s) to be excised using a single gRNA. An OgRRS located between the expression cassettes of event Gm_CSM63714 can be used to design a CgRRS that can be inserted in either the 5′ or 3′-flanking genomic sequence to permit excision of one or more expression cassettes using a single gRNA.


Table 18 shows OgRRS sequences located within the 5′ and 3′-flanking genomic sequences and in the transgenic insertion of event Gm_CSM63714 that can be used in a CRISPR editing system employing Cas12a, a Type V CRISPR-associated protein. The analysis was performed for four Cas12a endonucleases. Fn (SEQ ID NO:48) refers to Francisella novicida U112 Cas12a (also known as FnCas12a or FnCpf1), and requires the PAM sequence of 5′-TTN, where N is A, C, G or T (Zetsche et al., 2015). Lb (SEQ ID NO:45) refers to the Cas12a from Lachnospiraceae bacterium ND2006 (also known as LbCas12a or LbCpf1), and requires the PAM sequence of 5′-TTTV, where V is A, C, or G. Lb_V1 and Lb_V2 refer to engineered variants of Lachnospiraceae bacterium ND2006 Cas12a (Gao et al., 2017). The Lb_V1 variant (SEQ ID NO:46) contains the G532R/K595R mutations and recognizes 5′-TYCV PAM; whereas the Lb_V2 variant (SEQ ID NO:47) contains the G532R/K538V/Y542R mutations and recognizes 5′-TATV PAM, where Y is C or T, and V is A, C or G. The PAM sequence, the coordinates of the gRNA hybridization site (also known as OgRRS) relative to SEQ ID NO:10, and the corresponding Cas12a endonuclease are shown under the headings of “PAM”, “Cas12a Nuclease”, and “Start . . . End of gRNA Hybridization Site in SED ID NO:10”, respectively. “Strand of SEQ ID NO:10” indicates whether the identified gRNA hybridization site along with its PAM sequence is on the forward strand (+) or the complementary strand (−).









TABLE 18







OgRRS sequences within event Gm_CSM63714












Name of 







gRNA 


Start . . . End




Hybri-


of gRNA
Strand



dization


Hybridization
of



Site 

Cas12a 
Site in
SEQ ID
Target


(OgRRS)
PAM
Nuclease
SEQ ID NO: 10
NO: 10
Region





5F-1
TTA
Fn
    6 . . . 28
+
5′ Flanking Genomic DNA





5F-2
TTG
Fn
   16 . . . 38
+
5′ Flanking Genomic DNA





5F-3
TCCG
Lb_V1
    1 . . . 23

5′ Flanking Genomic DNA





5F-4
TTCC
Lb_V1
    2 . . . 24

5′ Flanking Genomic DNA





5F-5
TTC
Fn
    3 . . . 25

5′ Flanking Genomic DNA





5F-6
TTA
Fn
   18 . . . 40

5′ Flanking Genomic DNA





5F-7
TCCC
Lb_V1
   31 . . . 53

5′ Flanking Genomic DNA





5F-8
TTCC
Lb_V1
   32 . . . 54

5′ Flanking Genomic DNA





5F-9
TTC/
Fn/Lb_V1/
   33 . . . 55

5′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-10
TTC
Fn
   79 . . . 101
+
5′ Flanking Genomic DNA





5F-11
TTCG
Lb_V1
   80 . . . 102
+
5′ Flanking Genomic DNA





5F-12
TTA
Fn
   71 . . . 93

5′ Flanking Genomic DNA





5F-13
TTA/
Fn/Lb_V1/
   77 . . . 99

5′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-14
TTA/
Fn/Lb_V1/
  102 . . . 124
+
5′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-15
TTA
Fn
  111 . . . 133
+
5′ Flanking Genomic DNA





5F-16
TATG
Lb_V2
  113 . . . 135
+
5′ Flanking Genomic DNA





5F-17
TATC
Lb_V2
  117 . . . 139
+
5′ Flanking Genomic DNA





5F-18
TATA
Lb_V2
  123 . . . 145
+
5′ Flanking Genomic DNA





5F-19
TATG
Lb_V2
  125 . . . 147
+
5′ Flanking Genomic DNA





5F-20
TTCA
Lb_V1
  109 . . . 131

5′ Flanking Genomic DNA





5F-21
TTC/
Fn/Lb_V1/
  110 . . . 132

5′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-22
TTC/
Fn/Lb_V1/
  156 . . . 178
+
5′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-23
TTG/
Fn/Lb_V1/
  160 . . . 182
+
5′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-24
TTCA
Lb_V1
  173 . . . 195

5′ Flanking Genomic DNA





5F-25
TTC/
Fn/Lb_V1/
  174 . . . 196

5′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-26
TCCG
Lb_V1
  202 . . . 224

5′ Flanking Genomic DNA





5F-27
TTC/
Fn/Lb_V1/
  236 . . . 258
+
5′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-28
TTCA
Lb_V1
  237 . . . 259
+
5′ Flanking Genomic DNA





5F-29
TTA
Fn
  249 . . . 271
+
5′ Flanking Genomic DNA





5F-30
TTA/
Fn/Lb_V1/
  234 . . . 256

5′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-31
TTG/
Fn/Lb_V1/
  257 . . . 279
+
5′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-32
TTA
Fn
  245 . . . 267

5′ Flanking Genomic DNA





5F-33
TTA/
Fn/Lb_V1/
  257 . . . 279

5′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-34
TTA
Fn
  264 . . . 286

5′ Flanking Genomic DNA





5F-35
TTG/
Fn/Lb_V1/
  315 . . . 337
+
5′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-36
TTA
Fn
  312 . . . 334

5′ Flanking Genomic DNA





5F-37
TTA/
Fn/Lb_V1/
  403 . . . 425
+
5′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-38
TATC
Lb_V2
  405 . . . 427
+
5′ Flanking Genomic DNA





5F-39
TATA
Lb_V2
  407 . . . 429

5′ Flanking Genomic DNA





5F-40
TTG/
Fn/Lb_V1/
  512 . . . 534
+
5′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-41
TTA
Fn
  527 . . . 549
+
5' Flanking Genomic DNA





5F-42
TTA/
Fn/Lb_V1/
  509 . . . 531

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-43
TATC
Lb_V2
  514 . . . 536

5' Flanking Genomic DNA





5F-44
TATA
Lb_V2
  516 . . . 538

5' Flanking Genomic DNA





5F-45
TTA
Fn
  612 . . . 634
+
5' Flanking Genomic DNA





5F-46
TTA
Fn
  622 . . . 644
+
5' Flanking Genomic DNA





5F-47
TTA
Fn
  625 . . . 647
+
5' Flanking Genomic DNA





5F-48
TTA
Fn
  628 . . . 650
+
5' Flanking Genomic DNA





5F-49
TTCA
Lb_V1
  607 . . . 629

5' Flanking Genomic DNA





5F-50
TTC
Fn
  608 . . . 630

5' Flanking Genomic DNA





5F-51
TCCC
Lb_V1
  611 . . . 633

5' Flanking Genomic DNA





5F-52
TTCC
Lb_V1
  612 . . . 634

5' Flanking Genomic DNA





5F-53
TTC
Fn
  613 . . . 635

5' Flanking Genomic DNA





5F-54
TATC
Lb_V2
  649 . . . 671
+
5' Flanking Genomic DNA





5F-55
TTA/
Fn/Lb_V1/
  660 . . . 682
+
5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-56
TTC/
Fn/Lb_V1/
  665 . . . 687
+
5' Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-57
TTA
Fn
  668 . . . 690
+
5' Flanking Genomic DNA





5F-58
TTG/
Fn/Lb_V1/
  652 . . . 674

5' Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-59
TTC
Fn
  665 . . . 687

5' Flanking Genomic DNA





5F-60
TTG
Fn
  674 . . . 696

5' Flanking Genomic DNA





5F-61
TTA/
Fn/Lb_V1/
  678 . . . 700

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-62
TTA
Fn
  703 . . . 725
+
5' Flanking Genomic DNA





5F-63
TTA
Fn
  711 . . . 733
+
5' Flanking Genomic DNA





5F-64
TTA
Fn
  715 . . . 737
+
5' Flanking Genomic DNA





5F-65
TTA
Fn
  729 . . . 751
+
5' Flanking Genomic DNA





5F-66
TTA/
Fn/Lb_V1/
  708 . . . 730

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-67
TTA
Fn
  733 . . . 755
+
5' Flanking Genomic DNA





5F-68
TTA/
Fn/Lb_V1/
  712 . . . 734

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-69
TTA/
Fn/Lb_V1/
  716 . . . 738

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-70
TTC/
Fn/Lb_V1/
  730 . . . 752

5' Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-71
TTC
Fn
  766 . . . 788
+
5' Flanking Genomic DNA





5F-72
TTCA
Lb_V1
  767 . . . 789
+
5' Flanking Genomic DNA





5F-73
TTC
Fn
  770 . . . 792
+
5' Flanking Genomic DNA





5F-74
TTCC
Lb_V1
  771 . . . 793
+
5' Flanking Genomic DNA





5F-75
TCCA
Lb_V1
  772 . . . 794
+
5' Flanking Genomic DNA





5F-76
TTG
Fn
  777 . . . 799
+
5' Flanking Genomic DNA





5F-77
TATC
Lb_V2
  781 . . . 803
+
5' Flanking Genomic DNA





5F-78
TTC
Fn
  785 . . . 807
+
5' Flanking Genomic DNA





5F-79
TATA
Lb_V2
  766 . . . 788

5' Flanking Genomic DNA





5F-80
TTA
Fn
  768 . . . 790

5' Flanking Genomic DNA





5F-81
TTA/
Fn/Lb_V1/
  791 . . . 813
+
5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-82
TATA
Lb_V2
  793 . . . 815
+
5' Flanking Genomic DNA





5F-83
TTCA
Lb_V1
  783 . . . 805

5' Flanking Genomic DNA





5F-84
TTC/
Fn/Lb_V1/
  784 . . . 806

5' Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-85
TTCC
Lb_V1
  788 . . . 810

5' Flanking Genomic DNA





5F-86
TTC/
Fn/Lb_V1/
  789 . . . 811

5' Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-87
TTG/
Fn/Lb_V1/
  815 . . . 837

5' Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-88
TTG/
Fn/Lb_V1/
  849 . . . 871
+
5' Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-89
TATC
Lb_V2
  857 . . . 879
+
5' Flanking Genomic DNA





5F-90
TTC/
Fn/Lb_V1/
  863 . . . 885
+
5' Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









5F-91
TTCA
Lb_V1
  864 . . . 886
+
5' Flanking Genomic DNA





5F-92
TTA/
Fn/Lb_V1/
  862 . . . 884

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-93
TTA/
Fn/Lb_V1/
  866 . . . 888

5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-94
TATC
Lb_V2
  922 . . . 944

5' Flanking Genomic DNA





5F-95
TATG
Lb_V2
  951 . . . 973
+
5' Flanking Genomic DNA





5F-96
TTA
Fn
  961 . . . 983
+
5' Flanking Genomic DNA





5F-97
TTG/
Fn/Lb_V1/
  965 . . . 987
+
5' Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









5F-98
TTA
Fn
  965 . . . 987

5' Flanking Genomic DNA





5F-99
TTA
Fn
  945 . . . 967

5' Flanking Genomic DNA





5F-100
TTA/
Fn/Lb_V1/
  970 . . . 992
+
5' Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









5F-101
TCCA
Lb_V1
  975 . . . 997
+
5' Flanking Genomic DNA





5J-1
TCCC
Lb_V1
  982 . . . 1004
+
5' Junction





5J-2
TTA
Fn
  985 . . . 1007
+
5' Junction





5J-3
TTG
Fn
  999 . . . 1021
+
5' Junction





5J-4
TTG/
Fn/Lb_V1/
  998 . . . 1020

5' Junction



TTTG/
Lb_V2/Lb






TTTG









TI-1
TTA
Fn
 1030 . . . 1052
+
Transgenic Insert





TI-2
TTG/
Fn/Lb_V1/
 1045 . . . 1067
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-3
TTC/
Fn/Lb_V1/
 1028 . . . 1050

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-4
TTA
Fn
 1051 . . . 1073
+
Transgenic Insert





TI-5
TTG
Fn
 1037 . . . 1059

Transgenic Insert





TI-6
TTG
Fn
 1066 . . . 1088
+
Transgenic Insert





TI-7
TTA
Fn
 1062 . . . 1084

Transgenic Insert





TI-8
TATA
Lb_V2
 1066 . . . 1088

Transgenic Insert





TI-9
TTA
Fn
 1068 . . . 1090

Transgenic Insert





TI-10
TATA
Lb_V2
 1093 . . . 1115
+
Transgenic Insert





TI-11
TTA
Fn
 1077 . . . 1099

Transgenic Insert





TI-12
TTC
Fn
 1105 . . . 1127

Transgenic Insert





TI-13
TTA/
Fn/Lb_V1/
 1138 . . . 1160
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-14
TATG
Lb_V2
 1140 . . . 1162
+
Transgenic Insert





TI-15
TTA
Fn
 1158 . . . 1180
+
Transgenic Insert





TI-16
TTG
Fn
 1138 . . . 1160

Transgenic Insert





TI-17
TTC
Fn
 1141 . . . 1163

Transgenic Insert





TI-18
TATC
Lb_V2
 1144 . . . 1166

Transgenic Insert





TI-19
TATG
Lb_V2
 1154 . . . 1176

Transgenic Insert





TI-20
TTG
Fn
 1160 . . . 1182

Transgenic Insert





TI-21
TTCA
Lb_V1
 1165 . . . 1187

Transgenic Insert





TI-22
TTC/
Fn/Lb_V1/
 1166 . . . 1188

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-23
TTA/
Fn/Lb_V1/
 1171 . . . 1193

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-24
TATA
Lb_V2
 1214 . . . 1236
+
Transgenic Insert





TI-25
TATA
Lb_V2
 1216 . . . 1238
+
Transgenic Insert





TI-26
TTA
Fn
 1222 . . . 1244
+
Transgenic Insert





TI-27
TTC
Fn
 1228 . . . 1250
+
Transgenic Insert





TI-28
TATA
Lb_V2
 1207 . . . 1229

Transgenic Insert





TI-29
TATA
Lb_V2
 1209 . . . 1231

Transgenic Insert





TI-30
TATA
Lb_V2
 1211 . . . 1233

Transgenic Insert





TI-31
TATA
Lb_V2
 1234 . . . 1256
+
Transgenic Insert





TI-32
TATA
Lb_V2
 1236 . . . 1258
+
Transgenic Insert





TI-33
TATA
Lb_V2
 1238 . . . 1260
+
Transgenic Insert





TI-34
TTA
Fn
 1241 . . . 1263
+
Transgenic Insert





TI-35
TATG
Lb_V2
 1243 . . . 1265
+
Transgenic Insert





TI-36
TTG
Fn
 1247 . . . 1269
+
Transgenic Insert





TI-37
TTA
Fn
 1251 . . . 1273
+
Transgenic Insert





TI-38
TTA
Fn
 1232 . . . 1254

Transgenic Insert





TI-39
TTC
Fn
 1254 . . . 1276
+
Transgenic Insert





TI-40
TTA
Fn
 1257 . . . 1279
+
Transgenic Insert





TI-41
TTG
Fn
 1265 . . . 1287
+
Transgenic Insert





TI-42
TTA
Fn
 1245 . . . 1267
-
Transgenic Insert





TI-43
TTA
Fn
 1270 . . . 1292
+
Transgenic Insert





TI-44
TTG
Fn
 1249 . . . 1271

Transgenic Insert





TI-45
TATG
Lb_V2
 1254 . . . 1276

Transgenic Insert





TI-46
TTA
Fn
 1262 . . . 1284

Transgenic Insert





TI-47
TCCA
Lb_V1
 1265 . . . 1287

Transgenic Insert





TI-48
TTCC
Lb_V1
 1266 . . . 1288

Transgenic Insert





TI-49
TTC/
Fn/Lb_V1/
 1267 . . . 1289

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-50
TTC
Fn
 1271 . . . 1293

Transgenic Insert





TI-51
TTC/
Fn/Lb_V1/
 1315 . . . 1337
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-52
TTCC
Lb_V1
 1316 . . . 1338
+
Transgenic Insert





TI-53
TTA
Fn
 1319 . . . 1341
+
Transgenic Insert





TI-54
TATA
Lb_V2
 1311 . . . 1333

Transgenic Insert





TI-55
TTC/
Fn/Lb_V1/
 1315 . . . 1337

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-56
TCCA
Lb_V1
 1389 . . . 1411

Transgenic Insert





TI-57
TTA
Fn
 1398 . . . 1420

Transgenic Insert





TI-58
TTG
Fn
 1403 . . . 1425

Transgenic Insert





TI-59
TCCA
Lb_V1
 1428 . . . 1450
+
Transgenic Insert





TI-60
TATG
Lb_V2
 1413 . . . 1435

Transgenic Insert





TI-61
TTA/
Fn/Lb_V1/
 1443 . . . 1465

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-62
TATG
Lb_V2
 1490 . . . 1512
+
Transgenic Insert





TI-63
TATC
Lb_V2
 1499 . . . 1521
+
Transgenic Insert





TI-64
TATG
Lb_V2
 1504 . . . 1526
+
Transgenic Insert





TI-65
TTC
Fn
 1508 . . . 1530
+
Transgenic Insert





TI-66
TTCC
Lb_V1
 1509 . . . 1531
+
Transgenic Insert





TI-67
TTC
Fn
 1512 . . . 1534
+
Transgenic Insert





TI-68
TTCC
Lb_V1
 1513 . . . 1535
+
Transgenic Insert





TI-69
TTA/
Fn/Lb_V1/
 1517 . . . 1539
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-70
TTC/
Fn/Lb_V1/
 1522 . . . 1544
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-71
TTCG
Lb_V1
 1523 . . . 1545
+
Transgenic Insert





TI-72
TATC
Lb_V2
 1501 . . . 1523

Transgenic Insert





TI-73
TTA
Fn
 1503 . . . 1525

Transgenic Insert





TI-74
TTA
Fn
 1506 . . . 1528

Transgenic Insert





TI-75
TTG
Fn
 1513 . . . 1535

Transgenic Insert





TI-76
TATC
Lb_V2
 1518 . . . 1540

Transgenic Insert





TI-77
TTG/
Fn/Lb_V1/
 1614 . . . 1636
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-78
TTG/
Fn/Lb_V1/
 1619 . . . 1641
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-79
TATA
Lb_V2
 1626 . . . 1648
+
Transgenic Insert





TI-80
TTC
Fn
 1638 . . . 1660
+
Transgenic Insert





TI-81
TTCG
Lb_V1
 1639 . . . 1661
+
Transgenic Insert





TI-82
TCCA
Lb_V1
 1618 . . . 1640

Transgenic Insert





TI-83
TTCC
Lb_V1
 1619 . . . 1641

Transgenic Insert





TI-84
TTC
Fn
 1620 . . . 1642

Transgenic Insert





TI-85
TATC
Lb_V2
 1623 . . . 1645

Transgenic Insert





TI-86
TTA
Fn
 1625 . . . 1647

Transgenic Insert





TI-87
TTA
Fn
 1628 . . . 1650

Transgenic Insert





TI-88
TTC/
Fn/Lb_V1/
 1674 . . . 1696
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-89
TTC
Fn
 1683 . . . 1705
+
Transgenic Insert





TI-90
TTCA
Lb_V1
 1684 . . . 1706
+
Transgenic Insert





TI-91
TCCC
Lb_V1
 1693 . . . 1715
+
Transgenic Insert





TI-92
TTA/
Fn/Lb_V1/
 1676 . . . 1698

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-93
TTG/
Fn/Lb_V1/
 1690 . . . 1712

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-94
TTG
Fn
 1714 . . . 1736

Transgenic Insert





TI-95
TATA
Lb_V2
 1719 . . . 1741

Transgenic Insert





TI-96
TTG/
Fn/Lb_V1/
 1833 . . . 1855
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-97
TTG
Fn
 1842 . . . 1864
+
Transgenic Insert





TI-98
TTC
Fn
 1845 . . . 1867
+
Transgenic Insert





TI-99
TTCG
Lb_V1
 1846 . . . 1868
+
Transgenic Insert





TI-100
TTG
Fn
 1829 . . . 1851

Transgenic Insert





TI-101
TTA/
Fn/Lb_V1/
 1841 . . . 1863

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-102
TTG/
Fn/Lb_V1/
 1873 . . . 1895
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-103
TTA
Fn
 1882 . . . 1904
+
Transgenic Insert





TI-104
TATC
Lb_V2
 1892 . . . 1914
+
Transgenic Insert





TI-105
TTC
Fn
 1897 . . . 1919
+
Transgenic Insert





TI-106
TTCG
Lb_V1
 1898 . . . 1920
+
Transgenic Insert





TI-107
TTA/
Fn/Lb_V1/
 1907 . . . 1929
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-108
TTA
Fn
 1892 . . . 1914

Transgenic Insert





TI-109
TTC/
Fn/Lb_V1/
 1922 . . . 1944
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-110
TTCA
Lb_V1
 1910 . . . 1932

Transgenic Insert





TI-111
TTC/
Fn/Lb_V1/
 1911 . . . 1933

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-112
TTA/
Fn/Lb_V1/
 2002 . . . 2024
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-113
TTC/
Fn/Lb_V1/
 2008 . . . 2030
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-114
TTA
Fn
 2011 . . . 2033
+
Transgenic Insert





TI-115
TATG
Lb_V2
 2013 . . . 2035
+
Transgenic Insert





TI-116
TTA/
Fn/Lb_V1/
 2017 . . . 2039
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-117
TTG/
Fn/Lb_V1/
 2063 . . . 2085
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-118
TTG/
Fn/Lb_V1/
 2068 . . . 2090
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-119
TATA
Lb_V2
 2073 . . . 2095
+
Transgenic Insert





TI-120
TATG
Lb_V2
 2075 . . . 2097
+
Transgenic Insert





TI-121
TTC
Fn
 2078 . . . 2100
+
Transgenic Insert





TI-122
TTCG
Lb_V1
 2079 . . . 2101
+
Transgenic Insert





TI-123
TTA/
Fn/Lb_V1/
 2110 . . . 2132
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-124
TTC/
Fn/Lb_V1/
 2114 . . . 2136
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-125
TTCA
Lb_V1
 2115 . . . 2137
+
Transgenic Insert





TI-126
TATG
Lb_V2
 2122 . . . 2144
+
Transgenic Insert





TI-127
TTA/
Fn/Lb_V1/
 2156 . . . 2178
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-128
TTCC
Lb_V1
 2150 . . . 2172

Transgenic Insert





TI-129
TTC
Fn
 2151 . . . 2173

Transgenic Insert





TI-130
TCCG
Lb_V1
 2154 . . . 2176

Transgenic Insert





TI-131
TTCG
Lb_V1
 2162 . . . 2184

Transgenic Insert





TI-132
TTC
Fn
 2163 . . . 2185

Transgenic Insert





TI-133
TTC/
Fn/Lb_V1/
 2205 . . . 2227
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-134
TTC/
Fn/Lb_V1/
 2231 . . . 2253
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-135
TTCC
Lb_V1
 2232 . . . 2254
+
Transgenic Insert





TI-136
TCCG
Lb_V1
 2233 . . . 2255
+
Transgenic Insert





TI-137
TTC
Fn
 2247 . . . 2269
+
Transgenic Insert





TI-138
TTCC
Lb_V1
 2248 . . . 2270
+
Transgenic Insert





TI-139
TTG/
Fn/Lb_V1/
 2227 . . . 2249

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-140
TTC
Fn
 2251 . . . 2273
+
Transgenic Insert





TI-141
TTCA
Lb_V1
 2252 . . . 2274
+
Transgenic Insert





TI-142
TTG/
Fn/Lb_V1/
 2236 . . . 2258

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-143
TTA/
Fn/Lb_V1/
 2241 . . . 2263

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-144
TTA
Fn
 2266 . . . 2288
+
Transgenic Insert





TI-145
TTG
Fn
 2297 . . . 2319
+
Transgenic Insert





TI-146
TTC
Fn
 2311 . . . 2333
+
Transgenic Insert





TI-147
TTCG
Lb_V1
 2312 . . . 2334
+
Transgenic Insert





TI-148
TTG
Fn
 2315 . . . 2337
+
Transgenic Insert





TI-149
TCCG
Lb_V1
 2319 . . . 2341
+
Transgenic Insert





TI-150
TATG
Lb_V2
 2326 . . . 2348
+
Transgenic Insert





TI-151
TTC/
Fn/Lb_V1/
 2335 . . . 2357
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-152
TTCG
Lb_V1
 2336 . . . 2358
+
Transgenic Insert





TI-153
TTC/
Fn/Lb_V1/
 2316 . . . 2338

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-154
TTA
Fn
 2339 . . . 2361
+
Transgenic Insert





TI-155
TTG
Fn
 2349 . . . 2371
+
Transgenic Insert





TI-156
TTG
Fn
 2357 . . . 2379
+
Transgenic Insert





TI-157
TTC
Fn
 2366 . . . 2388
+
Transgenic Insert





TI-158
TTCC
Lb_V1
 2367 . . . 2389
+
Transgenic Insert





TI-159
TTG
Fn
 2377 . . . 2399
+
Transgenic Insert





TI-160
TTC
Fn
 2359 . . . 2381

Transgenic Insert





TI-161
TTCC
Lb_V1
 2369 . . . 2391

Transgenic Insert





TI-162
TTC
Fn
 2370 . . . 2392

Transgenic Insert





TI-163
TTC
Fn
 2373 . . . 2395

Transgenic Insert





TI-164
TATC
Lb_V2
 2404 . . . 2426
+
Transgenic Insert





TI-165
TATC
Lb_V2
 2384 . . . 2406

Transgenic Insert





TI-166
TCCA
Lb_V1
 2416 . . . 2438
+
Transgenic Insert





TI-167
TATC
Lb_V2
 2429 . . . 2451
+
Transgenic Insert





TI-168
TTG
Fn
 2408 . . . 2430

Transgenic Insert





TI-169
TCCG
Lb_V1
 2416 . . . 2438

Transgenic Insert





TI-170
TTG
Fn
 2447 . . . 2469
+
Transgenic Insert





TI-171
TATC
Lb_V2
 2438 . . . 2460

Transgenic Insert





TI-172
TTG
Fn
 2462 . . . 2484
+
Transgenic Insert





TI-173
TTG/
Fn/Lb_V1/
 2469 . . . 2491
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-174
TCCG
Lb_V1
 2473 . . . 2495
+
Transgenic Insert





TI-175
TTC
Fn
 2482 . . . 2504
+
Transgenic Insert





TI-176
TTCG
Lb_V1
 2483 . . . 2505
+
Transgenic Insert





TI-177
TCCG
Lb_V1
 2488 . . . 2510
+
Transgenic Insert





TI-178
TTG
Fn
 2491 . . . 2513
+
Transgenic Insert





TI-179
TTC
Fn
 2504 . . . 2526
+
Transgenic Insert





TI-180
TTG
Fn
 2485 . . . 2507

Transgenic Insert





TI-181
TCCG
Lb_V1
 2488 . . . 2510

Transgenic Insert





TI-182
TCCA
Lb_V1
 2523 . . . 2545
+
Transgenic Insert





TI-183
TATG
Lb_V2
 2505 . . . 2527

Transgenic Insert





TI-184
TCCA
Lb_V1
 2530 . . . 2552
+
Transgenic Insert





TI-185
TATC
Lb_V2
 2534 . . . 2556
+
Transgenic Insert





TI-186
TCCA
Lb_V1
 2517 . . . 2539

Transgenic Insert





TI-187
TTCC
Lb_V1
 2518 . . . 2540

Transgenic Insert





TI-188
TTC
Fn
 2519 . . . 2541

Transgenic Insert





TI-189
TTG/
Fn/Lb_V1/
 2549 . . . 2571
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-190
TCCG
Lb_V1
 2527 . . . 2549

Transgenic Insert





TI-191
TTG
Fn
 2548 . . . 2570

Transgenic Insert





TI-192
TCCA
Lb_V1
 2571 . . . 2593
+
Transgenic Insert





TI-193
TTG
Fn
 2560 . . . 2582

Transgenic Insert





TI-194
TCCG
Lb_V1
 2563 . . . 2585

Transgenic Insert





TI-195
TTC
Fn
 2604 . . . 2626
+
Transgenic Insert





TI-196
TTCA
Lb_V1
 2583 . . . 2605

Transgenic Insert





TI-197
TTC
Fn
 2584 . . . 2606

Transgenic Insert





TI-198
TTC
Fn
 2623 . . . 2645
+
Transgenic Insert





TI-199
TTCC
Lb_V1
 2624 . . . 2646
+
Transgenic Insert





TI-200
TCCC
Lb_V1
 2625 . . . 2647
+
Transgenic Insert





TI-201
TCCA
Lb_V1
 2607 . . . 2629

Transgenic Insert





TI-202
TTCC
Lb_V1
 2608 . . . 2630

Transgenic Insert





TI-203
TTC/
Fn/Lb_V1/
 2609 . . . 2631

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-204
TTG
Fn
 2647 . . . 2669
+
Transgenic Insert





TI-205
TCCA
Lb_V1
 2627 . . . 2649

Transgenic Insert





TI-206
TCCA
Lb_V1
 2638 . . . 2660

Transgenic Insert





TI-207
TCCA
Lb_V1
 2671 . . . 2693
+
Transgenic Insert





TI-208
TCCC
Lb_V1
 2686 . . . 2708
+
Transgenic Insert





TI-209
TATC
Lb_V2
 2695 . . . 2717
+
Transgenic Insert





TI-210
TCCC
Lb_V1
 2697 . . . 2719
+
Transgenic Insert





TI-211
TTG/
Fn/Lb_V1/
 2705 . . . 2727
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-212
TTG
Fn
 2717 . . . 2739
+
Transgenic Insert





TI-213
TCCA
Lb_V1
 2722 . . . 2744
+
Transgenic Insert





TI-214
TTA
Fn
 2727 . . . 2749
+
Transgenic Insert





TI-215
TCCG
Lb_V1
 2713 . . . 2735

Transgenic Insert





TI-216
TTA
Fn
 2745 . . . 2767
+
Transgenic Insert





TI-217
TCCA
Lb_V1
 2730 . . . 2752

Transgenic Insert





TI-218
TTG
Fn
 2737 . . . 2759

Transgenic Insert





TI-219
TTG
Fn
 2743 . . . 2765

Transgenic Insert





TI-220
TCCA
Lb_V1
 2754 . . . 2776

Transgenic Insert





TI-221
TTG
Fn
 2777 . . . 2799
+
Transgenic Insert





TI-222
TATC
Lb_V2
 2756 . . . 2778

Transgenic Insert





TI-223
TTA
Fn
 2758 . . . 2780

Transgenic Insert





TI-224
TCCA
Lb_V1
 2766 . . . 2788

Transgenic Insert





TI-225
TCCA
Lb_V1
 2773 . . . 2795

Transgenic Insert





TI-226
TTG
Fn
 2798 . . . 2820
+
Transgenic Insert





TI-227
TTA
Fn
 2800 . . . 2822

Transgenic Insert





TI-228
TTG/
Fn/Lb_V1/
 2807 . . . 2829

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-229
TATC
Lb_V2
 2822 . . . 2844

Transgenic Insert





TI-230
TTC
Fn
 2845 . . . 2867
+
Transgenic Insert





TI-231
TTCG
Lb_V1
 2846 . . . 2868
+
Transgenic Insert





TI-232
TTG
Fn
 2855 . . . 2877
+
Transgenic Insert





TI-233
TTG
Fn
 2873 . . . 2895
+
Transgenic Insert





TI-234
TCCA
Lb_V1
 2889 . . . 2911
+
Transgenic Insert





TI-235
TTCA
Lb_V1
 2874 . . . 2896

Transgenic Insert





TI-236
TTC
Fn
 2875 . . . 2897

Transgenic Insert





TI-237
TCCC
Lb_V1
 2907 . . . 2929
+
Transgenic Insert





TI-238
TTC
Fn
 2927 . . . 2949
+
Transgenic Insert





TI-239
TTA
Fn
 2911 . . . 2933

Transgenic Insert





TI-240
TTC
Fn
 2941 . . . 2963
+
Transgenic Insert





TI-241
TTG
Fn
 2944 . . . 2966
+
Transgenic Insert





TI-242
TTA
Fn
 2929 . . . 2951

Transgenic Insert





TI-243
TTG
Fn
 2966 . . . 2988
+
Transgenic Insert





TI-244
TCCA
Lb_V1
 2948 . . . 2970

Transgenic Insert





TI-245
TTCC
Lb_V1
 2949 . . . 2971

Transgenic Insert





TI-246
TTC
Fn
 2950 . . . 2972

Transgenic Insert





TI-247
TCCA
Lb_V1
 2963 . . . 2985

Transgenic Insert





TI-248
TCCG
Lb_V1
 2985 . . . 3007
+
Transgenic Insert





TI-249
TTCC
Lb_V1
 2964 . . . 2986

Transgenic Insert





TI-250
TTC
Fn
 2965 . . . 2987

Transgenic Insert





TI-251
TTA
Fn
 2968 . . . 2990

Transgenic Insert





TI-252
TTCA
Lb_V1
 2985 . . . 3007

Transgenic Insert





TI-253
TATG
Lb_V2
 3007 . . . 3029
+
Transgenic Insert





TI-254
TTC
Fn
 2986 . . . 3008

Transgenic Insert





TI-255
TTC
Fn
 3016 . . . 3038
+
Transgenic Insert





TI-256
TTCA
Lb_V1
 3017 . . . 3039
+
Transgenic Insert





TI-257
TCCG
Lb_V1
 3006 . . . 3028

Transgenic Insert





TI-258
TTCC
Lb_V1
 3007 . . . 3029

Transgenic Insert





TI-259
TTC
Fn
 3008 . . . 3030

Transgenic Insert





TI-260
TCCC
Lb_V1
 3011 . . . 3033

Transgenic Insert





TI-261
TTCG
Lb_V1
 3018 . . . 3040

Transgenic Insert





TI-262
TTC
Fn
 3019 . . . 3041

Transgenic Insert





TI-263
TTG
Fn
 3030 . . . 3052

Transgenic Insert





TI-264
TCCA
Lb_V1
 3060 . . . 3082
+
Transgenic Insert





TI-265
TCCC
Lb_V1
 3065 . . . 3087
+
Transgenic Insert





TI-266
TTCC
Lb_V1
 3044 . . . 3066

Transgenic Insert





TI-267
TTC
Fn
 3045 . . . 3067

Transgenic Insert





TI-268
TATG
Lb_V2
 3050 . . . 3072

Transgenic Insert





TI-269
TATC
Lb_V2
 3079 . . . 3101
+
Transgenic Insert





TI-270
TTA
Fn
 3083 . . . 3105
+
Transgenic Insert





TI-271
TTG
Fn
 3075 . . . 3097

Transgenic Insert





TI-272
TTA
Fn
 3111 . . . 3133
+
Transgenic Insert





TI-273
TTC
Fn
 3115 . . . 3137
+
Transgenic Insert





TI-274
TTC
Fn
 3118 . . . 3140
+
Transgenic Insert





TI-275
TTCG
Lb_V1
 3119 . . . 3141
+
Transgenic Insert





TI-276
TTC
Fn
 3126 . . . 3148
+
Transgenic Insert





TI-277
TTCC
Lb_V1
 3127 . . . 3149
+
Transgenic Insert





TI-278
TTG
Fn
 3106 . . . 3128

Transgenic Insert





TI-279
TCCC
Lb_V1
 3128 . . . 3150
+
Transgenic Insert





TI-280
TTC
Fn
 3136 . . . 3158
+
Transgenic Insert





TI-281
TTCG
Lb_V1
 3137 . . . 3159
+
Transgenic Insert





TI-282
TATA
Lb_V2
 3115 . . . 3137

Transgenic Insert





TI-283
TATA
Lb_V2
 3142 . . . 3164
+
Transgenic Insert





TI-284
TCCA
Lb_V1
 3151 . . . 3173
+
Transgenic Insert





TI-285
TCCA
Lb_V1
 3132 . . . 3154

Transgenic Insert





TI-286
TTC
Fn
 3167 . . . 3189
+
Transgenic Insert





TI-287
TTG
Fn
 3155 . . . 3177

Transgenic Insert





TI-288
TTG
Fn
 3161 . . . 3183

Transgenic Insert





TI-289
TTCA
Lb_V1
 3171 . . . 3193

Transgenic Insert





TI-290
TTC
Fn
 3172 . . . 3194

Transgenic Insert





TI-291
TTG/
Fn/Lb_V1/
 3181 . . . 3203

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-292
TTCA
Lb_V1
 3193 . . . 3215

Transgenic Insert





TI-293
TTC
Fn
 3194 . . . 3216

Transgenic Insert





TI-294
TTG
Fn
 3218 . . . 3240
+
Transgenic Insert





TI-295
TTCG
Lb_V1
 3202 . . . 3224

Transgenic Insert





TI-296
TTC/
Fn/Lb_V1/
 3203 . . . 3225

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-297
TATC
Lb_V2
 3226 . . . 3248
+
Transgenic Insert





TI-298
TCCG
Lb_V1
 3209 . . . 3231

Transgenic Insert





TI-299
TTA
Fn
 3243 . . . 3265
+
Transgenic Insert





TI-300
TTCG
Lb_V1
 3223 . . . 3245

Transgenic Insert





TI-301
TTC
Fn
 3224 . . . 3246

Transgenic Insert





TI-302
TTCG
Lb_V1
 3228 . . . 3250

Transgenic Insert





TI-303
TTC
Fn
 3229 . . . 3251

Transgenic Insert





TI-304
TCCC
Lb_V1
 3233 . . . 3255

Transgenic Insert





TI-305
TTG
Fn
 3277 . . . 3299
+
Transgenic Insert





TI-306
TATC
Lb_V2
 3306 . . . 3328
+
Transgenic Insert





TI-307
TCCC
Lb_V1
 3285 . . . 3307

Transgenic Insert





TI-308
TCCA
Lb_V1
 3308 . . . 3330
+
Transgenic Insert





TI-309
TTC
Fn
 3295 . . . 3317

Transgenic Insert





TI-310
TTG
Fn
 3317 . . . 3339
+
Transgenic Insert





TI-311
TTCG
Lb_V1
 3301 . . . 3323

Transgenic Insert





TI-312
TTC
Fn
 3302 . . . 3324

Transgenic Insert





TI-313
TTG
Fn
 3305 . . . 3327

Transgenic Insert





TI-314
TTC
Fn
 3311 . . . 3333

Transgenic Insert





TI-315
TTG
Fn
 3352 . . . 3374

Transgenic Insert





TI-316
TCCA
Lb_V1
 3377 . . . 3399
+
Transgenic Insert





TI-317
TCCA
Lb_V1
 3357 . . . 3379

Transgenic Insert





TI-318
TCCC
Lb_V1
 3369 . . . 3391

Transgenic Insert





TI-319
TTG
Fn
 3399 . . . 3421
+
Transgenic Insert





TI-320
TTA
Fn
 3378 . . . 3400

Transgenic Insert





TI-321
TATG
Lb_V2
 3381 . . . 3403

Transgenic Insert





TI-322
TTA/
Fn/Lb_V1/
 3383 . . . 3405

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-323
TTA
Fn
 3387 . . . 3409

Transgenic Insert





TI-324
TTA
Fn
 3401 . . . 3423

Transgenic Insert





TI-325
TTCA
Lb_V1
 3404 . . . 3426

Transgenic Insert





TI-326
TTC
Fn
 3405 . . . 3427

Transgenic Insert





TI-327
TTG
Fn
 3414 . . . 3436

Transgenic Insert





TI-328
TTC/
Fn/Lb_V1/
 3446 . . . 3468
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-329
TTA
Fn
 3456 . . . 3478
+
Transgenic Insert





TI-330
TTCA
Lb_V1
 3442 . . . 3464

Transgenic Insert





TI-331
TTC
Fn
 3443 . . . 3465

Transgenic Insert





TI-332
TTA/
Fn/Lb_V1/
 3484 . . . 3506
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-333
TATG
Lb_V2
 3486 . . . 3508
+
Transgenic Insert





TI-334
TTG/
Fn/Lb_V1/
 3510 . . . 3532
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-335
TTG
Fn
 3516 . . . 3538
+
Transgenic Insert





TI-336
TATA
Lb_V2
 3510 . . . 3532

Transgenic Insert





TI-337
TTA
Fn
 3512 . . . 3534

Transgenic Insert





TI-338
TTCA
Lb_V1
 3520 . . . 3542

Transgenic Insert





TI-339
TTC/
Fn/Lb_V1/
 3521 . . . 3543

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-340
TTCA
Lb_V1
 3620 . . . 3642

Transgenic Insert





TI-341
TTC
Fn
 3621 . . . 3643

Transgenic Insert





TI-342
TTA/
Fn/Lb_V1/
 3692 . . . 3714
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-343
TTA
Fn
 3729 . . . 3751
+
Transgenic Insert





TI-344
TTA
Fn
 3735 . . . 3757
+
Transgenic Insert





TI-345
TATA
Lb_V2
 3741 . . . 3763
+
Transgenic Insert





TI-346
TTC/
Fn/Lb_V1/
 3746 . . . 3768
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-347
TTCG
Lb_V1
 3747 . . . 3769
+
Transgenic Insert





TI-348
TTG
Fn
 3732 . . . 3754

Transgenic Insert





TI-349
TTG
Fn
 3739 . . . 3761

Transgenic Insert





TI-350
TCCG
Lb_V1
 3769 . . . 3791
+
Transgenic Insert





TI-351
TCCG
Lb_V1
 3775 . . . 3797
+
Transgenic Insert





TI-352
TTC
Fn
 3784 . . . 3806
+
Transgenic Insert





TI-353
TTCG
Lb_V1
 3785 . . . 3807
+
Transgenic Insert





TI-354
TCCA
Lb_V1
 3796 . . . 3818
+
Transgenic Insert





TI-355
TTA/
Fn/Lb_V1/
 3806 . . . 3828

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-356
TTA
Fn
 3841 . . . 3863
+
Transgenic Insert





TI-357
TTG
Fn
 3858 . . . 3880
+
Transgenic Insert





TI-358
TTA
Fn
 3865 . . . 3887
+
Transgenic Insert





TI-359
TATG
Lb_V2
 3867 . . . 3889
+
Transgenic Insert





TI-360
TTCG
Lb_V1
 3855 . . . 3877

Transgenic Insert





TI-361
TTC
Fn
 3856 . . . 3878

Transgenic Insert





TI-362
TTC
Fn
 3930 . . . 3952
+
Transgenic Insert





TI-363
TTC
Fn
 3933 . . . 3955
+
Transgenic Insert





TI-364
TTG
Fn
 3936 . . . 3958
+
Transgenic Insert





TI-365
TATG
Lb_V2
 3920 . . . 3942

Transgenic Insert





TI-366
TTG/
Fn/Lb_V1/
 3938 . . . 3960

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-367
TTA
Fn
 3977 . . . 3999
+
Transgenic Insert





TI-368
TTG
Fn
 3985 . . . 4007
+
Transgenic Insert





TI-369
TTG
Fn
 3978 . . . 4000

Transgenic Insert





TI-370
TTCA
Lb_V1
 3983 . . . 4005

Transgenic Insert





TI-371
TTC/
Fn/Lb_V1/
 3984 . . . 4006

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-372
TTA
Fn
 4031 . . . 4053
+
Transgenic Insert





TI-373
TTG/
Fn/Lb_V1/
 4038 . . . 4060
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-374
TTA/
Fn/Lb_V1/
 4040 . . . 4062

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-375
TTA
Fn
 4065 . . . 4087
+
Transgenic Insert





TI-376
TTG
Fn
 4071 . . . 4093
+
Transgenic Insert





TI-377
TTG/
Fn/Lb_V1/
 4068 . . . 4090

Transgenic Insert



TTTG
Lb








TI-378
TCCA
Lb_V1
 4110 . . . 4132
+
Transgenic Insert





TI-379
TTG
Fn
 4113 . . . 4135
+
Transgenic Insert





TI-380
TTA/
Fn/Lb_V1/
 4096 . . . 4118

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-381
TTA
Fn
 4121 . . . 4143
+
Transgenic Insert





TI-382
TTCA
Lb_V1
 4100 . . . 4122

Transgenic Insert





TI-383
TTC/
Fn/Lb_V1/
 4101 . . . 4123

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-384
TTG
Fn
 4110 . . . 4132

Transgenic Insert





TI-385
TTC/
Fn/Lb_V1/
 4113 . . . 4135

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-386
TTG/
Fn/Lb_V1/
 4126 . . . 4148

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-387
TTC/
Fn/Lb_V1/
 4174 . . . 4196
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-388
TTCA
Lb_V1
 4175 . . . 4197
+
Transgenic Insert





TI-389
TTC/
Fn/Lb_V1/
 4188 . . . 4210
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-390
TTCC
Lb_V1
 4189 . . . 4211
+
Transgenic Insert





TI-391
TCCA
Lb_V1
 4190 . . . 4212
+
Transgenic Insert





TI-392
TTC
Fn
 4195 . . . 4217
+
Transgenic Insert





TI-393
TTCA
Lb_V1
 4196 . . . 4218
+
Transgenic Insert





TI-394
TCCA
Lb_V1
 4175 . . . 4197

Transgenic Insert





TI-395
TATC
Lb_V2
 4177 . . . 4199

Transgenic Insert





TI-396
TTG
Fn
 4200 . . . 4222
+
Transgenic Insert





TI-397
TTG
Fn
 4184 . . . 4206

Transgenic Insert





TI-398
TATG
Lb_V2
 4198 . . . 4220

Transgenic Insert





TI-399
TTA/
Fn/Lb_V1/
 4200 . . . 4222

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-400
TTA/
Fn/Lb_V1/
 4255 . . . 4277

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-401
TCCA
Lb_V1
 4292 . . . 4314
+
Transgenic Insert





TI-402
TCCA
Lb_V1
 4309 . . . 4331
+
Transgenic Insert





TI-403
TTA
Fn
 4296 . . . 4318

Transgenic Insert





TI-404
TTA
Fn
 4335 . . . 4357
+
Transgenic Insert





TI-405
TTG
Fn
 4314 . . . 4336

Transgenic Insert





TI-406
TATC
Lb_V2
 4337 . . . 4359
+
Transgenic Insert





TI-407
TCCA
Lb_V1
 4339 . . . 4361
+
Transgenic Insert





TI-408
TTCG
Lb_V1
 4327 . . . 4349

Transgenic Insert





TI-409
TTC
Fn
 4328 . . . 4350

Transgenic Insert





TI-410
TCCA
Lb_V1
 4358 . . . 4380
+
Transgenic Insert





TI-411
TATA
Lb_V2
 4338 . . . 4360

Transgenic Insert





TI-412
TATA
Lb_V2
 4340 . . . 4362

Transgenic Insert





TI-413
TATA
Lb_V2
 4342 . . . 4364

Transgenic Insert





TI-414
TATA
Lb_V2
 4365 . . . 4387
+
Transgenic Insert





TI-415
TATA
Lb_V2
 4367 . . . 4389
+
Transgenic Insert





TI-416
TATA
Lb_V2
 4369 . . . 4391
+
Transgenic Insert





TI-417
TATG
Lb_V2
 4349 . . . 4371

Transgenic Insert





TI-418
TATA
Lb_V2
 4351 . . . 4373

Transgenic Insert





TI-419
TCCA
Lb_V1
 4374 . . . 4396
+
Transgenic Insert





TI-420
TTA
Fn
 4353 . . . 4375

Transgenic Insert





TI-421
TATA
Lb_V2
 4378 . . . 4400
+
Transgenic Insert





TI-422
TTG
Fn
 4382 . . . 4404

Transgenic Insert





TI-423
TTA/
Fn/Lb_V1/
 4386 . . . 4408

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-424
TTC/
Fn/Lb_V1/
 4447 . . . 4469
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-425
TTCA
Lb_V1
 4448 . . . 4470

Transgenic Insert





TI-426
TTA/
Fn/Lb_V1/
 4454 . . . 4476
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-427
TTC/
Fn/Lb_V1/
 4460 . . . 4482
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-428
TCCG
Lb_V1
 4466 . . . 4488
+
Transgenic Insert





TI-429
TTC/
Fn/Lb_V1/
 4478 . . . 4500
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-430
TTCG
Lb_V1
 4479 . . . 4501
+
Transgenic Insert





TI-431
TCCC
Lb_V1
 4512 . . . 4534
+
Transgenic Insert





TI-432
TCCG
Lb_V1
 4518 . . . 4540
+
Transgenic Insert





TI-433
TCCC
Lb_V1
 4534 . . . 4556
+
Transgenic Insert





TI-434
TCCG
Lb_V1
 4539 . . . 4561
+
Transgenic Insert





TI-435
TTG
Fn
 4550 . . . 4572
+
Transgenic Insert





TI-436
TTC
Fn
 4554 . . . 4576
+
Transgenic Insert





TI-437
TTCG
Lb_V1
 4555 . . . 4577
+
Transgenic Insert





TI-438
TTG
Fn
 4558 . . . 4580
+
Transgenic Insert





TI-439
TTC
Fn
 4564 . . . 4586
+
Transgenic Insert





TI-440
TTCA
Lb_V1
 4565 . . . 4587
+
Transgenic Insert





TI-441
TTA
Fn
 4577 . . . 4599
+
Transgenic Insert





TI-442
TATC
Lb_V2
 4564 . . . 4586

Transgenic Insert





TI-443
TATG
Lb_V2
 4571 . . . 4593

Transgenic Insert





TI-444
TTG
Fn
 4579 . . . 4601

Transgenic Insert





TI-445
TTC
Fn
 4603 . . . 4625
+
Transgenic Insert





TI-446
TTCA
Lb_V1
 4604 . . . 4626
+
Transgenic Insert





TI-447
TATC
Lb_V2
 4590 . . . 4612

Transgenic Insert





TI-448
TTG/
Fn/Lb_V1/
 4648 . . . 4670
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-449
TTG
Fn
 4673 . . . 4695
+
Transgenic Insert





TI-450
TTC
Fn
 4677 . . . 4699
+
Transgenic Insert





TI-451
TTCG
Lb_V1
 4678 . . . 4700
+
Transgenic Insert





TI-452
TTG/
Fn/Lb_V1/
 4683 . . . 4705
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-453
TTC
Fn
 4687 . . . 4709
+
Transgenic Insert





TI-454
TTC
Fn
 4694 . . . 4716
+
Transgenic Insert





TI-455
TTCG
Lb_V1
 4695 . . . 4717
+
Transgenic Insert





TI-456
TTG/
Fn/Lb_V1/
 4700 . . . 4722
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-457
TTG
Fn
 4682 . . . 4704

Transgenic Insert





TI-458
TTG
Fn
 4711 . . . 4733
+
Transgenic Insert





TI-459
TTA
Fn
 4699 . . . 4721

Transgenic Insert





TI-460
TTG/
Fn/Lb_V1/
 4754 . . . 4776
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-461
TCCC
Lb_V1
 4768 . . . 4790
+
Transgenic Insert





TI-462
TTA
Fn
 4790 . . . 4812
+
Transgenic Insert





TI-463
TTG
Fn
 4773 . . . 4795

Transgenic Insert





TI-464
TATG
Lb_V2
 4824 . . . 4846
+
Transgenic Insert





TI-465
TTA/
Fn/Lb_V1/
 4809 . . . 4831

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-466
TCCA
Lb_V1
 4856 . . . 4878
+
Transgenic Insert





TI-467
TTA/
Fn/Lb_V1/
 4836 . . . 4858

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-468
TTC/
Fn/Lb_V1/
 4868 . . . 4890
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-469
TTCG
Lb_V1
 4869 . . . 4891
+
Transgenic Insert





TI-470
TTCG
Lb_V1
 4849 . . . 4871

Transgenic Insert





TI-471
TTC
Fn
 4850 . . . 4872

Transgenic Insert





TI-472
TTG/
Fn/Lb_V1/
 4856 . . . 4878

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-473
TTCC
Lb_V1
 4867 . . . 4889

Transgenic Insert





TI-474
TTC
Fn
 4868 . . . 4890

Transgenic Insert





TI-475
TCCA
Lb_V1
 4871 . . . 4893

Transgenic Insert





TI-476
TTG
Fn
 4901 . . . 4923
+
Transgenic Insert





TI-477
TCCA
Lb_V1
 4884 . . . 4906

Transgenic Insert





TI-478
TTG
Fn
 4909 . . . 4931
+
Transgenic Insert





TI-479
TTG
Fn
 4895 . . . 4917

Transgenic Insert





TI-480
TATC
Lb_V2
 4931 . . . 4953
+
Transgenic Insert





TI-481
TCCG
Lb_V1
 4933 . . . 4955
+
Transgenic Insert





TI-482
TTCG
Lb_V1
 4927 . . . 4949

Transgenic Insert





TI-483
TTC
Fn
 4928 . . . 4950

Transgenic Insert





TI-484
TCCC
Lb_V1
 4942 . . . 4964

Transgenic Insert





TI-485
TTCC
Lb_V1
 4943 . . . 4965

Transgenic Insert





TI-486
TTC
Fn
 4944 . . . 4966

Transgenic Insert





TI-487
TCCA
Lb_V1
 4957 . . . 4979

Transgenic Insert





TI-488
TCCA
Lb_V1
 4964 . . . 4986

Transgenic Insert





TI-489
TTCC
Lb_V1
 4965 . . . 4987

Transgenic Insert





TI-490
TTC
Fn
 4966 . . . 4988

Transgenic Insert





TI-491
TTCG
Lb_V1
 4973 . . . 4995

Transgenic Insert





TI-492
TTC/
Fn/Lb_V1/
 4974 . . . 4996

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-493
TTA
Fn
 5007 . . . 5029
+
Transgenic Insert





TI-494
TCCA
Lb_V1
 4988 . . . 5010

Transgenic Insert





TI-495
TCCA
Lb_V1
 4995 . . . 5017

Transgenic Insert





TI-496
TTCC
Lb_V1
 4996 . . . 5018

Transgenic Insert





TI-497
TTC
Fn
 4997 . . . 5019

Transgenic Insert





TI-498
TCCA
Lb_V1
 5027 . . . 5049
+
Transgenic Insert





TI-499
TTA/
Fn/Lb_V1/
 5034 . . . 5056
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-500
TTA
Fn
 5089 . . . 5111
+
Transgenic Insert





TI-501
TTG/
Fn/Lb_V1/
 5068 . . . 5090

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-502
TCCA
Lb_V1
 5076 . . . 5098

Transgenic Insert





TI-503
TATG
Lb_V2
 5101 . . . 5123
+
Transgenic Insert





TI-504
TTA
Fn
 5092 . . . 5114

Transgenic Insert





TI-505
TTA/
Fn/Lb_V1/
 5117 . . . 5139
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-506
TCCG
Lb_V1
 5113 . . . 5135

Transgenic Insert





TI-507
TTA
Fn
 5122 . . . 5144

Transgenic Insert





TI-508
TTC
Fn
 5157 . . . 5179
+
Transgenic Insert





TI-509
TTCA
Lb_V1
 5146 . . . 5168

Transgenic Insert





TI-510
TTC
Fn
 5147 . . . 5169

Transgenic Insert





TI-511
TCCG
Lb_V1
 5170 . . . 5192

Transgenic Insert





TI-512
TTCC
Lb_V1
 5171 . . . 5193

Transgenic Insert





TI-513
TTC
Fn
 5172 . . . 5194

Transgenic Insert





TI-514
TTG
Fn
 5203 . . . 5225
+
Transgenic Insert





TI-515
TTG/
Fn/Lb_V1/
 5194 . . . 5216

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-516
TCCG
Lb_V1
 5200 . . . 5222

Transgenic Insert





TI-517
TCCA
Lb_V1
 5218 . . . 5240

Transgenic Insert





TI-518
TTG
Fn
 5243 . . . 5265
+
Transgenic Insert





TI-519
TTC
Fn
 5248 . . . 5270
+
Transgenic Insert





TI-520
TTG
Fn
 5228 . . . 5250

Transgenic Insert





TI-521
TCCC
Lb_V1
 5232 . . . 5254

Transgenic Insert





TI-522
TTCG
Lb_V1
 5239 . . . 5261

Transgenic Insert





TI-523
TTC
Fn
 5240 . . . 5262

Transgenic Insert





TI-524
TTC/
Fn/Lb_V1/
 5263 . . . 5285
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-525
TTCG
Lb_V1
 5264 . . . 5286
+
Transgenic Insert





TI-526
TTC
Fn
 5270 . . . 5292
+
Transgenic Insert





TI-527
TTCC
Lb_V1
 5271 . . . 5293
+
Transgenic Insert





TI-528
TCCA
Lb_V1
 5272 . . . 5294
+
Transgenic Insert





TI-529
TTG
Fn
 5256 . . . 5278

Transgenic Insert





TI-530
TCCA
Lb_V1
 5281 . . . 5303
+
Transgenic Insert





TI-531
TTA
Fn
 5291 . . . 5313
+
Transgenic Insert





TI-532
TTA
Fn
 5300 . . . 5322
+
Transgenic Insert





TI-533
TTG/
Fn/Lb_V1/
 5310 . . . 5332
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-534
TTA
Fn
 5289 . . . 5311

Transgenic Insert





TI-535
TTA
Fn
 5314 . . . 5336
+
Transgenic Insert





TI-536
TTA/
Fn/Lb_V1/
 5293 . . . 5315

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-537
TTA
Fn
 5318 . . . 5340
+
Transgenic Insert





TI-538
TATG
Lb_V2
 5299 . . . 5321

Transgenic Insert





TI-539
TTA/
Fn/Lb_V1/
 5351 . . . 5373
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-540
TTG
Fn
 5356 . . . 5378
+
Transgenic Insert





TI-541
TTG
Fn
 5365 . . . 5387
+
Transgenic Insert





TI-542
TTG/
Fn/Lb_V1/
 5426 . . . 5448
+
Transgenic Insert



TTTG
Lb








TI-543
TTA
Fn
 5440 . . . 5462
+
Transgenic Insert





TI-544
TATG
Lb_V2
 5442 . . . 5464
+
Transgenic Insert





TI-545
TTC
Fn
 5422 . . . 5444

Transgenic Insert





TI-546
TTA
Fn
 5430 . . . 5452

Transgenic Insert





TI-547
TTA/
Fn/Lb_V1/
 5455 . . . 5477
+
Transgenic Insert



TTTA
Lb








TI-548
TTTA
Lb_V2/Lb
 5455 . . . 5477
+
Transgenic Insert





TI-549
TTA/
Fn/Lb_V1/
 5494 . . . 5516
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-550
TTG
Fn
 5501 . . . 5523
+
Transgenic Insert





TI-551
TTG
Fn
 5507 . . . 5529
+
Transgenic Insert





TI-552
TTC
Fn
 5512 . . . 5534
+
Transgenic Insert





TI-553
TATA
Lb_V2
 5493 . . . 5515

Transgenic Insert





TI-554
TTA/
Fn/Lb_V1/
 5518 . . . 5540
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-555
TATA
Lb_V2
 5520 . . . 5542
+
Transgenic Insert





TI-556
TTG
Fn
 5499 . . . 5521

Transgenic Insert





TI-557
TTA
Fn
 5506 . . . 5528

Transgenic Insert





TI-558
TTA
Fn
 5509 . . . 5531

Transgenic Insert





TI-559
TTA
Fn
 5531 . . . 5553
+
Transgenic Insert





TI-560
TATG
Lb_V2
 5515 . . . 5537

Transgenic Insert





TI-561
TTA
Fn
 5517 . . . 5539

Transgenic Insert





TI-562
TATG
Lb_V2
 5520 . . . 5542

Transgenic Insert





TI-563
TTA/
Fn/Lb_V1/
 5522 . . . 5544

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-564
TTG
Fn
 5531 . . . 5553

Transgenic Insert





TI-565
TTG
Fn
 5538 . . . 5560

Transgenic Insert





TI-566
TTA/
Fn/Lb_V1/
 5542 . . . 5564

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-567
TATC
Lb_V2
 5577 . . . 5599
+
Transgenic Insert





TI-568
TCCA
Lb_V1
 5579 . . . 5601
+
Transgenic Insert





TI-569
TTA
Fn
 5567 . . . 5589

Transgenic Insert





TI-570
TTC/
Fn/Lb_V1/
 5570 . . . 5592

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-571
TTCC
Lb_V1
 5574 . . . 5596

Transgenic Insert





TI-572
TTC/
Fn/Lb_V1/
 5575 . . . 5597

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-573
TATG
Lb_V2
 5610 . . . 5632
+
Transgenic Insert





TI-574
TTA/
Fn/Lb_V1/
 5644 . . . 5666
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-575
TTC/
Fn/Lb_V1/
 5654 . . . 5676
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-576
TTC/
Fn/Lb_V1/
 5658 . . . 5680
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-577
TTCC
Lb_V1
 5659 . . . 5681
+
Transgenic Insert





TI-578
TCCC
Lb_V1
 5660 . . . 5682
+
Transgenic Insert





TI-579
TTC/
Fn/Lb_V1/
 5666 . . . 5688
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-580
TTG
Fn
 5669 . . . 5691
+
Transgenic Insert





TI-581
TTCA
Lb_V1
 5647 . . . 5669

Transgenic Insert





TI-582
TTC/
Fn/Lb_V1/
 5648 . . . 5670

Transgenic Insert



TTTC
Lb








TI-583
TTG
Fn
 5672 . . . 5694
+
Transgenic Insert





TI-584
TTA
Fn
 5654 . . . 5676

Transgenic Insert





TI-585
TTA/
Fn/Lb_V1/
 5767 . . . 5789
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-586
TTA
Fn
 5778 . . . 5800
+
Transgenic Insert





TI-587
TTC
Fn
 5784 . . . 5806
+
Transgenic Insert





TI-588
TTCG
Lb_V1
 5785 . . . 5807
+
Transgenic Insert





TI-589
TTG
Fn
 5788 . . . 5810
+
Transgenic Insert





TI-590
TTA
Fn
 5793 . . . 5815
+
Transgenic Insert





TI-591
TTG
Fn
 5774 . . . 5796

Transgenic Insert





TI-592
TTG
Fn
 5806 . . . 5828
+
Transgenic Insert





TI-593
TTG/
Fn/Lb_V1/
 5785 . . . 5807

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-594
TCCA
Lb_V1
 5810 . . . 5832
+
Transgenic Insert





TI-595
TTCA
Lb_V1
 5791 . . . 5813

Transgenic Insert





TI-596
TTC/
Fn/Lb_V1/
 5792 . . . 5814

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-597
TTCG
Lb_V1
 5814 . . . 5836

Transgenic Insert





TI-598
TTC
Fn
 5815 . . . 5837

Transgenic Insert





TI-599
TTG/
Fn/Lb_V1/
 5908 . . . 5930
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-600
TATC
Lb_V2
 5914 . . . 5936
+
Transgenic Insert





TI-601
TTA
Fn
 5910 . . . 5932

Transgenic Insert





TI-602
TTCA
Lb_V1
 5913 . . . 5935

Transgenic Insert





TI-603
TTC/
Fn/Lb_V1/
 5914 . . . 5936

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-604
TTA
Fn
 5949 . . . 5971
+
Transgenic Insert





TI-605
TTG
Fn
 5952 . . . 5974
+
Transgenic Insert





TI-606
TTG
Fn
 5959 . . . 5981
+
Transgenic Insert





TI-607
TTA/
Fn/Lb_V1/
 5952 . . . 5974

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-608
TCCA
Lb_V1
 5958 . . . 5980

Transgenic Insert





TI-609
TTG/
Fn/Lb_V1/
 5970 . . . 5992

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-610
TCCA
Lb_V1
 6006 . . . 6028
+
Transgenic Insert





TI-611
TTG
Fn
 6009 . . . 6031
+
Transgenic Insert





TI-612
TTCA
Lb_V1
 5991 . . . 6013

Transgenic Insert





TI-613
TTC
Fn
 5992 . . . 6014

Transgenic Insert





TI-614
TATG
Lb_V2
 6016 . . . 6038
+
Transgenic Insert





TI-615
TTA/
Fn/Lb_V1/
 5996 . . . 6018

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-616
TTA
Fn
 6021 . . . 6043
+
Transgenic Insert





TI-617
TTA
Fn
 6000 . . . 6022

Transgenic Insert





TI-618
TTG
Fn
 6003 . . . 6025

Transgenic Insert





TI-619
TTTA
Lb_V1/Lb
 6009 . . . 6031

Transgenic Insert





TI-620
TTG/
Fn/Lb_V1/
 6022 . . . 6044

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-621
TTA/
Fn/Lb_V1/
 6065 . . . 6087
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-622
TATC
Lb_V2
 6063 . . . 6085

Transgenic Insert





TI-623
TTG/
Fn/Lb_V1/
 6067 . . . 6089

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-624
TTA
Fn
 6102 . . . 6124
+
Transgenic Insert





TI-625
TATC
Lb_V2
 6104 . . . 6126
+
Transgenic Insert





TI-626
TTA
Fn
 6094 . . . 6116

Transgenic Insert





TI-627
TATG
Lb_V2
 6098 . . . 6120

Transgenic Insert





TI-628
TTG/
Fn/Lb_V1/
 6102 . . . 6124

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-629
TTA
Fn
 6154 . . . 6176
+
Transgenic Insert





TI-630
TTC/
Fn/Lb_V1/
 6172 . . . 6194
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-631
TTCA
Lb_V1
 6173 . . . 6195
+
Transgenic Insert





TI-632
TATA
Lb_V2
 6158 . . . 6180

Transgenic Insert





TI-633
TATG
Lb_V2
 6180 . . . 6202
+
Transgenic Insert





TI-634
TATC
Lb_V2
 6163 . . . 6185

Transgenic Insert





TI-635
TTA/
Fn/Lb_V1/
 6165 . . . 6187

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-636
TTC
Fn
 6169 . . . 6191

Transgenic Insert





TI-637
TTA/
Fn/Lb_V1/
 6225 . . . 6247
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-638
TATA
Lb_V2
 6227 . . . 6249
+
Transgenic Insert





TI-639
TTA/
Fn/Lb_V1/
 6221 . . . 6243

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-640
TTG/
Fn/Lb_V1/
 6228 . . . 6250

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-641
TTC/
Fn/Lb_V1/
 6273 . . . 6295

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-642
TTC
Fn
 6316 . . . 6338
+
Transgenic Insert





TI-643
TTCA
Lb_V1
 6317 . . . 6339
+
Transgenic Insert





TI-644
TCCC
Lb_V1
 6301 . . . 6323

Transgenic Insert





TI-645
TTG
Fn
 6314 . . . 6336

Transgenic Insert





TI-646
TTG
Fn
 6324 . . . 6346

Transgenic Insert





TI-647
TATA
Lb_V2
 6404 . . . 6426
+
Transgenic Insert





TI-648
TTA
Fn
 6421 . . . 6443
+
Transgenic Insert





TI-649
TTG
Fn
 6403 . . . 6425

Transgenic Insert





TI-650
TCCA
Lb_V1
 6410 . . . 6432

Transgenic Insert





TI-651
TTA
Fn
 6442 . . . 6464
+
Transgenic Insert





TI-652
TATG
Lb_V2
 6444 . . . 6466
+
Transgenic Insert





TI-653
TTC/
Fn/Lb_V1/
 6431 . . . 6453

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-654
TTA
Fn
 6454 . . . 6476
+
Transgenic Insert





TI-655
TTG
Fn
 6461 . . . 6483
+
Transgenic Insert





TI-656
TTG
Fn
 6467 . . . 6489
+
Transgenic Insert





TI-657
TTA
Fn
 6456 . . . 6478

Transgenic Insert





TI-658
TTA/
Fn/Lb_V1/
 6459 . . . 6481

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-659
TTG/
Fn/Lb_V1/
 6469 . . . 6491

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-660
TTG
Fn
 6503 . . . 6525
+
Transgenic Insert





TI-661
TTG
Fn
 6507 . . . 6529

Transgenic Insert





TI-662
TTA/
Fn/Lb_V1/
 6529 . . . 6551
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-663
TTG/
Fn/Lb_V1/
 6512 . . . 6534

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-664
TTG/
Fn/Lb_V1/
 6519 . . . 6541

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-665
TTG/
Fn/Lb_V1/
 6594 . . . 6616
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-666
TTG
Fn
 6586 . . . 6608

Transgenic Insert





TI-667
TTA/
Fn/Lb_V1/
 6628 . . . 6650
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-668
TTA
Fn
 6631 . . . 6653
+
Transgenic Insert





TI-669
TTA
Fn
 6634 . . . 6656
+
Transgenic Insert





TI-670
TTG
Fn
 6641 . . . 6663
+
Transgenic Insert





TI-671
TTC
Fn
 6645 . . . 6667
+
Transgenic Insert





TI-672
TTCA
Lb_V1
 6646 . . . 6668
+
Transgenic Insert





TI-673
TTA
Fn
 6654 . . . 6676
+
Transgenic Insert





TI-674
TTC/
Fn/Lb_V1/
 6660 . . . 6682
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-675
TATA
Lb_V2
 6703 . . . 6725
+
Transgenic Insert





TI-676
TTC
Fn
 6726 . . . 6748
+
Transgenic Insert





TI-677
TTC
Fn
 6729 . . . 6751
+
Transgenic Insert





TI-678
TTG
Fn
 6710 . . . 6732

Transgenic Insert





TI-679
TTC
Fn
 6732 . . . 6754
+
Transgenic Insert





TI-680
TTCA
Lb_V1
 6733 . . . 6755
+
Transgenic Insert





TI-681
TTG
Fn
 6722 . . . 6744

Transgenic Insert





TI-682
TTG/
Fn/Lb_V1/
 6730 . . . 6752

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-683
TTC/
Fn/Lb_V1/
 6772 . . . 6794
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-684
TTC
Fn
 6781 . . . 6803
+
Transgenic Insert





TI-685
TTG
Fn
 6771 . . . 6793

Transgenic Insert





TI-686
TTA/
Fn/Lb_V1/
 6776 . . . 6798

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-687
TTG/
Fn/Lb_V1/
 6801 . . . 6823

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-688
TTC/
Fn/Lb_V1/
 6846 . . . 6868
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-689
TTCG
Lb_V1
 6847 . . . 6869
+
Transgenic Insert





TI-690
TTC
Fn
 6850 . . . 6872
+
Transgenic Insert





TI-691
TTCG
Lb_V1
 6851 . . . 6873
+
Transgenic Insert





TI-692
TCCC
Lb_V1
 6856 . . . 6878
+
Transgenic Insert





TI-693
TTC/
Fn/Lb_V1/
 6862 . . . 6884
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-694
TTCG
Lb_V1
 6863 . . . 6885
+
Transgenic Insert





TI-695
TATA
Lb_V2
 6867 . . . 6889
+
Transgenic Insert





TI-696
TATG
Lb_V2
 6869 . . . 6891
+
Transgenic Insert





TI-697
TTC
Fn
 6872 . . . 6894
+
Transgenic Insert





TI-698
TTG/
Fn/Lb_V1/
 6876 . . . 6898
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-699
TTA/
Fn/Lb_V1/
 6881 . . . 6903
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-700
TTC
Fn
 6886 . . . 6908
+
Transgenic Insert





TI-701
TTA
Fn
 6866 . . . 6888

Transgenic Insert





TI-702
TTCG
Lb_V1
 6877 . . . 6899

Transgenic Insert





TI-703
TTC
Fn
 6878 . . . 6900

Transgenic Insert





TI-704
TTC/
Fn/Lb_V1/
 6914 . . . 6936
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-705
TTG/
Fn/Lb_V1/
 6922 . . . 6944
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-706
TTA
Fn
 6929 . . . 6951
+
Transgenic Insert





TI-707
TATC
Lb_V2
 6935 . . . 6957
+
Transgenic Insert





TI-708
TTA
Fn
 6916 . . . 6938

Transgenic Insert





TI-709
TTA
Fn
 6941 . . . 6963
+
Transgenic Insert





TI-710
TTC
Fn
 6945 . . . 6967
+
Transgenic Insert





TI-711
TTA
Fn
 6952 . . . 6974
+
Transgenic Insert





TI-712
TATG
Lb_V2
 6935 . . . 6957

Transgenic Insert





TI-713
TTC/
Fn/Lb_V1/
 6959 . . . 6981
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-714
TTCA
Lb_V1
 6960 . . . 6982
+
Transgenic Insert





TI-715
TATC
Lb_V2
 6939 . . . 6961

Transgenic Insert





TI-716
TATC
Lb_V2
 6968 . . . 6990
+
Transgenic Insert





TI-717
TCCG
Lb_V1
 6973 . . . 6995
+
Transgenic Insert





TI-718
TTG/
Fn/Lb_V1/
 6957 . . . 6979
-
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-719
TTA
Fn
 6961 . . . 6983

Transgenic Insert





TI-720
TTG/
Fn/Lb_V1/
 6998 . . . 7020
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-721
TTA
Fn
 7009 . . . 7031
+
Transgenic Insert





TI-722
TTC
Fn
 7015 . . . 7037
+
Transgenic Insert





TI-723
TTCG
Lb_V1
 7016 . . . 7038
+
Transgenic Insert





TI-724
TTG/
Fn/Lb_V1/
 7021 . . . 7043
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-725
TTC/
Fn/Lb_V1/
 7028 . . . 7050
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-726
TATC
Lb_V2
 7032 . . . 7054
+
Transgenic Insert





TI-727
TTA
Fn
 7046 . . . 7068
+
Transgenic Insert





TI-728
TTC/
Fn/Lb_V1/
 7051 . . . 7073
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-729
TTG/
Fn/Lb_V1/
 7058 . . . 7080
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-730
TTCG
Lb_V1
 7041 . . . 7063

Transgenic Insert





TI-731
TTC
Fn
 7042 . . . 7064

Transgenic Insert





TI-732
TTA
Fn
 7054 . . . 7076

Transgenic Insert





TI-733
TTC/
Fn/Lb_V1/
 7092 . . . 7114
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-734
TTA
Fn
 7098 . . . 7120
+
Transgenic Insert





TI-735
TTG/
Fn/Lb_V1/
 7125 . . . 7147
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-736
TTG/
Fn/Lb_V1/
 7134 . . . 7156
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-737
TTG
Fn
 7113 . . . 7135

Transgenic Insert





TI-738
TTG
Fn
 7116 . . . 7138

Transgenic Insert





TI-739
TATC
Lb_V2
 7147 . . . 7169
+
Transgenic Insert





TI-740
TTC
Fn
 7152 . . . 7174
+
Transgenic Insert





TI-741
TTCA
Lb_V1
 7153 . . . 7175
+
Transgenic Insert





TI-742
TTG
Fn
 7138 . . . 7160

Transgenic Insert





TI-743
TTC
Fn
 7162 . . . 7184
+
Transgenic Insert





TI-744
TTCA
Lb_V1
 7163 . . . 7185
+
Transgenic Insert





TI-745
TTA
Fn
 7195 . . . 7217
+
Transgenic Insert





TI-746
TCCG
Lb_V1
 7173 . . . 7195

Transgenic Insert





TI-747
TCCA
Lb_V1
 7178 . . . 7200

Transgenic Insert





TI-748
TCCC
Lb_V1
 7187 . . . 7209

Transgenic Insert





TI-749
TTA
Fn
 7221 . . . 7243
+
Transgenic Insert





TI-750
TCCA
Lb_V1
 7231 . . . 7253
+
Transgenic Insert





TI-751
TCCA
Lb_V1
 7210 . . . 7232

Transgenic Insert





TI-752
TTCC
Lb_V1
 7211 . . . 7233

Transgenic Insert





TI-753
TTC
Fn
 7212 . . . 7234

Transgenic Insert





TI-754
TTG
Fn
 7235 . . . 7257
+
Transgenic Insert





TI-755
TTC/
Fn/Lb_V1/
 7258 . . . 7280
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-756
TTCA
Lb_V1
 7259 . . . 7281
+
Transgenic Insert





TI-757
TTG
Fn
 7243 . . . 7265

Transgenic Insert





TI-758
TTA
Fn
 7273 . . . 7295
+
Transgenic Insert





TI-759
TATC
Lb_V2
 7275 . . . 7297
+
Transgenic Insert





TI-760
TCCA
Lb_V1
 7260 . . . 7282

Transgenic Insert





TI-761
TTC/
Fn/Lb_V1/
 7282 . . . 7304
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-762
TTCC
Lb_V1
 7283 . . . 7305
+
Transgenic Insert





TI-763
TTG
Fn
 7275 . . . 7297

Transgenic Insert





TI-764
TTG
Fn
 7315 . . . 7337
+
Transgenic Insert





TI-765
TTG/
Fn/Lb_V1/
 7298 . . . 7320

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-766
TTC
Fn
 7332 . . . 7354
+
Transgenic Insert





TI-767
TTCG
Lb_V1
 7333 . . . 7355
+
Transgenic Insert





TI-768
TCCA
Lb_V1
 7347 . . . 7369
+
Transgenic Insert





TI-769
TTG
Fn
 7328 . . . 7350

Transgenic Insert





TI-770
TTC
Fn
 7351 . . . 7373
+
Transgenic Insert





TI-771
TTCC
Lb_V1
 7352 . . . 7374
+
Transgenic Insert





TI-772
TCCA
Lb_V1
 7353 . . . 7375
+
Transgenic Insert





TI-773
TTC
Fn
 7357 . . . 7379
+
Transgenic Insert





TI-774
TTG/
Fn/Lb_V1/
 7335 . . . 7357

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-775
TCCA
Lb_V1
 7366 . . . 7388
+
Transgenic Insert





TI-776
TTG
Fn
 7369 . . . 7391
+
Transgenic Insert





TI-777
TTA
Fn
 7376 . . . 7398
+
Transgenic Insert





TI-778
TATC
Lb_V2
 7378 . . . 7400
+
Transgenic Insert





TI-779
TCCC
Lb_V1
 7380 . . . 7402
+
Transgenic Insert





TI-780
TTA
Fn
 7396 . . . 7418
+
Transgenic Insert





TI-781
TTC
Fn
 7378 . . . 7400

Transgenic Insert





TI-782
TTG
Fn
 7383 . . . 7405

Transgenic Insert





TI-783
TATG
Lb_V2
 7401 . . . 7423

Transgenic Insert





TI-784
TTG
Fn
 7439 . . . 7461
+
Transgenic Insert





TI-785
TTC
Fn
 7458 . . . 7480
+
Transgenic Insert





TI-786
TTCC
Lb_V1
 7459 . . . 7481
+
Transgenic Insert





TI-787
TTG
Fn
 7462 . . . 7484
+
Transgenic Insert





TI-788
TCCG
Lb_V1
 7473 . . . 7495
+
Transgenic Insert





TI-789
TTA
Fn
 7486 . . . 7508
+
Transgenic Insert





TI-790
TATG
Lb_V2
 7488 . . . 7510
+
Transgenic Insert





TI-791
TTG
Fn
 7469 . . . 7491

Transgenic Insert





TI-792
TCCG
Lb_V1
 7481 . . . 7503

Transgenic Insert





TI-793
TATC
Lb_V2
 7495 . . . 7517

Transgenic Insert





TI-794
TTC/
Fn/Lb_V1/
 7530 . . . 7552
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-795
TTCC
Lb_V1
 7531 . . . 7553
+
Transgenic Insert





TI-796
TTG
Fn
 7511 . . . 7533

Transgenic Insert





TI-797
TATC
Lb_V2
 7535 . . . 7557
+
Transgenic Insert





TI-798
TCCC
Lb_V1
 7526 . . . 7548

Transgenic Insert





TI-799
TTG
Fn
 7541 . . . 7563

Transgenic Insert





TI-800
TTG
Fn
 7549 . . . 7571

Transgenic Insert





TI-801
TTCA
Lb_V1
 7560 . . . 7582

Transgenic Insert





TI-802
TTC
Fn
 7561 . . . 7583

Transgenic Insert





TI-803
TTG
Fn
 7585 . . . 7607
+
Transgenic Insert





TI-804
TTA/
Fn/Lb_V1/
 7568 . . . 7590

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-805
TTC
Fn
 7603 . . . 7625
+
Transgenic Insert





TI-806
TTCA
Lb_V1
 7604 . . . 7626
+
Transgenic Insert





TI-807
TTA
Fn
 7590 . . . 7612

Transgenic Insert





TI-808
TCCG
Lb_V1
 7599 . . . 7621

Transgenic Insert





TI-809
TTCC
Lb_V1
 7600 . . . 7622

Transgenic Insert





TI-810
TTC
Fn
 7623 . . . 7645
+
Transgenic Insert





TI-811
TTC
Fn
 7601 . . . 7623

Transgenic Insert





TI-812
TTCG
Lb_V1
 7624 . . . 7646
+
Transgenic Insert





TI-813
TTA/
Fn/Lb_V1/
 7634 . . . 7656
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-814
TTCG
Lb_V1
 7619 . . . 7641

Transgenic Insert





TI-815
TTC
Fn
 7620 . . . 7642

Transgenic Insert





TI-816
TCCA
Lb_V1
 7624 . . . 7646

Transgenic Insert





TI-817
TTG
Fn
 7649 . . . 7671
+
Transgenic Insert





TI-818
TTC
Fn
 7656 . . . 7678
+
Transgenic Insert





TI-819
TTA
Fn
 7635 . . . 7657

Transgenic Insert





TI-820
TTCA
Lb_V1
 7657 . . . 7679
+
Transgenic Insert





TI-821
TTCA
Lb_V1
 7646 . . . 7668

Transgenic Insert





TI-822
TTC
Fn
 7647 . . . 7669

Transgenic Insert





TI-823
TCCA
Lb_V1
 7655 . . . 7677

Transgenic Insert





TI-824
TCCA
Lb_V1
 7661 . . . 7683

Transgenic Insert





TI-825
TCCA
Lb_V1
 7668 . . . 7690

Transgenic Insert





TI-826
TCCC
Lb_V1
 7676 . . . 7698

Transgenic Insert





TI-827
TCCA
Lb_V1
 7716 . . . 7738
+
Transgenic Insert





TI-828
TTA
Fn
 7726 . . . 7748
+
Transgenic Insert





TI-829
TTA
Fn
 7712 . . . 7734

Transgenic Insert





TI-830
TCCA
Lb_V1
 7716 . . . 7738

Transgenic Insert





TI-831
TTA/
Fn/Lb_V1/
 7757 . . . 7779
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-832
TTG
Fn
 7737 . . . 7759

Transgenic Insert





TI-833
TTA/
Fn/Lb_V1/
 7772 . . . 7794
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-834
TTC
Fn
 7755 . . . 7777

Transgenic Insert





TI-835
TCCC
Lb_V1
 7764 . . . 7786

Transgenic Insert





TI-836
TTCC
Lb_V1
 7765 . . . 7787

Transgenic Insert





TI-837
TCCA
Lb_V1
 7787 . . . 7809
+
Transgenic Insert





TI-838
TTC
Fn
 7766 . . . 7788

Transgenic Insert





TI-839
TCCG
Lb_V1
 7778 . . . 7800

Transgenic Insert





TI-840
TTA
Fn
 7785 . . . 7807

Transgenic Insert





TI-841
TCCC
Lb_V1
 7816 . . . 7838
+
Transgenic Insert





TI-842
TTG
Fn
 7798 . . . 7820

Transgenic Insert





TI-843
TTC
Fn
 7822 . . . 7844
+
Transgenic Insert





TI-844
TTCA
Lb_V1
 7823 . . . 7845
+
Transgenic Insert





TI-845
TTC
Fn
 7827 . . . 7849
+
Transgenic Insert





TI-846
TTCC
Lb_V1
 7828 . . . 7850
+
Transgenic Insert





TI-847
TTCG
Lb_V1
 7809 . . . 7831

Transgenic Insert





TI-848
TTC
Fn
 7810 . . . 7832

Transgenic Insert





TI-849
TTG
Fn
 7822 . . . 7844

Transgenic Insert





TI-850
TTC
Fn
 7851 . . . 7873
+
Transgenic Insert





TI-851
TTCG
Lb_V1
 7852 . . . 7874
+
Transgenic Insert





TI-852
TTC
Fn
 7857 . . . 7879
+
Transgenic Insert





TI-853
TTCA
Lb_V1
 7858 . . . 7880
+
Transgenic Insert





TI-854
TTG
Fn
 7862 . . . 7884
+
Transgenic Insert





TI-855
TTC
Fn
 7870 . . . 7892
+
Transgenic Insert





TI-856
TTCG
Lb_V1
 7871 . . . 7893
+
Transgenic Insert





TI-857
TCCA
Lb_V1
 7849 . . . 7871

Transgenic Insert





TI-858
TTCC
Lb_V1
 7850 . . . 7872

Transgenic Insert





TI-859
TTC
Fn
 7851 . . . 7873

Transgenic Insert





TI-860
TTC
Fn
 7854 . . . 7876

Transgenic Insert





TI-861
TTG
Fn
 7861 . . . 7883

Transgenic Insert





TI-862
TCCC
Lb_V1
 7874 . . . 7896

Transgenic Insert





TI-863
TATC
Lb_V2
 7876 . . . 7898

Transgenic Insert





TI-864
TTA
Fn
 7878 . . . 7900

Transgenic Insert





TI-865
TTG/
Fn/Lb_V1/
 7910 . . . 7932
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-866
TCCC
Lb_V1
 7918 . . . 7940

Transgenic Insert





TI-867
TTCC
Lb_V1
 7919 . . . 7941

Transgenic Insert





TI-868
TTC/
Fn/Lb_V1/
 7920 . . . 7942

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-869
TTC
Fn
 7950 . . . 7972
+
Transgenic Insert





TI-870
TTCC
Lb_V1
 7951 . . . 7973
+
Transgenic Insert





TI-871
TCCG
Lb_V1
 7952 . . . 7974
+
Transgenic Insert





TI-872
TATC
Lb_V2
 7957 . . . 7979
+
Transgenic Insert





TI-873
TCCG
Lb_V1
 7953 . . . 7975

Transgenic Insert





TI-874
TTG
Fn
 7959 . . . 7981

Transgenic Insert





TI-875
TTCA
Lb_V1
 7986 . . . 8008

Transgenic Insert





TI-876
TTC
Fn
 7987 . . . 8009

Transgenic Insert





TI-877
TTA
Fn
 7990 . . . 8012

Transgenic Insert





TI-878
TTG
Fn
 7994 . . . 8016

Transgenic Insert





TI-879
TATG
Lb_V2
 8000 . . . 8022

Transgenic Insert





TI-880
TTA/
Fn/Lb_V1/
 8002 . . . 8024

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-881
TTC/
Fn/Lb_V1/
 8033 . . . 8055
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-882
TTCA
Lb_V1
 8017 . . . 8039

Transgenic Insert





TI-883
TTC
Fn
 8018 . . . 8040

Transgenic Insert





TI-884
TTG/
Fn/Lb_V1/
 8058 . . . 8080
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-885
TTA
Fn
 8062 . . . 8084
+
Transgenic Insert





TI-886
TTG/
Fn/Lb_V1/
 8078 . . . 8100
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-887
TTA/
Fn/Lb_V1/
 8086 . . . 8108
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-888
TATG
Lb_V2
 8088 . . . 8110
+
Transgenic Insert





TI-889
TTA
Fn
 8068 . . . 8090

Transgenic Insert





TI-890
TTA/
Fn/Lb_V1/
 8071 . . . 8093

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-891
TTA
Fn
 8079 . . . 8101

Transgenic Insert





TI-892
TATC
Lb_V2
 8084 . . . 8106

Transgenic Insert





TI-893
TATA
Lb_V2
 8086 . . . 8108

Transgenic Insert





TI-894
TTCA
Lb_V1
 8168 . . . 8190
+
Transgenic Insert





TI-895
TATA
Lb_V2
 8229 . . . 8251

Transgenic Insert





TI-896
TTA/
Fn/Lb_V1/
 8254 . . . 8276
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-897
TATA
Lb_V2
 8256 . . . 8278
+
Transgenic Insert





TI-898
TTA/
Fn/Lb_V1/
 8250 . . . 8272

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-899
TTA/
Fn/Lb_V1/
 8255 . . . 8277

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-900
TTCA
Lb_V1
 8259 . . . 8281

Transgenic Insert





TI-901
TTC/
Fn/Lb_V1/
 8260 . . . 8282

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-902
TTG/
Fn/Lb_V1/
 8264 . . . 8286

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-903
TTA
Fn
 8298 . . . 8320
+
Transgenic Insert





TI-904
TTC
Fn
 8309 . . . 8331
+
Transgenic Insert





TI-905
TTCA
Lb_V1
 8310 . . . 8332
+
Transgenic Insert





TI-906
TTG
Fn
 8293 . . . 8315

Transgenic Insert





TI-907
TATA
Lb_V2
 8296 . . . 8318

Transgenic Insert





TI-908
TATA
Lb_V2
 8298 . . . 8320

Transgenic Insert





TI-909
TATA
Lb_V2
 8300 . . . 8322

Transgenic Insert





TI-910
TTA
Fn
 8302 . . . 8324

Transgenic Insert





TI-911
TTA/
Fn/Lb_V1/
 8306 . . . 8328

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-912
TATA
Lb_V2
 8343 . . . 8365
+
Transgenic Insert





TI-913
TTG
Fn
 8351 . . . 8373
+
Transgenic Insert





TI-914
TTC/
Fn/Lb_V1/
 8355 . . . 8377
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-915
TTC
Fn
 8358 . . . 8380
+
Transgenic Insert





TI-916
TTG
Fn
 8344 . . . 8366

Transgenic Insert





TI-917
TTCA
Lb_V1
 8350 . . . 8372

Transgenic Insert





TI-918
TTC/
Fn/Lb_V1/
 8351 . . . 8373

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-919
TTA/
Fn/Lb_V1/
 8383 . . . 8405
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-920
TTG
Fn
 8380 . . . 8402

Transgenic Insert





TI-921
TTC/
Fn/Lb_V1/
 8413 . . . 8435
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-922
TTCA
Lb_V1
 8414 . . . 8436
+
Transgenic Insert





TI-923
TTA/
Fn/Lb_V1/
 8424 . . . 8446
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-924
TATA
Lb_V2
 8426 . . . 8448
+
Transgenic Insert





TI-925
TTG
Fn
 8411 . . . 8433

Transgenic Insert





TI-926
TCCA
Lb_V1
 8419 . . . 8441

Transgenic Insert





TI-927
TATC
Lb_V2
 8421 . . . 8443

Transgenic Insert





TI-928
TTA
Fn
 8423 . . . 8445

Transgenic Insert





TI-929
TTA/
Fn/Lb_V1/
 8465 . . . 8487
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-930
TATA
Lb_V2
 8467 . . . 8489
+
Transgenic Insert





TI-931
TCCA
Lb_V1
 8468 . . . 8490

Transgenic Insert





TI-932
TTCC
Lb_V1
 8469 . . . 8491

Transgenic Insert





TI-933
TTC/
Fn/Lb_V1/
 8470 . . . 8492

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-934
TTG
Fn
 8506 . . . 8528
+
Transgenic Insert





TI-935
TTCG
Lb_V1
 8501 . . . 8523

Transgenic Insert





TI-936
TTC
Fn
 8502 . . . 8524

Transgenic Insert





TI-937
TTA/
Fn/Lb_V1/
 8544 . . . 8566
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-938
TTA
Fn
 8538 . . . 8560

Transgenic Insert





TI-939
TTG/
Fn/Lb_V1/
 8555 . . . 8577

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-940
TTA/
Fn/Lb_V1/
 8574 . . . 8596

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-941
TCCC
Lb_V1
 8581 . . . 8603

Transgenic Insert





TI-942
TATC
Lb_V2
 8583 . . . 8605

Transgenic Insert





TI-943
TTA
Fn
 8585 . . . 8607

Transgenic Insert





TI-944
TTC
Fn
 8631 . . . 8653
+
Transgenic Insert





TI-945
TTC
Fn
 8634 . . . 8656
+
Transgenic Insert





TI-946
TTG
Fn
 8637 . . . 8659
+
Transgenic Insert





TI-947
TTG
Fn
 8620 . . . 8642

Transgenic Insert





TI-948
TTA/
Fn/Lb_V1/
 8624 . . . 8646

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-949
TTA
Fn
 8649 . . . 8671
+
Transgenic Insert





TI-950
TTG
Fn
 8630 . . . 8652

Transgenic Insert





TI-951
TATA
Lb_V2
 8642 . . . 8664

Transgenic Insert





TI-952
TATA
Lb_V2
 8644 . . . 8666

Transgenic Insert





TI-953
TTA/
Fn/Lb_V1/
 8678 . . . 8700
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-954
TTA
Fn
 8680 . . . 8702

Transgenic Insert





TI-955
TTA/
Fn/Lb_V1/
 8737 . . . 8759
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-956
TATA
Lb_V2
 8739 . . . 8761
+
Transgenic Insert





TI-957
TTC/
Fn/Lb_V1/
 8749 . . . 8771
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-958
TTG/
Fn/Lb_V1/
 8739 . . . 8761

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-959
TTA/
Fn/Lb_V1/
 8746 . . . 8768

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-960
TTTC
Lb_V1/Lb
 8816 . . . 8838
+
Transgenic Insert





TI-961
TTA
Fn
 8819 . . . 8841
+
Transgenic Insert





TI-962
TATG
Lb_V2
 8825 . . . 8847
+
Transgenic Insert





TI-963
TTA
Fn
 8829 . . . 8851
+
Transgenic Insert





TI-964
TTC
Fn
 8833 . . . 8855
+
Transgenic Insert





TI-965
TTCA
Lb_V1
 8834 . . . 8856
+
Transgenic Insert





TI-966
TTA
Fn
 8815 . . . 8837

Transgenic Insert





TI-967
TCCA
Lb_V1
 8820 . . . 8842

Transgenic Insert





TI-968
TTCC
Lb_V1
 8821 . . . 8843

Transgenic Insert





TI-969
TTC
Fn
 8822 . . . 8844

Transgenic Insert





TI-970
TTG
Fn
 8830 . . . 8852

Transgenic Insert





TI-971
TTG/
Fn/Lb_V1/
 8837 . . . 8859

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-972
TTA
Fn
 8878 . . . 8900
+
Transgenic Insert





TI-973
TTA
Fn
 8884 . . . 8906
+
Transgenic Insert





TI-974
TATA
Lb_V2
 8862 . . . 8884

Transgenic Insert





TI-975
TTA
Fn
 8887 . . . 8909
+
Transgenic Insert





TI-976
TATA
Lb_V2
 8889 . . . 8911
+
Transgenic Insert





TI-977
TATA
Lb_V2
 8868 . . . 8890

Transgenic Insert





TI-978
TTA/
Fn/Lb_V1/
 8893 . . . 8915
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-979
TATA
Lb_V2
 8895 . . . 8917
+
Transgenic Insert





TI-980
TTG
Fn
 8874 . . . 8896

Transgenic Insert





TI-981
TTG
Fn
 8877 . . . 8899

Transgenic Insert





TI-982
TATG
Lb_V2
 8890 . . . 8912

Transgenic Insert





TI-983
TTC/
Fn/Lb_V1/
 8894 . . . 8916

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-984
TTC/
Fn/Lb_V1/
 8898 . . . 8920

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-985
TCCA
Lb_V1
 8973 . . . 8995
+
Transgenic Insert





TI-986
TCCA
Lb_V1
 8982 . . . 9004
+
Transgenic Insert





TI-987
TTA
Fn
 8966 . . . 8988

Transgenic Insert





TI-988
TATC
Lb_V2
 8970 . . . 8992

Transgenic Insert





TI-989
TTA
Fn
 8972 . . . 8994

Transgenic Insert





TI-990
TTG
Fn
 8980 . . . 9002

Transgenic Insert





TI-991
TTC
Fn
 9004 . . . 9026

Transgenic Insert





TI-992
TTA
Fn
 9035 . . . 9057
+
Transgenic Insert





TI-993
TTG
Fn
 9014 . . . 9036

Transgenic Insert





TI-994
TATC
Lb_V2
 9037 . . . 9059
+
Transgenic Insert





TI-995
TCCA
Lb_V1
 9039 . . . 9061
+
Transgenic Insert





TI-996
TTG/
Fn/Lb_V1/
 9031 . . . 9053

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-997
TTA
Fn
 9063 . . . 9085
+
Transgenic Insert





TI-998
TATC
Lb_V2
 9065 . . . 9087
+
Transgenic Insert





TI-999
TCCA
Lb_V1
 9067 . . . 9089
+
Transgenic Insert





TI-1000
TATA
Lb_V2
 9048 . . . 9070

Transgenic Insert





TI-1001
TTC
Fn
 9071 . . . 9093
+
Transgenic Insert





TI-1002
TATA
Lb_V2
 9050 . . . 9072

Transgenic Insert





TI-1003
TATA
Lb_V2
 9052 . . . 9074

Transgenic Insert





TI-1004
TATA
Lb_V2
 9075 . . . 9097
+
Transgenic Insert





TI-1005
TTA
Fn
 9054 . . . 9076

Transgenic Insert





TI-1006
TATA
Lb_V2
 9077 . . . 9099
+
Transgenic Insert





TI-1007
TATA
Lb_V2
 9079 . . . 9101
+
Transgenic Insert





TI-1008
TTC
Fn
 9087 . . . 9109
+
Transgenic Insert





TI-1009
TTC
Fn
 9090 . . . 9112
+
Transgenic Insert





TI-1010
TTA
Fn
 9096 . . . 9118
+
Transgenic Insert





TI-1011
TTG/
Fn/Lb_V1/
 9093 . . . 9115

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1012
TTC/
Fn/Lb_V1/
 9166 . . . 9188
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1013
TTC
Fn
 9169 . . . 9191
+
Transgenic Insert





TI-1014
TTC
Fn
 9174 . . . 9196
+
Transgenic Insert





TI-1015
TTC/
Fn/Lb_V1/
 9216 . . . 9238
+
Transgenic Insert



TTTC
Lb








TI-1016
TTG/
Fn/Lb_V1/
 9225 . . . 9247
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1017
TTG/
Fn/Lb_V1/
 9229 . . . 9251
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1018
TTG/
Fn/Lb_V1/
 9234 . . . 9256
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1019
TCCA
Lb_V1
 9214 . . . 9236

Transgenic Insert





TI-1020
TTG/
Fn/Lb_V1/
 9239 . . . 9261
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1021
TTG/
Fn/Lb_V1/
 9287 . . . 9309
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1022
TTG/
Fn/Lb_V1/
 9291 . . . 9313
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1023
TTC
Fn
 9294 . . . 9316
+
Transgenic Insert





TI-1024
TTCA
Lb_V1
 9295 . . . 9317
+
Transgenic Insert





TI-1025
TTA
Fn
 9300 . . . 9322
+
Transgenic Insert





TI-1026
TTC
Fn
 9303 . . . 9325
+
Transgenic Insert





TI-1027
TTCA
Lb_V1
 9304 . . . 9326
+
Transgenic Insert





TI-1028
TATC
Lb_V2
 9284 . . . 9306

Transgenic Insert





TI-1029
TATA
Lb_V2
 9286 . . . 9308

Transgenic Insert





TI-1030
TATA
Lb_V2
 9288 . . . 9310

Transgenic Insert





TI-1031
TTG/
Fn/Lb_V1/
 9297 . . . 9319

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1032
TTG/
Fn/Lb_V1/
 9367 . . . 9389
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1033
TTG
Fn
 9371 . . . 9393
+
Transgenic Insert





TI-1034
TTG
Fn
 9374 . . . 9396
+
Transgenic Insert





TI-1035
TTG
Fn
 9377 . . . 9399
+
Transgenic Insert





TI-1036
TTC
Fn
 9389 . . . 9411
+
Transgenic Insert





TI-1037
TTA/
Fn/Lb_V1/
 9395 . . . 9417
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1038
TATG
Lb_V2
 9397 . . . 9419
+
Transgenic Insert





TI-1039
TTG/
Fn/Lb_V1/
 9439 . . . 9461
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1040
TTG
Fn
 9469 . . . 9491
+
Transgenic Insert





TI-1041
TCCA
Lb_V1
 9471 . . . 9493

Transgenic Insert





TI-1042
TATC
Lb_V2
 9485 . . . 9507

Transgenic Insert





TI-1043
TTG
Fn
 9492 . . . 9514

Transgenic Insert





TI-1044
TATC
Lb_V2
 9532 . . . 9554

Transgenic Insert





TI-1045
TCCC
Lb_V1
 9544 . . . 9566

Transgenic Insert





TI-1046
TTC/
Fn/Lb_V1/
 9548 . . . 9570

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1047
TTC
Fn
 9583 . . . 9605
+
Transgenic Insert





TI-1048
TTG
Fn
 9566 . . . 9588

Transgenic Insert





TI-1049
TCCG
Lb_V1
 9589 . . . 9611

Transgenic Insert





TI-1050
TCCC
Lb_V1
 9625 . . . 9647
+
Transgenic Insert





TI-1051
TTG
Fn
 9633 . . . 9655
+
Transgenic Insert





TI-1052
TTG
Fn
 9644 . . . 9666

Transgenic Insert





TI-1053
TTC
Fn
 9665 . . . 9687

Transgenic Insert





TI-1054
TTG
Fn
 9694 . . . 9716
+
Transgenic Insert





TI-1055
TTC
Fn
 9701 . . . 9723
+
Transgenic Insert





TI-1056
TTC
Fn
 9704 . . . 9726
+
Transgenic Insert





TI-1057
TTCC
Lb_V1
 9705 . . . 9727
+
Transgenic Insert





TI-1058
TTA
Fn
 9711 . . . 9733
+
Transgenic Insert





TI-1059
TCCA
Lb_V1
 9695 . . . 9717

Transgenic Insert





TI-1060
TTC
Fn
 9702 . . . 9724

Transgenic Insert





TI-1061
TCCA
Lb_V1
 9715 . . . 9737

Transgenic Insert





TI-1062
TTCA
Lb_V1
 9727 . . . 9749

Transgenic Insert





TI-1063
TTC
Fn
 9728 . . . 9750

Transgenic Insert





TI-1064
TTG
Fn
 9758 . . . 9780
+
Transgenic Insert





TI-1065
TTC
Fn
 9770 . . . 9792
+
Transgenic Insert





TI-1066
TTG
Fn
 9749 . . . 9771

Transgenic Insert





TI-1067
TTC
Fn
 9773 . . . 9795
+
Transgenic Insert





TI-1068
TTCA
Lb_V1
 9774 . . . 9796
+
Transgenic Insert





TI-1069
TTG
Fn
 9757 . . . 9779

Transgenic Insert





TI-1070
TTCG
Lb_V1
 9761 . . . 9783

Transgenic Insert





TI-1071
TTC
Fn
 9762 . . . 9784

Transgenic Insert





TI-1072
TCCG
Lb_V1
 9765 . . . 9787

Transgenic Insert





TI-1073
TTCC
Lb_V1
 9766 . . . 9788

Transgenic Insert





TI-1074
TTC
Fn
 9767 . . . 9789

Transgenic Insert





TI-1075
TTC/
Fn/Lb_V1/
 9773 . . . 9795

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1076
TTC
Fn
 9803 . . . 9825
+
Transgenic Insert





TI-1077
TTG
Fn
 9782 . . . 9804

Transgenic Insert





TI-1078
TTCA
Lb_V1
 9804 . . . 9826
+
Transgenic Insert





TI-1079
TTG
Fn
 9812 . . . 9834
+
Transgenic Insert





TI-1080
TTG
Fn
 9797 . . . 9819

Transgenic Insert





TI-1081
TTC
Fn
 9800 . . . 9822

Transgenic Insert





TI-1082
TTC
Fn
 9830 . . . 9852
+
Transgenic Insert





TI-1083
TTCC
Lb_V1
 9831 . . . 9853
+
Transgenic Insert





TI-1084
TCCA
Lb_V1
 9832 . . . 9854
+
Transgenic Insert





TI-1085
TTG
Fn
 9813 . . . 9835

Transgenic Insert





TI-1086
TTC
Fn
 9837 . . . 9859
+
Transgenic Insert





TI-1087
TTCA
Lb_V1
 9838 . . . 9860
+
Transgenic Insert





TI-1088
TCCA
Lb_V1
 9821 . . . 9843

Transgenic Insert





TI-1089
TTCC
Lb_V1
 9822 . . . 9844

Transgenic Insert





TI-1090
TTC
Fn
 9823 . . . 9845

Transgenic Insert





TI-1091
TATG
Lb_V2
 9846 . . . 9868
+
Transgenic Insert





TI-1092
TTA
Fn
 9864 . . . 9886
+
Transgenic Insert





TI-1093
TTG
Fn
 9843 . . . 9865

Transgenic Insert





TI-1094
TCCA
Lb_V1
 9856 . . . 9878

Transgenic Insert





TI-1095
TTG
Fn
 9899 . . . 9921
+
Transgenic Insert





TI-1096
TTCA
Lb_V1
 9887 . . . 9909

Transgenic Insert





TI-1097
TTC
Fn
 9888 . . . 9910

Transgenic Insert





TI-1098
TTG
Fn
 9912 . . . 9934
+
Transgenic Insert





TI-1099
TTG
Fn
 9893 . . . 9915

Transgenic Insert





TI-1100
TTG
Fn
 9903 . . . 9925

Transgenic Insert





TI-1101
TTG
Fn
 9936 . . . 9958
+
Transgenic Insert





TI-1102
TTC
Fn
 9941 . . . 9963
+
Transgenic Insert





TI-1103
TTCA
Lb_V1
 9932 . . . 9954

Transgenic Insert





TI-1104
TTC
Fn
 9933 . . . 9955

Transgenic Insert





TI-1105
TCCC
Lb V1
 9943 . . . 9965

Transgenic Insert





TI-1106
TTC/
Fn/Lb_V1/
 9965 . . . 9987
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1107
TTCA
Lb_V1
 9966 . . . 9988
+
Transgenic Insert





TI-1108
TTCA
Lb_V1
 9952 . . . 9974

Transgenic Insert





TI-1109
TTC
Fn
 9975 . . . 9997
+
Transgenic Insert





TI-1110
TTC
Fn
 9953 . . . 9975

Transgenic Insert





TI-1111
TTG
Fn
 9956 . . . 9978

Transgenic Insert





TI-1112
TTCC
Lb_V1
 9969 . . . 9991

Transgenic Insert





TI-1113
TTC
Fn
 9970 . . . 9992

Transgenic Insert





TI-1114
TTA/
Fn/Lb_V1/
 9974 . . . 9996

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1115
TTA
Fn
10008 . . . 10030
+
Transgenic Insert





TI-1116
TATC
Lb_V2
10019 . . . 10041
+
Transgenic Insert





TI-1117
TTC
Fn
10023 . . . 10045
+
Transgenic Insert





TI-1118
TTCA
Lb_V1
10024 . . . 10046
+
Transgenic Insert





TI-1119
TATG
Lb_V2
10031 . . . 10053
+
Transgenic Insert





TI-1120
TTG
Fn
10010 . . . 10032

Transgenic Insert





TI-1121
TTC
Fn
10041 . . . 10063
+
Transgenic Insert





TI-1122
TTG
Fn
10044 . . . 10066
+
Transgenic Insert





TI-1123
TTG
Fn
10050 . . . 10072
+
Transgenic Insert





TI-1124
TTA
Fn
10060 . . . 10082
+
Transgenic Insert





TI-1125
TTC
Fn
10064 . . . 10086
+
Transgenic Insert





TI-1126
TCCA
Lb_V1
10042 . . . 10064

Transgenic Insert





TI-1127
TTG
Fn
10067 . . . 10089
+
Transgenic Insert





TI-1128
TTG
Fn
10052 . . . 10074

Transgenic Insert





TI-1129
TTCG
Lb_V1
10055 . . . 10077

Transgenic Insert





TI-1130
TTC
Fn
10056 . . . 10078

Transgenic Insert





TI-1131
TTG
Fn
10072 . . . 10094

Transgenic Insert





TI-1132
TTC
Fn
10094 . . . 10116
+
Transgenic Insert





TI-1133
TTCG
Lb_V1
10095 . . . 10117
+
Transgenic Insert





TI-1134
TTG
Fn
10079 . . . 10101

Transgenic Insert





TI-1135
TTC
Fn
10103 . . . 10125
+
Transgenic Insert





TI-1136
TTCA
Lb_V1
10104 . . . 10126
+
Transgenic Insert





TI-1137
TCCC
Lb_V1
10118 . . . 10140
+
Transgenic Insert





TI-1138
TTG
Fn
10099 . . . 10121

Transgenic Insert





TI-1139
TCCA
Lb_V1
10124 . . . 10146
+
Transgenic Insert





TI-1140
TTG
Fn
10137 . . . 10159
+
Transgenic Insert





TI-1141
TTC
Fn
10142 . . . 10164
+
Transgenic Insert





TI-1142
TTCG
Lb_V1
10143 . . . 10165
+
Transgenic Insert





TI-1143
TCCG
Lb_V1
10161 . . . 10183
+
Transgenic Insert





TI-1144
TTG
Fn
10175 . . . 10197
+
Transgenic Insert





TI-1145
TTC
Fn
10182 . . . 10204
+
Transgenic Insert





TI-1146
TTC
Fn
10185 . . . 10207
+
Transgenic Insert





TI-1147
TTG/
Fn/Lb_V1/
10169 . . . 10191

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1148
TTG
Fn
10188 . . . 10210

Transgenic Insert





TI-1149
TTC
Fn
10218 . . . 10240
+
Transgenic Insert





TI-1150
TTCA
Lb_V1
10219 . . . 10241
+
Transgenic Insert





TI-1151
TCCC
Lb_V1
10198 . . . 10220

Transgenic Insert





TI-1152
TTG
Fn
10205 . . . 10227

Transgenic Insert





TI-1153
TTG
Fn
10214 . . . 10236

Transgenic Insert





TI-1154
TCCA
Lb_V1
10239 . . . 10261
+
Transgenic Insert





TI-1155
TTG
Fn
10245 . . . 10267
+
Transgenic Insert





TI-1156
TTG
Fn
10225 . . . 10247

Transgenic Insert





TI-1157
TTG
Fn
10265 . . . 10287
+
Transgenic Insert





TI-1158
TTG
Fn
10247 . . . 10269

Transgenic Insert





TI-1159
TTA
Fn
10277 . . . 10299
+
Transgenic Insert





TI-1160
TCCA
Lb_V1
10264 . . . 10286

Transgenic Insert





TI-1161
TTA
Fn
10270 . . . 10292

Transgenic Insert





TI-1162
TTG
Fn
10277 . . . 10299

Transgenic Insert





TI-1163
TTC
Fn
10313 . . . 10335
+
Transgenic Insert





TI-1164
TTCA
Lb_V1
10314 . . . 10336
+
Transgenic Insert





TI-1165
TTG/
Fn/Lb_V1/
10315 . . . 10337

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1166
TTC
Fn
10325 . . . 10347

Transgenic Insert





TI-1167
TCCC
Lb_V1
10365 . . . 10387
+
Transgenic Insert





TI-1168
TATA
Lb_V2
10351 . . . 10373

Transgenic Insert





TI-1169
TTA
Fn
10376 . . . 10398
+
Transgenic Insert





TI-1170
TATA
Lb_V2
10378 . . . 10400
+
Transgenic Insert





TI-1171
TTCA
Lb_V1
10360 . . . 10382

Transgenic Insert





TI-1172
TTC
Fn
10361 . . . 10383

Transgenic Insert





TI-1173
TTC/
Fn/Lb_V1/
10370 . . . 10392

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1174
TTG
Fn
10404 . . . 10426
+
Transgenic Insert





TI-1175
TCCA
Lb_V1
10399 . . . 10421

Transgenic Insert





TI-1176
TTG/
Fn/Lb_V1/
10421 . . . 10443
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1177
TTC
Fn
10406 . . . 10428

Transgenic Insert





TI-1178
TTG
Fn
10417 . . . 10439

Transgenic Insert





TI-1179
TATC
Lb_V2
10420 . . . 10442

Transgenic Insert





TI-1180
TTCC
Lb_V1
10426 . . . 10448

Transgenic Insert





TI-1181
TTC/
Fn/Lb_V1/
10427 . . . 10449

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1182
TTCG
Lb_V1
10439 . . . 10461

Transgenic Insert





TI-1183
TTC
Fn
10440 . . . 10462

Transgenic Insert





TI-1184
TCCC
Lb_V1
10455 . . . 10477

Transgenic Insert





TI-1185
TCCA
Lb_V1
10463 . . . 10485

Transgenic Insert





TI-1186
TTCC
Lb_V1
10464 . . . 10486

Transgenic Insert





TI-1187
TTC/
Fn/Lb_V1/
10465 . . . 10487

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1188
TTC
Fn
10496 . . . 10518
+
Transgenic Insert





TI-1189
TCCC
Lb_V1
10524 . . . 10546
+
Transgenic Insert





TI-1190
TTA
Fn
10521 . . . 10543

Transgenic Insert





TI-1191
TTA
Fn
10546 . . . 10568
+
Transgenic Insert





TI-1192
TTA
Fn
10525 . . . 10547

Transgenic Insert





TI-1193
TTA
Fn
10550 . . . 10572
+
Transgenic Insert





TI-1194
TTA
Fn
10529 . . . 10551

Transgenic Insert





TI-1195
TTA
Fn
10554 . . . 10576
+
Transgenic Insert





TI-1196
TTA
Fn
10533 . . . 10555

Transgenic Insert





TI-1197
TTA
Fn
10558 . . . 10580
+
Transgenic Insert





TI-1198
TTC
Fn
10586 . . . 10608
+
Transgenic Insert





TI-1199
TTCA
Lb_V1
10587 . . . 10609
+
Transgenic Insert





TI-1200
TTG/
Fn/Lb_V1/
10594 . . . 10616
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1201
TTA/
Fn/Lb_V1/
10598 . . . 10620
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1202
TTC/
Fn/Lb_V1/
10602 . . . 10624
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1203
TTCC
Lb_V1
10603 . . . 10625
+
Transgenic Insert





TI-1204
TTA/
Fn/Lb_V1/
10642 . . . 10664
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1205
TATA
Lb_V2
10644 . . . 10666
+
Transgenic Insert





TI-1206
TTG/
Fn/Lb_V1/
10673 . . . 10695
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1207
TTG/
Fn/Lb_V1/
10678 . . . 10700
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1208
TTG/
Fn/Lb_V1/
10684 . . . 10706
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1209
TTC/
Fn/Lb_V1/
10688 . . . 10710
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1210
TTCC
Lb_V1
10689 . . . 10711
+
Transgenic Insert





TI-1211
TCCA
Lb_V1
10690 . . . 10712
+
Transgenic Insert





TI-1212
TTG
Fn
10696 . . . 10718
+
Transgenic Insert





TI-1213
TCCA
Lb_V1
10704 . . . 10726
+
Transgenic Insert





TI-1214
TATC
Lb_V2
10714 . . . 10736
+
Transgenic Insert





TI-1215
TTA
Fn
10693 . . . 10715

Transgenic Insert





TI-1216
TTA/
Fn/Lb_V1/
10700 . . . 10722

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1217
TTG/
Fn/Lb_V1/
10723 . . . 10745
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1218
TTG
Fn
10710 . . . 10732

Transgenic Insert





TI-1219
TTA/
Fn/Lb_V1/
10713 . . . 10735

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1220
TTA/
Fn/Lb_V1/
10717 . . . 10739

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1221
TTA
Fn
10722 . . . 10744

Transgenic Insert





TI-1222
TTA/
Fn/Lb_V1/
10725 . . . 10747

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1223
TTA
Fn
10747 . . . 10769
+
Transgenic Insert





TI-1224
TTG/
Fn/Lb_V1/
10756 . . . 10778
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1225
TTC/
Fn/Lb_V1/
10761 . . . 10783
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1226
TATA
Lb_V2
10745 . . . 10767

Transgenic Insert





TI-1227
TATA
Lb_V2
10772 . . . 10794
+
Transgenic Insert





TI-1228
TATG
Lb_V2
10774 . . . 10796
+
Transgenic Insert





TI-1229
TCCA
Lb_V1
10759 . . . 10781

Transgenic Insert





TI-1230
TTG/
Fn/Lb_V1/
10784 . . . 10806
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1231
TTG
Fn
10792 . . . 10814
+
Transgenic Insert





TI-1232
TTG/
Fn/Lb_V1/
10796 . . . 10818
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1233
TTG/
Fn/Lb_V1/
10825 . . . 10847
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1234
TTG
Fn
10881 . . . 10903
+
Transgenic Insert





TI-1235
TTG/
Fn/Lb_V1/
10886 . . . 10908
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1236
TTG
Fn
10871 . . . 10893

Transgenic Insert





TI-1237
TTG/
Fn/Lb_V1/
10874 . . . 10896

Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1238
TTA
Fn
10897 . . . 10919

Transgenic Insert





TI-1239
TTA
Fn
10922 . . . 10944
+
Transgenic Insert





TI-1240
TTG
Fn
10943 . . . 10965
+
Transgenic Insert





TI-1241
TTCA
Lb_V1
10934 . . . 10956

Transgenic Insert





TI-1242
TTC
Fn
10935 . . . 10957

Transgenic Insert





TI-1243
TTA
Fn
10948 . . . 10970

Transgenic Insert





TI-1244
TTG/
Fn/Lb_V1/
10985 . . . 11007
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1245
TTCG
Lb_V1
10981 . . . 11003

Transgenic Insert





TI-1246
TTC/
Fn/Lb_V1/
10982 . . . 11004

Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1247
TTA/
Fn/Lb_V1/
10986 . . . 11008

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1248
TTCG
Lb_V1
10996 . . . 11018

Transgenic Insert





TI-1249
TTC
Fn
10997 . . . 11019

Transgenic Insert





TI-1250
TTC/
Fn/Lb_V1/
11019 . . . 11041
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1251
TTCC
Lb_V1
11020 . . . 11042
+
Transgenic Insert





TI-1252
TCCG
Lb_V1
11021 . . . 11043
+
Transgenic Insert





TI-1253
TTC
Fn
11003 . . . 11025

Transgenic Insert





TI-1254
TTA
Fn
11026 . . . 11048
+
Transgenic Insert





TI-1255
TTA
Fn
11006 . . . 11028

Transgenic Insert





TI-1256
TTG/
Fn/Lb_V1/
11036 . . . 11058
+
Transgenic Insert



TTTG/
Lb_V2/Lb






TTTG









TI-1257
TTA/
Fn/Lb_V1/
11040 . . . 11062
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1258
TTG
Fn
11043 . . . 11065
+
Transgenic Insert





TI-1259
TTC/
Fn/Lb_V1/
11048 . . . 11070
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1260
TTCG
Lb_V1
11049 . . . 11071
+
Transgenic Insert





TI-1261
TATA
Lb_V2
11028 . . . 11050

Transgenic Insert





TI-1262
TTA/
Fn/Lb_V1/
11030 . . . 11052

Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1263
TATA
Lb_V2
11055 . . . 11077
+
Transgenic Insert





TI-1264
TCCG
Lb_V1
11039 . . . 11061

Transgenic Insert





TI-1265
TTA
Fn
11046 . . . 11068

Transgenic Insert





TI-1266
TTA/
Fn/Lb_V1/
11105 . . . 11127
+
Transgenic Insert



TTTA/
Lb_V2/Lb






TTTA









TI-1267
TATA
Lb_V2
11107 . . . 11129
+
Transgenic Insert





TI-1268
TTC/
Fn/Lb_V1/
11170 . . . 11192
+
Transgenic Insert



TTTC/
Lb_V2/Lb






TTTC









TI-1269
TCCA
Lb_V1
11174 . . . 11196
+
Transgenic Insert





TI-1270
TTA
Fn
11173 . . . 11195

Transgenic Insert





3J-1
TTG
Fn
11179 . . . 11201
+
3′ Flanking Genomic DNA





3J-2
TTG
Fn
11195 . . . 11217
+
3′ Flanking Genomic DNA





3F-1
TTG
Fn
11202 . . . 11224
+
3′ Flanking Genomic DNA





3F-2
TTC
Fn
11207 . . . 11229
+
3′ Flanking Genomic DNA





3F-3
TTCG
Lb_V1
11203 . . . 11225

3′ Flanking Genomic DNA





3F-4
TTC/
Fn/Lb_V1/
11204 . . . 11226

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-5
TTA
Fn
11255 . . . 11277
+
3′ Flanking Genomic DNA





3F-6
TTA/
Fn/Lb_V1/
11274 . . . 11296
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-7
TTC
Fn
11277 . . . 11299
+
3′ Flanking Genomic DNA





3F-8
TTA
Fn
11282 . . . 11304
+
3′ Flanking Genomic DNA





3F-9
TTG/
Fn/Lb_V1/
11268 . . . 11290

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-10
TTG
Fn
11273 . . . 11295

3′ Flanking Genomic DNA





3F-11
TTC/
Fn/Lb_V1/
11279 . . . 11301

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-12
TTA/
Fn/Lb_V1/
11355 . . . 11377
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-13
TTA/
Fn/Lb_V1/
11355 . . . 11377

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-14
TTA/
Fn/Lb_V1/
11380 . . . 11402
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-15
TTA/
Fn/Lb_V1/
11409 . . . 11431
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-16
TTA
Fn
11412 . . . 11434
+
3′ Flanking Genomic DNA





3F-17
TTC/
Fn/Lb_V1/
11416 . . . 11438
+
3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-18
TTCA
Lb_V1
11417 . . . 11439
+
3′ Flanking Genomic DNA





3F-19
TTA
Fn
11421 . . . 11443
+
3′ Flanking Genomic DNA





3F-20
TATC
Lb_V2
11423 . . . 11445
+
3′ Flanking Genomic DNA





3F-21
TTCA
Lb_V1
11405 . . . 11427

3′ Flanking Genomic DNA





3F-22
TTC
Fn
11406 . . . 11428

3′ Flanking Genomic DNA





3F-23
TTG
Fn
11430 . . . 11452
+
3′ Flanking Genomic DNA





3F-24
TTG
Fn
11435 . . . 11457
+
3′ Flanking Genomic DNA





3F-25
TTG/
Fn/Lb_V1/
11415 . . . 11437

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-26
TTC/
Fn/Lb_V1/
11446 . . . 11468
+
3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-27
TTG
Fn
11426 . . . 11448

3′ Flanking Genomic DNA





3F-28
TTC
Fn
11455 . . . 11477
+
3′ Flanking Genomic DNA





3F-29
TTA
Fn
11440 . . . 11462

3′ Flanking Genomic DNA





3F-30
TTA/
Fn/Lb_V1/
11465 . . . 11487
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-31
TTA
Fn
11450 . . . 11472

3′ Flanking Genomic DNA





3F-32
TTA
Fn
11454 . . . 11476

3′ Flanking Genomic DNA





3F-33
TTC
Fn
11509 . . . 11531

3′ Flanking Genomic DNA





3F-34
TTA/
Fn/Lb_V1/
11508 . . . 11530

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-35
TTA
Fn
11555 . . . 11577
+
3′ Flanking Genomic DNA





3F-36
TATA
Lb_V2
11557 . . . 11579
+
3′ Flanking Genomic DNA





3F-37
TTA
Fn
11561 . . . 11583
+
3′ Flanking Genomic DNA





3F-38
TTG
Fn
11576 . . . 11598
+
3′ Flanking Genomic DNA





3F-39
TTG
Fn
11582 . . . 11604
+
3′ Flanking Genomic DNA





3F-40
TCCA
Lb_V1
11560 . . . 11582

3′ Flanking Genomic DNA





3F-41
TTG
Fn
11585 . . . 11607
+
3′ Flanking Genomic DNA





3F-42
TATA
Lb_V2
11580 . . . 11602

3′ Flanking Genomic DNA





3F-43
TTA/
Fn/Lb_V1/
11582 . . . 11604

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-44
TTA
Fn
11618 . . . 11640
+
3′ Flanking Genomic DNA





3F-45
TTG
Fn
11622 . . . 11644

3′ Flanking Genomic DNA





3F-46
TTG
Fn
11628 . . . 11650

3′ Flanking Genomic DNA





3F-47
TTG
Fn
11636 . . . 11658

3′ Flanking Genomic DNA





3F-48
TTG/
Fn/Lb_V1/
11658 . . . 11680
+
3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-49
TTG
Fn
11641 . . . 11663

3′ Flanking Genomic DNA





3F-50
TTC
Fn
11644 . . . 11666

3′ Flanking Genomic DNA





3F-51
TTC/
Fn/Lb_V1/
11683 . . . 11705
+
3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-52
TTCC
Lb_V1
11684 . . . 11706
+
3′ Flanking Genomic DNA





3F-53
TTA
Fn
11663 . . . 11685

3′ Flanking Genomic DNA





3F-54
TCCA
Lb_V1
11685 . . . 11707
+
3′ Flanking Genomic DNA





3F-55
TTA
Fn
11688 . . . 11710
+
3′ Flanking Genomic DNA





3F-56
TTA
Fn
11667 . . . 11689

3′ Flanking Genomic DNA





3F-57
TTG
Fn
11675 . . . 11697

3′ Flanking Genomic DNA





3F-58
TTG
Fn
11693 . . . 11715

3′ Flanking Genomic DNA





3F-59
TATG
Lb_V2
11700 . . . 11722

3′ Flanking Genomic DNA





3F-60
TTG/
Fn/Lb_V1/
11716 . . . 11738

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-61
TTG
Fn
11763 . . . 11785
+
3′ Flanking Genomic DNA





3F-62
TTA
Fn
11757 . . . 11779

3′ Flanking Genomic DNA





3F-63
TTA
Fn
11763 . . . 11785

3′ Flanking Genomic DNA





3F-64
TTA/
Fn/Lb_V1/
11788 . . . 11810
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-65
TTG
Fn
11795 . . . 11817
+
3′ Flanking Genomic DNA





3F-66
TTA
Fn
11800 . . . 11822
+
3′ Flanking Genomic DNA





3F-67
TATA
Lb_V2
11802 . . . 11824
+
3′ Flanking Genomic DNA





3F-68
TTCA
Lb_V1
11784 . . . 11806

3′ Flanking Genomic DNA





3F-69
TTC/
Fn/Lb_V1/
11785 . . . 11807

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-70
TATG
Lb_V2
11802 . . . 11824

3′ Flanking Genomic DNA





3F-71
TTA/
Fn/Lb_V1/
11835 . . . 11857
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-72
TATA
Lb_V2
11844 . . . 11866
+
3′ Flanking Genomic DNA





3F-73
TCCG
Lb_V1
11839 . . . 11861

3′ Flanking Genomic DNA





3F-74
TTG/
Fn/Lb_V1/
11870 . . . 11892
+
3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-75
TTCA
Lb_V1
11849 . . . 11871

3′ Flanking Genomic DNA





3F-76
TTC
Fn
11850 . . . 11872

3′ Flanking Genomic DNA





3F-77
TTA/
Fn/Lb_V1/
11868 . . . 11890

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-78
TTG/
Fn/Lb_V1/
11881 . . . 11903

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-79
TATC
Lb_V2
11917 . . . 11939
+
3′ Flanking Genomic DNA





3F-80
TATC
Lb_V2
11921 . . . 11943
+
3′ Flanking Genomic DNA





3F-81
TTA
Fn
11925 . . . 11947
+
3′ Flanking Genomic DNA





3F-82
TTC
Fn
11935 . . . 11957
+
3′ Flanking Genomic DNA





3F-83
TTCC
Lb_V1
11936 . . . 11958
+
3′ Flanking Genomic DNA





3F-84
TTG
Fn
11924 . . . 11946

3′ Flanking Genomic DNA





3F-85
TTG
Fn
11929 . . . 11951

3′ Flanking Genomic DNA





3F-86
TTG
Fn
11934 . . . 11956

3′ Flanking Genomic DNA





3F-87
TTC/
Fn/Lb_V1/
11937 . . . 11959

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-88
TATG
Lb V2
11967 . . . 11989

3′ Flanking Genomic DNA





3F-89
TTA/
Fn/Lb_V1/
11969 . . . 11991

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-90
TTG
Fn
12001 . . . 12023
+
3′ Flanking Genomic DNA





3F-91
TTA/
Fn/Lb_V1/
12009 . . . 12031
+
3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-92
TATA
Lb_V2
12011 . . . 12033
+
3′ Flanking Genomic DNA





3F-93
TTA
Fn
11996 . . . 12018

3′ Flanking Genomic DNA





3F-94
TTA/
Fn/Lb_V1/
12003 . . . 12025

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-95
TTG
Fn
12033 . . . 12055
+
3′ Flanking Genomic DNA





3F-96
TTG/
Fn/Lb_V1/
12014 . . . 12036

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-97
TTA
Fn
12019 . . . 12041

3′ Flanking Genomic DNA





3F-98
TTG/
Fn/Lb_V1/
12034 . . . 12056

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-99
TTC
Fn
12076 . . . 12098
+
3′ Flanking Genomic DNA





3F-100
TTCG
Lb_V1
12077 . . . 12099
+
3′ Flanking Genomic DNA





3F-101
TATG
Lb_V2
12059 . . . 12081

3′ Flanking Genomic DNA





3F-102
TTA/
Fn/Lb_V1/
12061 . . . 12083

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-103
TTC
Fn
12103 . . . 12125
+
3′ Flanking Genomic DNA





3F-104
TTG
Fn
12106 . . . 12128
+
3′ Flanking Genomic DNA





3F-105
TTG/
Fn/Lb_V1/
12088 . . . 12110

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-106
TTA
Fn
12119 . . . 12141
+
3′ Flanking Genomic DNA





3F-107
TTC
Fn
12123 . . . 12145
+
3′ Flanking Genomic DNA





3F-108
TTCC
Lb_V1
12124 . . . 12146
+
3′ Flanking Genomic DNA





3F-109
TCCA
Lb V1
12125 . . . 12147
+
3′ Flanking Genomic DNA





3F-110
TATG
Lb_V2
12103 . . . 12125

3′ Flanking Genomic DNA





3F-111
TTA/
Fn/Lb_V1/
12105 . . . 12127

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-112
TTG/
Fn/Lb_V1/
12109 . . . 12131

3′ Flanking Genomic DNA



TTTG/
Lb_V2/Lb






TTTG









3F-113
TCCC
Lb_V1
12113 . . . 12135

3′ Flanking Genomic DNA





3F-114
TTCC
Lb V1
12121 . . . 12143

3′ Flanking Genomic DNA





3F-115
TTC/
Fn/Lb_V1/
12122 . . . 12144

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









3F-116
TTG
Fn
12126 . . . 12148

3′ Flanking Genomic DNA





3F-117
TATG
Lb_V2
12131 . . . 12153

3′ Flanking Genomic DNA





3F-118
TTA/
Fn/Lb_V1/
12133 . . . 12155

3′ Flanking Genomic DNA



TTTA/
Lb_V2/Lb






TTTA









3F-119
TTCC
Lb_V1
12146 . . . 12168

3′ Flanking Genomic DNA





3F-120
TTC/
Fn/Lb_V1/
12147 . . . 12169

3′ Flanking Genomic DNA



TTTC/
Lb_V2/Lb






TTTC









gRNAs which include a gRNA repeat of GAATTTCTACTAAGTGTAGAT (SEQ ID NO:49) for LbCas12a, or GTAATTTCTACTGTTGTAGAT (SEQ ID NO:50) for FnCas12a+an OgRRS sequence (as shown in the fourth column of Table 18)+TTTTTTT (poly-T transcript termination region) can be used to target the Cas12a nuclease to cut within both the OgRRS and CgRRS sequences. Illustrative examples of such gRNAs for FnCas12a are shown in Table 19, wherein the gRNA repeat of GTAATTTCTACTGTTGTAGAT is underlined, and the poly-T transcript termination sequence of TTTTTTT is shown in italic font.









TABLE 19







Illustrative examples of gRNAs useful in 


targeting FnCas12a nuclease








gRNA
Sequence





gRNA_5F-65

GTAATTTCTACTGTTGTAGATGTTAAATAAA



(SEQ ID 
TAAAGAGGGTAGGTTTTTTT


NO: 51)






gRNA_TI-605

GTAATTTCTACTGTTGTAGATGTCATTGGAC



(SEQ ID 
TGAACACGAGTGTTTTTTTT


NO: 52)






gRNA_TI-934

GTAATTTCTACTGTTGTAGATGGCCGTGACG



(SEQ ID 
GCCACGAGCGAACTTTTTTT


NO: 53)






gRNA_TI-946

GTAATTTCTACTGTTGTAGATGCGCGCCAAT



(SEQ ID
TAAATTCAACACGTTTTTTT


NO: 54)






gRNA_3F-41

GTAATTTCTACTGTTGTAGATGAGTATTACA



(SEQ ID 
GTAGAGGCTATAATTTTTTT


NO: 55)









Any of the OgRRS sequences presented in Table 18 can be used alternatively as a site to insert a CgRRS that is designed using a different OgRRS. For example, a CgRRS can be inserted into a flanking sequence to allow for the excision of the entire transgenic insertion of event Gm_CSM63714. To illustrate this approach, OgRRS 3F-41 is selected as the OgRRS that can be used to design a corresponding CgRRS 3F-41 comprising DNA fragment, and OgRRS 5F-65 is selected as the target site into which the CgRRS 3F-41 comprising DNA fragment is inserted. Using a Cas12a editing system such as with the Fn Cas12a endonuclease, the OgRRS 5F-65 site is targeted using the gRNA, gRNA_5F-65 presented in Table 19 to cut within the OgRRS 5F-65 site. The CgRRS 3F-41 comprising DNA fragment that comprises the OgRRS 3F-41 target site is then inserted within the cut site that was introduced into the OgRRS 5F-65 sequence. After selection of a transgenic event comprising the introduced CgRRS 3F-41 site, the event can be bred into another germplasm. When desired, the transgenic insert of Gm_CSM63714 can be excised from the plant using a Cas12a editing system and the gRNA, gRNA_3F-41 as presented in Table 19.


Any of the OgRRS sequences presented in Table 18 that is within the 5′ or 3′-flanking genomic sequences of event Gm_CSM63714 can be used as a site to insert a CgRRS comprising DNA fragment, comprising an OgRRS sequence that is present between the first (DMO) and the second (PAT) expression cassettes, or between the third (FT_Tv7) and the fourth (TDO) expression cassettes of the transgenic insert, to permit the excision or removal of the first (DMO) or the fourth (TDO) expression cassette, which are next to the 5′ or 3′ flanking genomic sequence, respectively, using a single gRNA. Similar methods could also be used to remove expression cassettes that are in between the first and the fourth expression cassettes (i.e., the second or the third expression cassettes, or the PAT or the FT_Tv7 cassettes). To illustrate this approach, OgRRS TI-946 is selected as the OgRRS that will be used to design a corresponding CgRRS TI-946 comprising DNA fragment, and OgRRS 3F-41 is selected as the target site into which the CgRRS TI-946 comprising DNA fragment is inserted. Using a Cas12a editing system such as the FnCas12a endonuclease, the OgRRS 3F-41 site is targeted using the gRNA, gRNA_3F-41 presented in Table 19 to cut within the OgRRS 3F-41 site. The CgRRS TI-946 comprising DNA fragment that comprises the OgRRS TI-946 target site is then inserted within the cut site that is induced into the OgRRS 3F-41 sequence. After selection of a transgenic event comprising the introduced CgRRS TI-946 site, the event can be bred into another germplasm. When desired, the TDO expression cassette which expresses the triketone dioxygenase protein can be excised from the plant using a Cas12a editing system and the gRNA, gRNA_TI-946 as presented in Table 19.


The CgRRS can be introduced into the transgenic insertion locus through multiple methods using a CRISPR system. For example, a CRISPR system can be utilized for targeting 5′ insertion of a blunt-end double-stranded DNA fragment into a genomic target site of interest such as an OgRRS that is not the OgRRS that has been selected for the design of the CgRRS. The CRISPR-mediated endonuclease activity can introduce a double stand break (DSB) in the selected genomic target site and DNA repair, such as microhomology-driven nonhomologous end-joining DNA repair, results in insertion of the blunt-end double-stranded DNA fragment into the DSB. Blunt-end double-stranded DNA fragments can be designed with 1-10 bp of microhomology, on both the 5′ and 3′ ends of the DNA fragment, that correspond to the 5′ and 3′-flanking sequence at the cut site of the protospacer in the genomic target site.


The CRISPR system can be introduced into event Gm_CSM63714 by several methods. One or more expression cassettes encoding the gRNA and/or CRISPR associated protein components of a Type I, Type II, Type III, Type IV, Type V, or Type VI CRISPR-Cas system is transiently introduced into a cell. The introduced one or more expression cassettes encoding the gRNA and/or CRISPR associated protein, along with a DNA fragment comprising the CgRRS is provided in sufficient quantity to modify the cell but does not persist after a contemplated period of time has passed or after one or more cell divisions. In such embodiments, no further steps are needed to remove or segregate the one or more expression cassettes encoding the gRNA and/or CRISPR associated protein from the modified cell. Double-stranded DNA fragments can also be transiently introduced into a cell along with one or more expression cassettes encoding the gRNA and/or CRISPR associated protein. The introduced double-stranded DNA fragments are provided in sufficient quantity to modify the cell but do not persist after a contemplated period of time has passed or after one or more cell divisions.


Alternatively, an expression construct comprising one or more expression cassettes for the expression of one or more gRNAs, and an expression construct encoding a Type I, Type II, Type III, Type IV, Type V, or Type VI CRISPR associated protein is stably transformed into event Gm_CSM63714 to modify the plant cell in the targeted region of the transgene insertion locus, to introduce the CgRRS within the desired target locus.


Example 9, Modification of Soybean Event Gm_CSM63714 with Genome Editing Techniques Using Two Guide RNAs

This example describes how one may excise the transgenic insertion present in soybean event Gm_CSM63714 using CRISPR editing systems comprising two guide RNAs by genome editing methods. Excision of the event Gm_CSM63714 transgenic insertion or expression cassettes within SEQ ID NO:9 or SEQ ID NO:10 can be performed through genome editing using a variety of methods. In one embodiment, Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) editing systems comprising a CRISPR associated protein and two cognate guide RNAs may be used for targeted excision. The CRISPR-associated protein is an RNA guided nuclease and can be selected from a Type I CRISPR-associated protein, a Type II CRISPR-associated protein, a Type III CRISPR-associated protein, a Type IV CRISPR-associated protein, Type V CRISPR-associated protein, or a Type VI CRISPR-associated protein, such as but not limited to, Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9 (also known as Csn1 and Csx12), Cas10, Cas 12a (also known as Cpf1), Csy1, Csy2, Csy3, Cse1, Cse2, Csc1, Csc2, Csa5, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, Csf4, CasX, CasY, and Mad7. The CRISPR-associated protein and two guide RNAs (gRNA) can be introduced into a plant cell comprising the soybean event Gm_CSM63714 to target a specific sequence within the transgene insertion locus. In one embodiment, the CRISPR nuclease system cleaves at two distinct guide RNA hybridization sites thereby permitting the excision of the intervening sequence. Following DNA cleavage, the genomic sequence can be repaired via a double strand break repair pathway, which may include, for example, non-homologous end-joining (NHEJ), microhomology-mediated end joining (MMEJ), homologous recombination, synthesis-dependent strand annealing (SDSA), single-strand annealing (SSA), or a combination thereof, at the genomic target site.


Sequences corresponding to the 5′ and 3′ flanking genomic sequences, and the transgenic insert of event Gm_CSM63714 (presented as SEQ ID NOs:11, 12, and 9, respectively) and the 5′ and 3′ junction regions (presented as SEQ ID NOs:1-6) were scanned for potential guide RNA recognition sites which comprise a protospacer adjacent motif (PAM) site that will be recognized by a Cas12a endonuclease, operably linked to a guide RNA hybridization site, and the results are shown in Table 18. The identified gRNA recognition sites are located within the 5′ or 3′ flanking genomic sequence, within the 5′ or 3′ junction regions, or within the transgenic insertion.


Two functional guide RNAs (gRNAs) for an RNA guided nuclease system are created to target the event Gm_CSM63714 transgenic insertion locus in a manner that will permit the excision of a fragment of DNA corresponding to either the entire transgenic insertion of event Gm_CSM63714, or a fragment within the transgenic insertion of event Gm_CSM63714 such as an expression cassette or genetic element within the transgene cassette. Illustrative examples are described below using FnCas12a editing system (see Table 19), in which the gRNAs include a gRNA repeat of GTAATTTCTACTGTTGTAGAT (SEQ ID NO:50, underlined)+an OgRRS sequence (as shown in the fourth column of Table 18)+TTTTTTT (poly-T transcript termination region, italic) to target the FnCas12a nuclease to the gRNA recognition sites. Similar methods can be used to excise either the entire transgene insertion or a fragment within the transgene insertion such as an expression cassette by selecting gRNAs targeted to the specific regions. Alternatively, the LbCas12a editing systems can be used, in which the gRNAs include a gRNA repeat of GAATTTCTACTAAGTGTAGAT (SEQ ID NO:49)+an OgRRS sequence (as shown in the third column of Table 18)+TTTTTTT (poly-T transcript termination region).


To excise the entire transgenic insertion of event Gm_CSM63714, the first gRNA targets an area in the 5′ flanking genomic sequence such as 5F-65 (Table 18), and the second gRNA targets a region in the 3′ flanking genomic sequence such as 3F-41 (Table 18). A transfer DNA (T-DNA) construct suitable for use in Agrobacterium-mediated transformation is used. The T-DNA construct comprises several expression cassettes between a left border (LB) sequence and a right border (RB) sequence. The first expression cassette comprises a promoter that is operable in a plant cell operably linked to a polynucleotide encoding a Cas12a RNA guided nuclease. A second expression cassette comprises a promoter that is operable in a plant cell operably linked to a selection marker gene, such as aadA for conferring resistance to spectinomycin and/or streptomycin. The construct also comprises expression cassettes comprising Polymerase III promoters operable in a plant cell operably linked to polynucleotides encoding the two gRNAs gRNA_5F-65 and gRNA_3F-41 (Table 19).


To facilitate excision of a fragment within the transgenic insertion of event Gm_CSM63714 such as an expression cassette near the 3′ flanking genomic sequence (the TDO cassette), the first gRNA targets an area in the 3′ flanking genomic sequence such as 3F-41 (Table 18), and the second gRNA targets a region between the FT_Tv7 expression cassette and the TDO expression cassette such as TI-946 (Table 18). A transfer DNA (T-DNA) construct suitable for use in Agrobacterium-mediated transformation is used. The T-DNA construct comprises several expression cassettes between a left border (LB) sequence and a right border (RB) sequence. The first expression cassette comprises a promoter that is operable in a plant cell operably linked to a polynucleotide encoding a Cas12a RNA guided nuclease. A second expression cassette comprises a promoter that is operable in a plant cell operably linked to a selection marker gene, such as aadA for conferring resistance to spectinomycin and/or streptomycin. The construct also comprises expression cassettes comprising Polymerase III promoters operable in a plant cell operably linked to polynucleotides encoding the two gRNAs gRNA_3F-41 and gRNA_TI-946 (Table 19).


To facilitate excision of a fragment within the transgenic insertion of event Gm_CSM63714 such as FT_Tv7 expression cassette, the first gRNA targets a region between the PAT expression cassette and the FT_Tv7 expression cassette in the transgenic insert such as TI-605 (Table 18), and the second gRNA targets a region between the FT_Tv7 expression cassette and the TDO expression cassette such as TI-934 (Table 18). A transfer DNA (T-DNA) construct suitable for use in Agrobacterium-mediated transformation is used. The T-DNA construct comprises several expression cassettes between a left border (LB) sequence and a right border (RB) sequence. The first expression cassette comprises a promoter that is operable in a plant cell operably linked to a polynucleotide encoding a Cas12a RNA guided nuclease. A second expression cassette comprises a promoter that is operable in a plant cell operably linked to a selection marker gene, such as aadA for conferring resistance to spectinomycin and/or streptomycin. The construct also comprises expression cassettes comprising Polymerase III promoters operable in a plant cell operably linked to polynucleotides encoding the two gRNAs gRNA_TI-605 and gRNA_TI-934 (Table 19).


Following Agrobacterium-mediated transformation of soybean comprising event Gm_CSM63714, and upon expression of the integrated polynucleotides, the gRNAs guide the nuclease to each of the two target sites at the transgenic insertion locus, where the nuclease creates a double-stranded break at each target site, resulting in deletion of the region between the target sites, and non-homologous end-joining repair mechanisms joins the flanking regions. Suitable methods known in the art (e.g., PCR, DNA hybridization (Southern) blots, sequencing) are used to identify plants comprising a complete deletion.


REFERENCES



  • X. Chen, L. Levine and P.-Y. Kwok (1999). Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res. 9:492-498.

  • S. Cheng, C. Fockler, W. M. Barnes and R. Higuchi (1994). Effective amplification of long targets from cloned int Proc. Natl. Acad. Sci. USA 91:5695-5699.

  • F. B. Dean, S. Hosono, L. Fang, X. Wu, A. F. Faruqi, P. Bray-Ward, Z. Sun, Q. Zong, Y. Du, J. Du, M. Driscoll, W. Song, S. F. Kingsmore, M. Egholm and R. S. Lasken (2002). Proc. Natl. Acad Sci. USA 99:5261-5266.

  • A. Fire and S. Q. Xu (1995). Rolling replication of short DNA circles. Proc. Natl. Acad Sci. USA 92:4641-4645.

  • L. Gao, D. B. T. Cox, W. X. Yan, J. C. Manteiga, M. W. Schneider, T. Yamano, H. Nishimasu, O. Nureki, N. Crosetto and F. Zhang (2017). Engineered Cpf1 variants with altered PAM specificities. Nature Biotechnology 35(8):789-792.

  • J. C. Guatelli, K. M. Whitefield, D. Y. Kwon, K. J. Barringer, D. D. Richman and T. R. Gingeras (1990). Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. Proc. Natl. Acad. Sci. USA 87:1874-1878.

  • I. M. Heap (2021). International Survey of Herbicide Resistant Weeds. http://www.weedscience.org/Home.aspx.

  • S. Khan, A. Latif, S. Q, Ahmad, F. Ahmad and M. Ghaffar (2010). Double haploid technique: in soybean and other species. International Journal of Applied Agricultural Research 5:649-655.

  • D. Liu, S. L. Daubendiek, M. Zillman, K. Ryan and E. T. Kool (1996). Rolling circle DNA synthesis: small circular oligonucleotides as efficient templates for DNA polymerases. J. Am. Chem. Soc. 118:1587-1594.

  • P. M. Lizardi, X. Huang, Z. Zhu, P. Bray-Ward, D. C. Thomas and D. C. Ward (1998). Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nature Genetics 19:225-232.

  • T. T. Nikiforov, R. B. Rendie, P. Goelet, Y.-H. Rogers, M. L. Kotewicz, S. Anderson, G. L. Trainor and M. R. Knapp (1994). Genetic bit analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res. 22:4167-4175.

  • T. Notomi, H. Okayama, H. Masubuchi, T. Yonekawa, K. Watanabe, N. Amino, T. Hase (2000). Loop-mediated isothermal amplification of DNA”. Nucleic Acids Res. 28 (12): 63e-63.

  • M. D. Pearson, L. Nguyen, Y. Zhao, W. L. McKenna, T. J. Morin and W. B. Dunbar (2019). Past and accurate quantification of insertion-site specific transgene levels from raw seed samples using solid-state nanopore technology. PloS One 14(12):e0226719.

  • D. Shoup, S. Duncan and IA. Ciampitti (2016). Soybean Production Handbook. Kansas State University Agricultural Experiment Station and Cooperative Extension Service.

  • J. Schmutz, S. B. Cannon, J. Schlueter, J. Ma, T. Mitros, W. Nelson, D. L. Hyten, Q. Song, J. J. Thelen, J. Cheng, D. Xu, U. Hellsten, G. D. May, Y. Yu, T. Sakurai, T. Umezawa, M. K. Bhattacharyya, D. Sandhu, B. Valliyodan, E. Lindquist, M. Peto, D. Grant, S. Shu, D. Goodstein, K. Barry, M. Futrell-Griggs, B. Abernathy, J. Du, Z. Tian, L. Zhu, N. Gill, T. Joshi, M. Libault, A. Sethuraman, X.-C. Zhang, K. Shinozaki, H. T. Nguyen, R. A. Wing, P. Cregan, J. Specht, J. Grimwood, D. Rokhsar, G. Stacey, R. D. Shoemaker and S. A. Jackson (2010). Genome sequence of the palaeopolyploid soybean. Nature 463:178-183.

  • A. D. Taylor, L. Mataseje, C. J. Urfano, L. Schmidt, K. S. Antonation, M. R. Mulvey and C. R. Corbett (2018). Ecaluation of Oxford Nanopore's MinION Sequencing Device for Microbial Whole Genome Sequencing Applications. Scientific Reports 8:10931.

  • S. Tyagi and F. R. Kramer (1996). Molecular beacons: probes that fluoresce upon hybridization. Nature Biotechnology 14:303-308.

  • A. Verkest, S. Bourout, J. Debaveye, K. Reynaert, B. Saey, I. Van den Brande and K. D'Halluin (2019). Impact of differential DNA methylation on transgene expression in cotton (Gossypium hirsutum L.) events generated by targeted sequence insertion. Plant Biotechnology J. 17:1236-1247.

  • M. Vincent, Y. Xu and H. Kong (2004). Helicase-dependent isothermal DNA amplification. EMBO Reports 5(8):795-800.

  • Y. Wan, J. F. Petolino and J. M. Widholm (1989). Efficient Production of Doubled Haploid Plants Through Colchicine Treatment of Anther-Derived Maize Callus. Theor. Appl. Genet. 77:889-892.

  • C. Wang, K. C. Glenn, C. Kessenich, E. Bell, L. A. Burzio, M. S. Koch, B. Li and A. Silvanovich (2016). Safety assessment of dicamba mono-oxygenases that confer dicamba tolerance to various crops. Regulatory Toxicology and Pharmacology 81:171-182.

  • Y. Wang, Y. Zhao, A. Bollas, Y. Wang and K. F. Au (2021). Nanopore sequencing technology, bioinformatics and applications. Nature Biotechnology 39:1348-1365.

  • M. Winge (2000). Pyrosequencing-a new approach to DNA analysis. Innovation in Pharma. Tech. 00:18-24.

  • B. Zetsche, J. S. Gootenberg, O. O. Abudayyeh, I. M. Slaymaker, K. S. Makarova, P. Essletzbichler, S. E. Volz, J. Joung, J. v.d. Oost, A. Regev, E. V. Koonin and F. Zhang (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 163(3):759-771.


Claims
  • 1. A recombinant DNA molecule comprising a nucleotide sequence selected from the group consisting of SEQ ID NO:10, SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, a polynucleotide having a nucleotide sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO:10 or the full length of SEQ ID NO: 9, and a complete complement of any of the foregoing.
  • 2. The recombinant DNA molecule of claim 1, wherein the recombinant DNA molecule: a) is derived from a soybean plant, seed, plant part, plant cell, progeny plant, or commodity product comprising soybean event Gm_CSM63714, a representative sample of seed comprising the event having been deposited as ATCC Accession No. PTA-127099;b) is comprised in a soybean plant, seed, plant part, plant cell, or progeny plant comprising soybean event Gm_CSM63714, or a commodity product produced therefrom, a representative sample of seed comprising the event having been deposited as ATCC Accession No. PTA-127099;c) is formed by the insertion of a heterologous nucleic acid molecule into the genomic DNA of a soybean plant or soybean cell; ord) comprises an amplicon diagnostic for the presence of soybean event Gm_CSM63714.
  • 3.-5. (canceled)
  • 6. A DNA molecule comprising a polynucleotide segment of sufficient length to function as a DNA probe: a) that hybridizes specifically under stringent hybridization conditions with soybean event Gm_CSM63714 DNA in a sample, wherein detecting hybridization of the DNA molecule under the stringent hybridization conditions is diagnostic for the presence of soybean event Gm_CSM63714 in the sample; orb) specific for detecting in a sample at least one of: i) a 5′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714;ii) a 3′ junction sequence between the transgenic insert of soybean event Gm_CSM63714 and flanking soybean genomic DNA;iii) SEQ ID NO:9; oriv) a fragment of SEQ ID NO:9 comprising a sufficient length of contiguous nucleotides of SEQ ID NO:9 to identify the sequence as a fragment of the transgenic insert of Gm_CSM63714.
  • 7. (canceled)
  • 8. The DNA molecule of claim 6, wherein; a) the DNA probe comprises SEQ ID NO:16;b) the DNA molecule comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and a complement of any of the foregoing; orc) the sample is derived from a soybean plant, seed, plant part, plant cell, progeny plant, or commodity product.
  • 9.-10. (canceled)
  • 11. A pair of DNA molecules comprising a first DNA molecule and a second DNA molecule, wherein the first and the second DNA molecules comprise a fragment of SEQ ID NO:10 or a complement thereof and function as DNA primers when used together in an amplification reaction with DNA comprising soybean event Gm_CSM63714 to produce an amplicon diagnostic for soybean event Gm_CSM63714 in a sample.
  • 12. The pair of DNA molecules of claim 11, wherein; a) the first and the second DNA molecules comprise SEQ ID NO:14 and SEQ ID NO:15; orb) the amplicon comprises a nucleotide sequence selected from the group consisting of: SEQ ID NO:1;SEQ ID NO:2;SEQ ID NO:3;SEQ ID NO:4;SEQ ID NO:5;SEQ ID NO:6;SEQ ID NO:7;SEQ ID NO:8;SEQ ID NO:9;SEQ ID NO:10; anda fragment of any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, wherein the fragment is at least 10 nucleotides in length and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10.
  • 13. (canceled)
  • 14. A method of detecting the presence of soybean event Gm_CSM63714 in a sample derived from a soybean seed, plant, plant part, plant cell, progeny plant, or commodity product, the method comprising: a) contacting the sample with the DNA molecule that functions as a DNA probe of claim 6; subjecting the sample and the DNA molecule that functions as a probe to stringent hybridization conditions; anddetecting the hybridization of the DNA molecule that functions as a probe to a DNA molecule in the sample,wherein the hybridization of the DNA molecule that functions as a probe to the DNA molecule in the sample is diagnostic for the presence of soybean event Gm_CSM63714 in the sample;b) contacting the sample with the pair of DNA molecules of claim 11; performing an amplification reaction sufficient to produce a DNA amplicon; anddetecting the presence of the DNA amplicon;wherein the DNA amplicon comprises at least one of: a 5′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714,a 3′ junction sequence between flanking soybean genomic DNA and the transgenic insert of soybean event Gm_CSM63714,SEQ ID NO: 9, anda fragment of SEQ ID NO: 9 comprising a sufficient length of contiguous nucleotides of SEQ ID NO: 9 to identify the sequence as a fragment of the transgenic insert of Gm_CSM63714; andwherein the presence of the DNA amplicon indicates the presence of soybean event Gm_CSM63714 in the sample;c) contacting the sample with the DNA molecule of claim 6; and performing a sequencing reaction to produce a target sequence,wherein the target sequence comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, a complete complement of any thereof, and a fragment of any of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:10 that is at least 10 nucleotides long and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10; ord) contacting the sample with at least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714; and detecting binding of the antibody to the protein in the sample,wherein the binding of the antibody indicates the presence of soybean event Gm_CSM63714 in the sample.
  • 15. (canceled)
  • 16. The method of claim 14, wherein: a) the DNA amplicon is at least 10 nucleotides in length, at least 11 nucleotides in length, at least 12 nucleotides in length, at least 13 nucleotides in length, at least 14 nucleotides in length, at least 15 nucleotides in length, at least 16 nucleotides in length, at least 17 nucleotides in length, at least 18 nucleotides in length, at least 19 nucleotides in length, at least 20 nucleotides in length, at least 25 nucleotides in length, at least 30 nucleotides in length, at least 35 nucleotides in length, at least 40 nucleotides in length, at least 45 nucleotides in length, at least 50 nucleotides in length, at least 60 nucleotides in length, at least 70 nucleotides in length, at least 80 nucleotides in length, at least 90 nucleotides in length, or at least 100 nucleotides in length; orb) the DNA amplicon comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:10; SEQ ID NO:9; SEQ ID NO:8; SEQ ID NO:7; SEQ ID NO:6; SEQ ID NO:5; SEQ ID NO:4; SEQ ID NO:3; SEQ ID NO:2; SEQ ID NO:1; and a fragment of any of SEQ ID NO:10, SEQ ID NO:8, SEQ ID NO:7, SEQ ID NO:6, SEQ ID NO:5, SEQ ID NO:4, SEQ ID NO:3, SEQ ID NO:2, and SEQ ID NO:1 that is at least 10 nucleotides in length and comprises nucleotides 1,000-1,001 or 11,196-11,197 of SEQ ID NO:10.
  • 17.-19. (canceled)
  • 20. A detection kit for detecting the presence of soybean event Gm_CSM63714 in a sample, wherein the kit comprises: a) the pair of DNA primers of claim 11;b) the DNA molecule that functions as a probe of claim 6; orc) at least one antibody specific for at least one protein encoded by soybean event Gm_CSM63714; wherein detecting binding of the at least one antibody to the at least one protein encoded by soybean event Gm_CSM63714 in a sample is diagnostic for the presence of soybean event Gm_CSM63714 in the sample.
  • 21. (canceled)
  • 22. A soybean plant, plant seed, plant part, or plant cell comprising; a) the recombinant DNA molecule of claim 1; orb) soybean event Gm_CSM63714, a representative sample of seed comprising soybean event Gm_CSM63714 having been deposited under ATCC Accession No. PTA-127099.
  • 23. The soybean plant, plant seed, plant part, or plant cell of claim 22, wherein: a) the plant, plant seed, plant part, or plant cell expresses at least one herbicide tolerance gene selected from the group consisting of dicamba monooxygenase (DMO), phosphinothricin N-acetyltransferase (PAT), alpha-ketoglutarate-dependent non-heme iron dioxygenase variant FT_Tv7, triketone dioxygenase (TDO), and any combination thereof;b) the plant, plant seed, plant part, or plant cell is tolerant to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and combinations of any thereof;c) the plant, plant seed, plant part, or plant cell further comprises an additional transgene for tolerance to at least one additional herbicide;d) the plant, plant seed, plant part, or plant cell is further defined as a progeny plant of any generation of a soybean plant comprising soybean event Gm_CSM63714, or a soybean plant part, plant seed, or plant cell derived therefrom; and/ore) the plant part comprises a microspore, pollen, an anther, an ovule, an ovary, a flower, a pod, an embryo, a stem, a leaf, a root, or a callus.
  • 24.-27. (canceled)
  • 28. The soybean plant, plant seed, plant part, or plant cell of claim 22, wherein the at least one additional herbicide is glyphosate and/or wherein the additional transgene comprises a polynucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO:57.
  • 29.-33. (canceled)
  • 34. A method for controlling or preventing weed growth in an area, the method comprising planting soybean comprising event Gm_CSM63714 in the area and applying an effective amount of at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof, to control weeds in the area without injury to the soybean or with less than about 10% injury to the soybean.
  • 35. The method of claim 34, wherein; a) applying the effective amount of at least one herbicide comprises applying at least two or more herbicides selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof over a growing season;b) the β-triketone HPPD inhibitor is selected from the group consisting of mesotrione, benzobicyclon (BBC), tembotrione, sulcotrione, tefuryltrione, and any combination thereof; orc) the effective amount of dicamba is about 0.5 lb/acre to about 2 lb/acre over a growing season; the effective amount of glufosinate is about 0.4 lb/acre to about 1.6 lb/acre over a growing season; the effective amount of 2,4-D is about 0.5 lb/acre to about 4 lb/acre over a growing season; and/or the β-triketone HPPD inhibitor comprises mesotrione and the effective amount of mesotrione is about 0.09 lb/acre to about 0.36 lb/acre over a growing season.
  • 36.-37. (canceled)
  • 38. A method for controlling volunteer soybean comprising soybean event Gm_CSM63714 in an area, the method comprising applying an herbicidally effective amount of at least one herbicide other than dicamba, glufosinate, 2,4-D, or a β-triketone HPPD inhibitor, wherein the herbicide application prevents growth of soybean comprising soybean event Gm_CSM63714.
  • 39.-40. (canceled)
  • 41. A method of obtaining a seed of a soybean plant or a soybean plant that is tolerant to benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, or any combination thereof, the method comprising: a) obtaining a population of progeny seed or plants grown therefrom, at least one of which comprises soybean event Gm_CSM63714; andb) identifying at least a first progeny seed or plant grown therefrom that comprises soybean event Gm_CSM63714.
  • 42.-45. (canceled)
  • 46. A method of determining the zygosity of a soybean plant, plant part, plant seed, or plant cell comprising soybean event Gm_CSM63714, the method comprising: a) contacting a sample comprising DNA derived from the soybean plant, plant part, plant seed, or plant cell with a primer set capable of producing a first amplicon diagnostic for the presence of soybean event Gm_CSM63714 and a second amplicon diagnostic for the wild-type soybean genomic DNA not comprising soybean event Gm_CSM63714; performing a nucleic acid amplification reaction; anddetecting the first amplicon and the second amplicon, wherein the presence of both amplicons indicates that the plant, plant part, seed or cell is heterozygous for soybean event Gm_CSM63714, and the presence of only the first amplicon indicates that the plant, plant part, seed, or cell is homozygous for soybean event Gm_CSM63714; orb) contacting a sample comprising DNA derived from the soybean plant, plant part, plant seed, or plant cell with a probe set comprising at least a first probe that specifically hybridizes to soybean event Gm_CSM63714, and at least a second probe that specifically hybridizes to soybean genomic DNA that was disrupted by insertion of the heterologous DNA of soybean event Gm_CSM63714 but does not hybridize to soybean event Gm_CSM63714; and hybridizing the probe set with the sample under stringent hybridization conditions, wherein detecting hybridization of only the first probe under the hybridization conditions is diagnostic for a soybean plant, plant part, seed or plant cell homozygous for soybean event Gm_CSM63714, and wherein detecting hybridization of both the first probe and the second probe under the hybridization conditions is diagnostic for a soybean plant, plant part, seed, or plant cell heterozygous for soybean event Gm_CSM63714.
  • 47.-49. (canceled)
  • 50. A DNA construct comprising: a) a first expression cassette, a second expression cassette, a third expression cassette and a fourth expression cassette, wherein: the first expression cassette comprises in operable linkage i) ubiquitin (UB3) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) a chloroplast transit peptide coding sequence of APG6 (Albino and Pale Green 6) from Arabidopsis thaliana, iii) a codon-optimized dicamba monooxygenase coding sequence (DMO) from Stenotrophomonas maltophilia, and iv) a 3′ UTR sequence of the aluminum-induced Sali3-2 protein from Medicago truncatula; the second expression cassette comprises in operable linkage i) a promoter and an intron sequence derived from multiple promoter and intron sequences from Arabidopsis thaliana, ii) a codon-optimized phosphinothricin N-acetyltransferase (PAT) coding sequence from Streptomyces viridochromogene, and iii) a 3′ UTR of a small heat shock protein (Hsp20) from Medicago truncatula; the third expression cassette comprises in operable linkage i) polyubiquitin (UBQ10) promoter, leader, and intron sequences from Arabidopsis thaliana, ii) an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7) from Sphingobium herbicidovorans, and iii) a 3′ UTR sequence of a putative protein from Medicago truncatula, andthe fourth expression cassette comprises in operable linkage i) promoter, leader, and intron sequences derived from multiple promoter, leader and intron sequences from Arabidopsis thaliana, ii) a codon-optimized coding sequence of the triketone dioxygenase (TDO) from Oryza sativa, and iii) a 3′ UTR sequence derived from multiple 3′ UTR sequences from Zea mays; b) a first expression cassette, a second expression cassette, a third expression cassette and a fourth expression cassette, wherein: the first expression cassette comprises a dicamba monooxygenase coding sequence; the second expression cassette comprises a phospinothricin N-acetyltransferase (PAT) coding sequence;the third expression cassette comprises an alpha-ketoglutarate-dependent non-heme iron dioxygenase variant coding sequence (FT_Tv7) capable of degrading 2,4-D; and the fourth expression cassette comprises a triketone dioxygenase (TDO) coding sequence; and wherein the DNA construct further comprises at the 5′ or 3′ end of said construct (i) at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO:98; or (ii) at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO:99; orc) a polynucleotide having a sequence that is at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.1%, at least 99.2%, at least 99.3%, at least 99.4%, at least 99.5%, at least 99.6%, at least 99.7%, at least 99.8%, or at least 99.9% identical to the full length of SEQ ID NO: 9; and wherein the DNA construct comprises at the 5′ or 3′ end of said construct (i) at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO:98; or (ii) at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO:99.
  • 51. The DNA construct of claim 50: wherein a) the DNA construct comprises SEQ ID NO:9;b) the DNA construct further comprises at the 5′ or 3′ end of said construct: i) at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO:98; or ii) at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO:99;c) the DNA construct comprises at least 50 contiguous nucleotides of SEQ ID NO: 11 or SEQ ID NO:98 at the 5′ end of the construct and at least 50 contiguous nucleotides of SEQ ID NO: 12 or SEQ ID NO:99 at the 3′ end of the construct;d) the construct comprises at the 5′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:58-77 and SEQ ID NOs:100-139; ore) the construct comprises at the 3′ end of said construct one or more nucleotide sequences selected from SEQ ID NOs:78-97 and SEQ ID NOs:140-179.
  • 52. A method of improving tolerance to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, inhibitors of glutamine synthetase, β-triketone HPPD inhibitors, and any combination thereof in a soybean plant comprising: a) inserting the DNA construct of claim 50 or 51 into the genome of a soybean cell;b) generating a soybean plant from the soybean cell; andc) selecting a soybean plant comprising the DNA construct.
  • 53.-54. (canceled)
  • 55. A soybean plant, plant seed, plant part, or plant cell: a) tolerant to herbicides with at least three different herbicide modes of action at a single genomic location; orb) tolerant to at least one herbicide selected from the group consisting of benzoic acid auxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and any combination thereof, wherein the soybean plant, plant seed, plant part, or plant cell comprises the DNA construct of claim 50.
  • 56.-65. (canceled)
  • 66. A commodity product comprising; a) the recombinant DNA molecule of claim 1; orb) the DNA construct of claim 50.
  • 67.-69. (canceled)
  • 70. A method of controlling, preventing, or reducing the development of herbicide-tolerant weeds comprising: a) cultivating in a crop growing environment a soybean plant comprising transgenes that provide tolerance to herbicides with at least three different herbicide modes of action at a single genomic location; orb) cultivating in a crop growing environment a soybean plant comprising the DNA construct of claim 50 or 51 for providing tolerance to herbicides with at least three different herbicide modes of action at a single genomic location; and applying to the crop growing environment at least one herbicide selected from the group consisting of dicamba, glufosinate, 2,4-D, a β-triketone HPPD inhibitor, and any combination thereof, wherein the soybean plant is tolerant to the at least one herbicide.
  • 71.-75. (canceled)
  • 76. A method of reducing loci for soybean breeding by inserting transgenes at a single genomic location for tolerance to at least three different classes of herbicides.
  • 77.-85. (canceled)
  • 86. A soybean plant, plant cell, plant part, or plant seed comprising a recombinant DNA construct integrated in chromosome 13, wherein the recombinant DNA construct confers tolerance to at least one herbicide selected from the group consisting of benzoic acidauxins, phenoxy auxins, glutamine synthetase inhibitors, β-triketone HPPD inhibitors, and combinations of any thereof, and wherein the recombinant DNA construct is integrated in a position of said chromosome flanked by at least 50 contiguous nucleotides of SEQ ID NO:11 or SEQ ID NO:98 and 50 contiguous nucleotides of SEQ ID NO:12 or SEQ ID NO:99.
  • 87.-89. (canceled)
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 63/335,470, filed Apr. 27, 2022, herein incorporated by reference in its entirety.

Provisional Applications (1)
Number Date Country
63335470 Apr 2022 US